
<html lang="en"     class="pb-page"  data-request-id="e5372355-8870-4d9d-b7e5-6629d300f184"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm201346g;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2012.55.issue-3;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Ligand-Based Design of a Potent and Selective Inhibitor of Cytochrome P450 2C19" /></meta><meta name="dc.Creator" content="Robert S.  Foti" /></meta><meta name="dc.Creator" content="Dan A.  Rock" /></meta><meta name="dc.Creator" content="Xiaogang  Han" /></meta><meta name="dc.Creator" content="Robert A.  Flowers, II" /></meta><meta name="dc.Creator" content="Larry C.  Wienkers" /></meta><meta name="dc.Creator" content="Jan L.  Wahlstrom" /></meta><meta name="dc.Description" content="A series of omeprazole-based analogues was synthesized and assessed for inhibitory activity against CYP2C19. The data was used to build a CYP2C19 inhibition pharmacophore model for the series. The ..." /></meta><meta name="Description" content="A series of omeprazole-based analogues was synthesized and assessed for inhibitory activity against CYP2C19. The data was used to build a CYP2C19 inhibition pharmacophore model for the series. The ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 31, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201346g" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201346g" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201346g" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201346g" /></link>
        
    
    

<title>Ligand-Based Design of a Potent and Selective Inhibitor of Cytochrome P450 2C19 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201346g" /></meta><meta property="og:title" content="Ligand-Based Design of a Potent and Selective Inhibitor of Cytochrome P450 2C19" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0004.jpeg" /></meta><meta property="og:description" content="A series of omeprazole-based analogues was synthesized and assessed for inhibitory activity against CYP2C19. The data was used to build a CYP2C19 inhibition pharmacophore model for the series. The model was employed to design additional analogues with inhibitory potency against CYP2C19. Upon identifying inhibitors of CYP2C19, ligand-based design shifted to attenuating the rapid clearance observed for many of the inhibitors. While most analogues underwent metabolism on their aliphatic side chain, metabolite identification indicated that for analogues such as compound 30 which contain a heterocycle adjacent to the sulfur moiety, metabolism primarily occurred on the benzimidazole moiety. Compound 30 exhibited improved metabolic stability (Clint = 12.4 mL/min/nmol) and was selective in regard to inhibition of CYP2C19-catalyzed (S)-mephenytoin hydroxylation in human liver microsomes. Finally, representative compounds were docked into a homology model of CYP2C19 in an effort to understand the enzyme–ligand interactions that may lead to favorable inhibition or metabolism properties." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201346g"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201346g">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201346g&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201346g&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201346g&amp;href=/doi/10.1021/jm201346g" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1205-1214</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2013453" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201362h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Ligand-Based Design of a Potent and Selective Inhibitor of Cytochrome P450 2C19</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+S.++Foti">Robert S. Foti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan+A.++Rock">Dan A. Rock</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaogang++Han">Xiaogang Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+A.++Flowers%2C++II">Robert A. Flowers, II</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Larry+C.++Wienkers">Larry C. Wienkers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan+L.++Wahlstrom">Jan L. Wahlstrom</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Pharmacokinetics and Drug Metabolism, Amgen Inc., Seattle, Washington 98119, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Pharmacokinetics and Drug Metabolism Biomarkers, Pfizer, Inc., Groton, Connecticut 06340, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Chemistry, Lehigh University, Bethlehem, Pennsylvania 18015, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 206-265-7423. E-mail: <a href="/cdn-cgi/l/email-protection#c9a3a8a7be89a8a4aeaca7e7aaa6a4"><span class="__cf_email__" data-cfemail="e88289869fa889858f8d86c68b8785">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201346g&amp;href=/doi/10.1021%2Fjm201346g" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1205–1214</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 12, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 October 2011</li><li><span class="item_label"><b>Published</b> online</span>31 January 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 February 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201346g" title="DOI URL">https://doi.org/10.1021/jm201346g</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1205%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobert%2BS.%2BFoti%252C%2BDan%2BA.%2BRock%252C%2BXiaogang%2BHan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D3%26contentID%3Djm201346g%26title%3DLigand-Based%2BDesign%2Bof%2Ba%2BPotent%2Band%2BSelective%2BInhibitor%2Bof%2BCytochrome%2BP450%2B2C19%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1214%26publicationDate%3DFebruary%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201346g"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1674</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201346g" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Ligand-Based Design of a Potent and Selective Inhibitor of Cytochrome P450 2C19&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;S. Foti&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;A. Rock&quot;},{&quot;first_name&quot;:&quot;Xiaogang&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;A. Flowers&quot;},{&quot;first_name&quot;:&quot;Larry&quot;,&quot;last_name&quot;:&quot;C. Wienkers&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;L. Wahlstrom&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;1205-1214&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201346g&quot;},&quot;abstract&quot;:&quot;A series of omeprazole-based analogues was synthesized and assessed for inhibitory activity against CYP2C19. The data was used to build a CYP2C19 inhibition pharmacophore model for the series. The model was employed to design additional analogues with inhibitory potency against CYP2C19. Upon identifying inhibitors of CYP2C19, ligand-based design shifted to attenuating the rapid clearance observed for many of the inhibitors. While most analogues underwent metabolism on their aliphatic side chain, metabolite identification indicated that for analogues such as compound 30 which contain a heterocycle adjacent to the sulfur moiety, metabolism primarily occurred on the benzimidazole moiety. Compound 30 exhibited improved metabolic stability (Clint = 12.4 mL/min/nmol) and was selective in regard to inhibition of CYP2C19-catalyzed (S)-mephenytoin hydroxylation in human liver microsomes. Finally, representative compounds were docked into a homology model of CYP2C19 in an effort to understand the enzyme–ligand interact&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201346g&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201346g" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201346g&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201346g" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201346g&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201346g" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201346g&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201346g&amp;href=/doi/10.1021/jm201346g" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201346g" /></input><a href="/doi/pdf/10.1021/jm201346g" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201346g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201346g%26sid%3Dliteratum%253Aachs%26pmid%3D22239545%26genre%3Darticle%26aulast%3DFoti%26date%3D2012%26atitle%3DLigand-Based%2BDesign%2Bof%2Ba%2BPotent%2Band%2BSelective%2BInhibitor%2Bof%2BCytochrome%2BP450%2B2C19%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D3%26spage%3D1205%26epage%3D1214%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290663" title="Pharmacophores">Pharmacophores</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jmcmar.2012.55.issue-3/production/jmcmar.2012.55.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of omeprazole-based analogues was synthesized and assessed for inhibitory activity against CYP2C19. The data was used to build a CYP2C19 inhibition pharmacophore model for the series. The model was employed to design additional analogues with inhibitory potency against CYP2C19. Upon identifying inhibitors of CYP2C19, ligand-based design shifted to attenuating the rapid clearance observed for many of the inhibitors. While most analogues underwent metabolism on their aliphatic side chain, metabolite identification indicated that for analogues such as compound <b>30</b> which contain a heterocycle adjacent to the sulfur moiety, metabolism primarily occurred on the benzimidazole moiety. Compound <b>30</b> exhibited improved metabolic stability (Cl<sub>int</sub> = 12.4 mL/min/nmol) and was selective in regard to inhibition of CYP2C19-catalyzed (<i>S</i>)-mephenytoin hydroxylation in human liver microsomes. Finally, representative compounds were docked into a homology model of CYP2C19 in an effort to understand the enzyme–ligand interactions that may lead to favorable inhibition or metabolism properties.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The cytochromes P450 (P450) are a superfamily of heme-containing proteins that are capable of catalyzing the oxidative metabolism of a wide range of substrates. Common metabolic pathways that occur through P450 catalysis include hydroxylation, heteroatom oxidation or dealkylation, and aromatic oxidation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Nearly 60 human P450s have been identified, with the major isoforms involved in drug metabolism being CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4, and CYP3A5.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In addition to being involved in the metabolism of a wide array of drugs, P450 enzymes can also be the target of clinically relevant drug interactions or can form bioreactive metabolites that can have toxicological consequences.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Multiple examples exist within the literature describing the synthesis of potent and selective P450 inhibitors in order to invoke a pharmacological response or as diagnostic tools to assess the role of a given P450 isoform in a test compound’s metabolism or drug interaction potential. Recent medicinal chemistry efforts have identified potent and selective inhibitors of CYP1B1, CYP2A6, and CYP26 through a combination of traditional synthesis and computational tools.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a></div><div class="NLM_p">CYP2C19 is a polymorphic enzyme that is localized in the liver (approximately 5% of hepatic P450) and intestine (less than 3% of intestinal P450).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> The enzyme is inducible by rifampicin, phenobarbital, and dexamethasone.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> The typical reactions used to monitor CYP2C19 activity include (<i>S</i>)<i>-</i>mephenytoin 4′-hydroxylation, omeprazole 5-hydroxylation, and fluoxetine <i>O-</i>demethylation with the choice of substrate playing an important role in the observed CYP2C19 activities and drug interaction profiles.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Drugs that are metabolized in vivo by CYP2C19 include anticonvulsants such as phenytoin, psychotropic drugs such as imipramine and diazepam, and the proton pump inhibitors omeprazole, lansoprazole, and rabeprazole.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Proton pump inhibitors such as omeprazole block the release of gastric acid through inhibition of the H<sup>+</sup>/K<sup>+</sup>-ATPase pump in gastric parietal cells.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> They are widely used to treat gastresophageal reflux disease (GERD) and Zollinger–Ellison syndrome.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> The substituted benzimidazole sulfoxides are metabolized by a number of P450s, including CYP2C19, CYP3A4, and CYP2D6.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> The various proton pump inhibitors have gained attention from a drug metabolism standpoint because of their potential to cause drug interactions both in vitro and in vivo. In human liver microsomes, omeprazole and lansoprazole have <i>K</i><sub>i</sub> values of approximately 3 μM against CYP2C19.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In vivo, omeprazole has been shown to have drug interactions with diazepam<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> and phenprocoumon.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The combination of the CYP2C19 metabolism and inhibition profiles of proton pump inhibitors such as omeprazole makes the class of compounds a useful tool to study both the substrate selectivity and active site characteristics of CYP2C19.</div><div class="NLM_p">An inherent difficulty in optimizing the properties of P450 ligands is the simultaneous interplay of catalysis and inhibition. Unlike the development of a series of inhibitors against a therapeutic target where target potency and metabolic stability are assessed in discrete in vitro systems, compounds designed to inhibit a given P450 enzyme may be subject to metabolism by the same enzyme. In addition, the relationship between inhibition and metabolism may be series dependent. For example, a positive correlation between intrinsic clearance and inhibition potency has been noted for a series of quinoline-4-carboxamide compounds with CYP3A4, potentially due to their ability to type II bind to the here iron.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Conversely, for a series of HIV protease inhibitors, compounds with a lower intrinsic clearance were able to more potently inhibit CYP3A4.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Few examples exist of both catalytic and inhibitory models applied to the same set of compounds, most likely due to the complexities added by metabolism by multiple enzymes or at different sites on a molecule.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p last">The aim of this study was to design and synthesize a potent and selective inhibitor of CYP2C19 based on a series of omeprazole-based analogues. An initial set of 26 diverse structural omeprazole analogues was synthesized and assessed for inhibition of CYP2C19 (<i>K</i><sub>i</sub>). The data was subsequently used to populate pharmacophore-based models. Information gained from the pharmacophore models was used to direct the synthesis of additional analogues within the series. Upon identification of potent inhibitors of CYP2C19, the aim of the study shifted toward improving metabolic stability within the series. To this end, compounds were assessed for rates and sites of metabolism by CYP2C19. Both ligand- and active-site modeling were incorporated in order to more fully understand the chemical properties that confer both metabolism by and inhibition of CYP2C19. Finally, the interplay of metabolism and inhibition was examined in order to identify a highly potent and metabolically stable inhibitor of CYP2C19.<div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Omeprazole-Like Inhibitors of CYP2C19</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0006.gif" alt="" id="fx1" /></img><div></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53161" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53161" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Assessment of CYP2C19 Inhibition</h3><div class="NLM_p">A series of omeprazole analogues was synthesized as depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. The initial set of 26 omeprazole-based analogues was assessed for inhibition of CYP2C19-catalyzed 3-<i>O</i>-methylfluorescein metabolism. Prior to conducting the inhibition assay, a <i>K</i><sub>m</sub>was determined for the formation of fluorescein from 3-<i>O</i>-methylfluorescein in recombinant CYP2C19 (1.18 ± 0.06 μM) using reaction conditions that were previously determined to be linear with respect to time and protein concentration. IC<sub>50</sub> values were obtained for each compound and used to determine the range of inhibitor concentrations for the <i>K</i><sub>i</sub> assay. Following the 5 min incubation, <i>K</i><sub>i</sub> values ranged from 0.04 μM (compound <b>19</b>) to >50 μM (compound <b>11</b> and <b>20</b>; Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. General synthetic route for the omeprazole-based analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. LogD<sub>(pH=7.4)</sub>, <i>K</i><sub>i</sub>, and Intrinsic Clearance Values for Omeprazole-Based Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">LogD (pH = 7.4)</th><th class="colsep0 rowsep0" align="center" char=".">CYP2C19 <i>K</i><sub>i</sub><br /></br>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">CYP2C19 Cl<sub>int</sub><br /></br>(mL/min/nmol P450)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">2.92</td><td class="colsep0 rowsep0" align="char" char=".">42.5</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">3.45</td><td class="colsep0 rowsep0" align="char" char=".">4.79</td><td class="colsep0 rowsep0" align="char" char=".">2.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">3.98</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td><td class="colsep0 rowsep0" align="char" char=".">8.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">4.51</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">23.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">5.05</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">29.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">5.58</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">24.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">8.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">4.15</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="char" char=".">5.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">3.29</td><td class="colsep0 rowsep0" align="char" char=".">1.94</td><td class="colsep0 rowsep0" align="char" char=".">2.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">4.98</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">22.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">1.98</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char="."><0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">–0.34</td><td class="colsep0 rowsep0" align="char" char=".">40.8</td><td class="colsep0 rowsep0" align="char" char="."><0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">4.17</td><td class="colsep0 rowsep0" align="char" char=".">1.10</td><td class="colsep0 rowsep0" align="char" char="."><0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">4.63</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">24.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">5.51</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">20.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">5.86</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td><td class="colsep0 rowsep0" align="char" char=".">28.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">4.76</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">26.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">4.94</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">25.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">19.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">3.88</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">20.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">5.92</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">11.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">34.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">4.03</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char="."><0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">6.16</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">19.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">5.74</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">15.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">2.67</td><td class="colsep0 rowsep0" align="char" char=".">2.43</td><td class="colsep0 rowsep0" align="char" char=".">1.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">3.21</td><td class="colsep0 rowsep0" align="char" char=".">10.9</td><td class="colsep0 rowsep0" align="char" char=".">1.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">2.76</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">6.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">3.22</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">12.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">2.85</td><td class="colsep0 rowsep0" align="char" char=".">3.20</td><td class="colsep0 rowsep0" align="char" char=".">2.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">1.47</td><td class="colsep0 rowsep0" align="char" char=".">9.90</td><td class="colsep0 rowsep0" align="char" char="."><0.43</td></tr></tbody></table></div></div><div class="NLM_p">A feature-based pharmacophore model was generated using the inhibition data obtained from the <i>K</i><sub>i</sub> assay. The data was fit to a three, four, five, or six feature model. In all cases, the hydrophobic regions (H) of the compound set represented a key feature of the model. In addition to hydrophobicity, the aromatic rings (R) of the benzimidazole moiety were also taken into account (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). For the three feature (HHR) and four feature (HHRR) pharmacophore models, the best fit was obtained when using three partial-least squared factors. When generating the pharmacophore models with five (ADHHR) or six (DHHHRR) features, the hydrogen bond accepting (A) and hydrogen bond donating (D) characteristics of the benzimidazole nitrogens were taken into account. The best overall fit from the pharmacophore models was obtained from the five feature ADHHR model (<i>r</i><sup>2</sup> = 0.958, <i>q</i><sup>2</sup> = 0.607, RMSE = 0.603). The features for this model corresponded to the hydrogen bond accepting (A) and donating (D) features of the benzimidazole nitrogens, the hydrophobicity of the side chains off of the sulfur atom (H), the side chain off of the benzimidazole moiety (H), and the aromaticity of the benzimidazole rings (R).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CYP2C19 inhibition pharmacophore model for the omeprazole-based analogues. The features for this five-feature model corresponded to the hydrogen bond accepting (blue) and donating (pink) features of the benzimidazole nitrogens, the hydrophobicity of the side chains off of the sulfur atom and the benzimidazole moiety (green), and the aromaticity of the benzimidazole rings (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Following pharmacophore analysis, the series of omeprazole analogues was expanded to include a pyridine moiety linked to the mercapto-benzimidazole group at the R2 position with varying side-chains at R1. Upon synthesis of the heterocycle-containing compounds (compounds <b>27</b>–<b>32</b>), an increase in the observed potency was noted (compound <b>30</b>, <i>K</i><sub>i</sub> = 0.02 μM).</div><div class="NLM_p">To assess the selectivity of the omeprazole-based analogues for CYP2C19, inhibition assays were repeated in human liver microsomes with selective probe substrates. Similar inhibition parameters (<i>r</i><sup>2</sup> = 0.86) were observed for compounds that were active in both the recombinant system utilizing 3-<i>O</i>-methylfluorescein as the probe substrate or human liver microsomes which utilized (<i>S</i>)-mephenytoin as the probe substrate. Two of the most potent CYP2C19 inhibitors, compounds <b>15</b> and <b>30</b>, were 37- and 66-fold selective, respectively, for CYP2C19 in human liver microsomes as compared to the next most potently inhibited P450 isoform (CYP1A2 for both compounds). In general, inhibitor selectivity for CYP2C19 decreased as less potent CYP2C19 inhibitors were evaluated (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> and Intrinsic Clearance Values for Omeprazole-Based Analogues in Human Liver Microsomes</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center">IC<sub>50</sub>, μM (HLM)</th><th class="rowsep1 colsep0" colspan="2" align="center">HLM</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">selectivity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">1A2</th><th class="colsep0 rowsep0" align="center" char=".">2B6</th><th class="colsep0 rowsep0" align="center" char=".">2C8</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">2C19</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">2E1</th><th class="colsep0 rowsep0" align="center" char=".">3A4mdz</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub>, app</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">2.34</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">6.97</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">4.93</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="center">14.0</td><td class="colsep0 rowsep0" align="center">493.6</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.93</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">3.12</td><td class="colsep0 rowsep0" align="char" char=".">35.8</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">1.94</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">27.1</td><td class="colsep0 rowsep0" align="center">9.6</td><td class="colsep0 rowsep0" align="center">724.1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.71</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">33.7</td><td class="colsep0 rowsep0" align="char" char=".">39.9</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">2.63</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="center">8.4</td><td class="colsep0 rowsep0" align="center">823.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">0.44</td><td class="colsep0 rowsep0" align="char" char=".">10.5</td><td class="colsep0 rowsep0" align="char" char=".">9.64</td><td class="colsep0 rowsep0" align="char" char=".">9.18</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">19.4</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">26.3</td><td class="colsep0 rowsep0" align="center">3.7</td><td class="colsep0 rowsep0" align="center">1852.9</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" align="char" char=".">15.4</td><td class="colsep0 rowsep0" align="char" char=".">2.42</td><td class="colsep0 rowsep0" align="char" char=".">2.92</td><td class="colsep0 rowsep0" align="char" char=".">6.25</td><td class="colsep0 rowsep0" align="char" char=".">2.61</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">5.33</td><td class="colsep0 rowsep0" align="center">3.8</td><td class="colsep0 rowsep0" align="center">1843.1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="char" char=".">14.8</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">4.57</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">5.33</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">15.7</td><td class="colsep0 rowsep0" align="center">2.6</td><td class="colsep0 rowsep0" align="center">2665.4</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="left">CYP1A2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">1.02</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">31.9</td><td class="colsep0 rowsep0" align="char" char=".">32.7</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">11.6</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="center">10.7</td><td class="colsep0 rowsep0" align="center">650.1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">49.9</td><td class="colsep0 rowsep0" align="char" char=".">16.6</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">21.2</td><td class="colsep0 rowsep0" align="char" char=".">14.1</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="center">59.3</td><td class="colsep0 rowsep0" align="center">116.9</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">CYP2B6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">22.1</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">29.4</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">16.4</td><td class="colsep0 rowsep0" align="center">12.9</td><td class="colsep0 rowsep0" align="center">538.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">2.67</td><td class="colsep0 rowsep0" align="char" char=".">21.4</td><td class="colsep0 rowsep0" align="char" char=".">5.11</td><td class="colsep0 rowsep0" align="char" char=".">4.41</td><td class="colsep0 rowsep0" align="char" char=".">5.91</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">6.23</td><td class="colsep0 rowsep0" align="center">9.3</td><td class="colsep0 rowsep0" align="center">744.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">8.08</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">5.65</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">4.17</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">5.49</td><td class="colsep0 rowsep0" align="center">37.4</td><td class="colsep0 rowsep0" align="center">185.3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="char" char=".">28.8</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50.0 ></td><td class="colsep0 rowsep0" align="center">120</td><td class="colsep0 rowsep0" align="center"><57.8</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">9.73</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.08 ></td><td class="colsep0 rowsep0" align="center">120</td><td class="colsep0 rowsep0" align="center"><57.8</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">1.39</td><td class="colsep0 rowsep0" align="char" char=".">17.7</td><td class="colsep0 rowsep0" align="char" char=".">3.32</td><td class="colsep0 rowsep0" align="char" char=".">6.73</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">4.28</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">8.86</td><td class="colsep0 rowsep0" align="center">6.1</td><td class="colsep0 rowsep0" align="center">1141.7</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">1.48</td><td class="colsep0 rowsep0" align="char" char=".">14.4</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">3.42</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">2.05</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">8.34</td><td class="colsep0 rowsep0" align="center">5.8</td><td class="colsep0 rowsep0" align="center">1194.8</td><td class="colsep0 rowsep0" align="char" char=".">37.0</td><td class="colsep0 rowsep0" align="left">CYP1A2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">0.97</td><td class="colsep0 rowsep0" align="char" char=".">2.54</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">1.36</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">12.3</td><td class="colsep0 rowsep0" align="center">16.5</td><td class="colsep0 rowsep0" align="center">420.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">1.44</td><td class="colsep0 rowsep0" align="char" char=".">5.98</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">1.23</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">4.86</td><td class="colsep0 rowsep0" align="center">4.4</td><td class="colsep0 rowsep0" align="center">1560.8</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td><td class="colsep0 rowsep0" align="char" char=".">1.87</td><td class="colsep0 rowsep0" align="char" char=".">3.25</td><td class="colsep0 rowsep0" align="char" char=".">0.78</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">4.23</td><td class="colsep0 rowsep0" align="center">4.2</td><td class="colsep0 rowsep0" align="center">1669.9</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">1.81</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">3.87</td><td class="colsep0 rowsep0" align="char" char=".">5.15</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">4.91</td><td class="colsep0 rowsep0" align="center">85.7</td><td class="colsep0 rowsep0" align="center">80.9</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="left">CYP2D6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="center">8.06</td><td class="colsep0 rowsep0" align="center">859.8</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">10.69</td><td class="colsep0 rowsep0" align="char" char=".">19.9</td><td class="colsep0 rowsep0" align="char" char=".">3.35</td><td class="colsep0 rowsep0" align="char" char=".">2.32</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">9.12</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="center">12.8</td><td class="colsep0 rowsep0" align="center">543.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">0.67</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">1.87</td><td class="colsep0 rowsep0" align="center">1.8</td><td class="colsep0 rowsep0" align="center">3893.3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">1.34</td><td class="colsep0 rowsep0" align="char" char=".">12.6</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">2.27</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">2.73</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">3.11</td><td class="colsep0 rowsep0" align="center">11.4</td><td class="colsep0 rowsep0" align="center">608.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.73</td><td class="colsep0 rowsep0" align="char" char=".">15.5</td><td class="colsep0 rowsep0" align="char" char=".">3.49</td><td class="colsep0 rowsep0" align="char" char=".">6.18</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">10.5</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">2.81</td><td class="colsep0 rowsep0" align="center">4.92</td><td class="colsep0 rowsep0" align="center">1408.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">0.63</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.96</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">2.49</td><td class="colsep0 rowsep0" align="center">5.12</td><td class="colsep0 rowsep0" align="center">1353.5</td><td class="colsep0 rowsep0" align="char" char=".">9.0</td><td class="colsep0 rowsep0" align="left">CYP1A2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">0.68</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">3.56</td><td class="colsep0 rowsep0" align="center">16.3</td><td class="colsep0 rowsep0" align="center">424.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">8.56</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.55</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">13.15</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">4.01</td><td class="colsep0 rowsep0" align="center">26.53</td><td class="colsep0 rowsep0" align="center">261.2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="char" char=".">9.9</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">24.2</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="center">20.2</td><td class="colsep0 rowsep0" align="center">343.1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">12.94</td><td class="colsep0 rowsep0" align="char" char=".">24.0</td><td class="colsep0 rowsep0" align="char" char=".">4.78</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">8.79</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">3.75 ></td><td class="colsep0 rowsep0" align="center">120</td><td class="colsep0 rowsep0" align="center"><57.8</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">3.29</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">3.61</td><td class="colsep0 rowsep0" align="center">31.3</td><td class="colsep0 rowsep0" align="center">221.4</td><td class="colsep0 rowsep0" align="char" char=".">65.8</td><td class="colsep0 rowsep0" align="left">CYP1A2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="char" char=".">21.8</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">22.3</td><td class="colsep0 rowsep0" align="char" char=".">28.5</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">10.7</td><td class="colsep0 rowsep0" align="center">16.1</td><td class="colsep0 rowsep0" align="center">430.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char=".">0.99</td><td class="colsep0 rowsep0" align="char" char=".">6.97</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">2.17</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="center">11.95</td><td class="colsep0 rowsep0" align="center">579.9</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Assessment of CYP2C19 Metabolism</h3><div class="NLM_p">Intrinsic clearance of each of the analogues was determined in both recombinant CYP2C19 and human liver microsomes. In general, the longer chain aliphatic analogues and substituted phenyl analogues were cleared the most rapidly (Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Hydroxyl and carboxylic acid analogues demonstrated the greatest degree of stability in both systems. Heterocyclic analogues were moderately stable in both systems (rCYP2C19 Cl<sub>int</sub>, 0.43–12.3 mL/min/nmol; HLM Cl<sub>int</sub>, 57.8–579.9 μL/min/mg).</div><div class="NLM_p">A feature-based pharmacophore model was also generated using the intrinsic clearance values for the series of compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). For the intrinsic clearance pharmacophore model, a minimum of five features (AADHR) with three partial least squared factors predicted intrinsic clearance values within an acceptable range (<i>r</i><sup>2</sup> = 0.857; <i>q</i><sup>2</sup> = 0.603; RMSE = 0.378). Both <i>r</i><sup>2</sup> and <i>q</i><sup>2</sup> values decreased significantly when the model was generated using only one or two partial least squared factors. For the metabolism pharmacophore model, the five features corresponded to the hydrogen bond accepting properties of one of the benzimidazole nitrogens (A) as well as the oxygen atom of the benzimidazole methoxy moiety (A), the hydrogen bond donating properties of the second benzimidazole nitrogen (D), the hydrophobicity of the side chains off of the sulfur atom (H), and the aromaticity of the benzimidazole rings (R).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CYP2C19 metabolism pharmacophore model for the omeprazole-based analogues. The five features for the metabolism pharmacophore model corresponded to the hydrogen bond accepting properties of a benzimidazole nitrogen and the oxygen atom of the benzimidazole methoxy moiety (pink), the hydrogen bond donating properties of the second benzimidazole nitrogen (blue), the hydrophobicity of the side chains off of the sulfur atom (green), and the aromaticity of the benzimidazole rings (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Correlation of CYP2C19 Inhibitory Potency and Metabolic Stability With Physicochemical Properties</h3><div class="NLM_p">Physical properties for each of the 32 analogues were calculated using ChemDraw Ultra 9.0 (CambridgeSoft, Cambridge, MA) or a proprietary data analysis prediction software package. Inhibition potency values showed the best correlation with hydrophobic descriptors such as LogD<sub>7.4</sub>. Plotting inhibition and intrinsic clearance values versus LogD<sub>7.4</sub> gave <i>r</i><sup>2</sup> values of 0.78 and 0.64, respectively. The most potent inhibition values were observed for compounds with a LogD<sub>7.4</sub> greater than 4. In general, the most potent inhibitors were also the most rapidly cleared in recombinant CYP2C19 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Plotting <i>K</i><sub>i</sub> values determined in rCYP2C19 against intrinsic clearance values in the same system resulted in an <i>r</i><sup>2</sup> value of 0.87.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Three-dimensional correlation between inhibition potency (<i>K</i><sub>i</sub>), intrinsic clearance (Cl<sub>int</sub>), and LogD<sub>7.4</sub>. Calculated <i>r</i><sup>2</sup> values were 0.78 (<i>K</i><sub>i</sub> versus LogD<sub>7.4</sub>), 0.64 (Cl<sub>int</sub> versus LogD<sub>7.4</sub>), and 0.87 (<i>K</i><sub>i</sub> versus Cl<sub>int</sub>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Metabolite Identification</h3><div class="NLM_p">To determine the primary sites of metabolism for the omeprazole-based series, qualitative metabolite identification experiments were conducted on representative aliphatic/phenyl and heterocycle compounds. For the compounds that had an aliphatic side chain or phenyl moiety, the primary site of metabolism was on the hydrophobic side chain adjacent to the sulfur of the 2-mercapto-5-methoxybenzimidazole core structure. For compounds <b>3</b>, <b>5</b>, and <b>6</b>, monohydroxylation on the alkyl chain was the major route of metabolism (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Fragmentation patterns from product ion scans indicated an increase of 16 amu to each of the alkyl chains, although the fragmentation was not specific enough to assign the hydroxyl group to a specific carbon on the chain. Synthesis of metabolite standards further indicated that metabolism was primarily occurring at the ω-1 carbon of the alkyl chain (data not shown). The primary metabolites of compound <b>7</b> (isopropyl) and compound <b>8</b> (<i>t</i>-butyl) were determined to be hydroxylation of one of the terminal carbons of the alkyl chain. Compounds <b>10</b> (cyclohexyl), <b>14</b> (<i>p</i>-tolyl), and <b>15</b> (<i>p</i>-cumyl) all showed a monohydroxylation on the respective cyclic ring as the major metabolite in recombinant CYP2C19. As with the alkyl side chains, the mass spectral fragmentation patterns did not allow for the specific site of metabolism on the cyclohexyl or aromatic rings to be elucidated. Minor routes of metabolism included hydroxylation of the benzimidazole moiety and <i>O</i>-demethylation at the 5-methoxy position.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Identification of the primary sites of metabolism for this series of compounds. Compounds with a methoxy group at the 5-position of the benzimidazole ring and an aliphatic chain off of the sulfur were oxidatively metabolized at the ω-1 carbon of the aliphatic side chain, while compounds lacking the methoxy group and containing a heterocyclic ring off of the sulfur atom were primarily metabolized on the substituent at the 5-position of the benzimidazole ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">When heterocyclic pyridine analogues attached to either a 2-mercapto-5-methoxybenzimidazole or 2-mercapto-5-methylbenzimidazole core were assessed for metabolite formation in recombinant CYP2C19, the major routes of metabolism were observed to be a combination of hydroxylation on the benzimidazole moiety and <i>O</i>-demethylation (compound <b>27</b>) or hydroxylation on the 5-methyl substituent of the benzimidazole core (compound <b>30</b>). Only minimal amounts of sulfoxide or sulfone formation were observed for any of the compounds noted above.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> CYP2C19 Active Site Docking</h3><div class="NLM_p">To evaluate the active site docking poses for CYP2C19 ligand interactions, a homology model of CYP2C19 was built and compounds <b>6</b> and <b>30</b> docked in the active site. Compound <b>6</b> docked in the active site of CYP2C19 with the heptyl side chain oriented toward the heme. The ω-1 carbon was located approximately 3.11 Å from the heme iron. Compound <b>30</b> docked in the opposite orientation, with the 5-methyl substituent of the benzimidazole core oriented toward the heme at a distance of 3.07 Å. The pyridine nitrogen of compound <b>30</b> occupied a similar space in the active site of CYP2C19 as the 5-methoxy moiety of compound <b>6</b>. In addition, both compounds were located within 2.00 Å of the CYP2C19 active site residues Val113, Val208, Glu300, Leu366, and Ala477. Additional interactions (within 3.00 Å) included Phe114, Ile205, Ser209, Thr301, Thr304, Ile362, Phe476, and Val479 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Active-site docking of compounds <b>6</b> (green) and <b>30</b> (orange) into a homology model of CYP2C19 (I-helix shown in red). Primary sites of metabolism were located approximately 3 Å from the heme iron, with the 5-methoxy group of compound <b>6</b> and the pyridine nitrogen of compound <b>30</b> occupying a similar space in the active site within approximately 2 Å of Ala477.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83283" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83283" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Computational modeling of P450–ligand interactions has gained an increased amount of attention in recent years. Within this area of research, CYP2C19 has been the focus of a number of computational models aimed at predicting metabolism, structure–activity relationships, and the drug interaction potential for a given series of compounds. Examples include a series of benzbromarone-based analogues that was used to assess the effects of substrate charge and functional groups on affinity and metabolism,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> the use of a GRID/CPCA (consensus principal component analysis) approach to compare the selectivity of CYP2C19 to CYP2C8, CYP2C9, and CYP2C18,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and a homology model/active site docking study to evaluate the metabolism of the sulfonylurea compound gliclazide.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">The most potent CYP2C19 inhibitors identified to date include (+)-<i>N-</i>3-benzylnirvanol, (−)-<i>N</i>-3-benzylphenobarbital, and 3,5″-dimethyl-4″-hydroxybenzbromarone, with <i>K</i><sub>i</sub> values ranging from 33 nM for the benzbromarone analogue to 250 nM for (+)-<i>N-</i>3-benzylnirvanol.<a onclick="showRef(event, 'ref26 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref29">(26, 29)</a> Thus, the primary aim of this study was achieved in that the current set of compounds equals or surpasses these known inhibitors with respect to inhibitory potency against CYP2C19, with 14 of 32 compounds having <i>K</i><sub>i</sub> values equal to or less than 100 nM. Compound <b>30</b>, the 2-mercapto-5-methylbenzimidazole pyridine analogue, was the most potent compound synthesized, with a <i>K</i><sub>i</sub> value of 20 nM. While the range of inhibition values for the omeprazole-based analogues is comparable to what has been observed for the benzylnirvanol, benzylphenobarbital, and benzbromarone data sets, a striking difference between the compounds is the metabolic lability of the omeprazole-based compounds as compared to the other chemotypes.</div><div class="NLM_p">While a significant amount of attention has been placed on using reaction conditions that avoid the depletion of the probe substrate in enzyme activity assays,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> the stability of the test compound being assessed for inhibition is often neglected, except under conditions where inhibitory metabolites are suspected. For example, <i>N-</i>desmethyldiltiazem and <i>N</i>,<i>N-</i>didesmethyldiltiazem are both more potent inhibitors of CYP3A4 than diltiazem.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Conversely, <i>O-</i>desmethyldiltiazem was shown to have no inhibitory potential against CYP3A4. The compounds in this data set appear to be rapidly converted by CYP2C19 to metabolites with a decreased inhibitory affinity for the enzyme. This was observed by a decrease in the observed <i>K</i><sub>i</sub> values when enzyme activity was evaluated after a 5 min coincubation of probe substrate and inhibitor as compared to a 20 min coincubation (data not shown). In addition, compounds such as <b>11</b>, <b>12</b>, and <b>20</b> that contained either hydroxyl or carboxylic acid moieties showed no inhibitory potential against CYP2C19, suggesting a detrimental effect of polar groups on the affinity of the compounds for CYP2C19 and corroborating the importance of the hydrophobicity incorporated into both pharmacophore models. In light of this finding, it is quite likely that the hydroxylated metabolites of this series of analogues also have a decreased inhibitory potential for CYP2C19. Thus, for those compounds which were rapidly metabolized, calculating a <i>K</i><sub>i</sub> in human liver microsomes on a time scale consistent with the ability to measure an adequate amount of (<i>S</i>)-mephenytoin hydroxylation may be difficult, as the actual concentration of inhibitor in the incubation will be much less than the original concentration added. Furthermore, if the actual amount of inhibitor is depleted to a point where it is equal to or less than the concentration of enzyme in the incubation, a percentage of the inhibitor will exist in equilibrium as the enzyme–inhibitor complex. The resulting deviation from starting conditions can result in an incorrect assessment of the inhibitor’s potency.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> A similar underestimation of the observed <i>K</i><sub>i</sub> or <i>K</i><sub>d</sub> has been reported for assays carried out using small volumes with an excess amount of enzyme.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In the previous case, however, the depletion of inhibitory ligand was caused by binding to a receptor that is in excess compared to the ligand.</div><div class="NLM_p">When the metabolism and inhibition data were probed for physicochemical trends, the greatest correlation for both sets was versus the LogD<sub>7.4</sub> values for the compound set. Other descriptors of lipophilicity that showed a good correlation with the metabolism and inhibition values were cLogP, LogD<sub>4.0</sub>, LogD<sub>6.5</sub> as well as the number of hydrogen bond donors. It has been previously reported that lipophilicity is an important factor in determining the potency of a set of CYP2C19 inhibitors.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> More specifically, the lipophilic properties at the N-3 position of a series of phenytoin, nirvanol, or phenobarbital analogues were shown to drive the inhibitory potency of the compounds against both CYP2C9 and CYP2C19.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">To explore the structure–activity relationships for a given set of compounds, pharmacophore and docking/homology modeling are often utilized. The premise behind pharmacophore modeling is the superimposition of structural analogues with structural features including hydrogen bond acceptors or donors and π-stacking aromatic groups that may interact with the enzyme active site. Pharmacophore models can then be more fully incorporated as a useful descriptor in quantitative structure–activity modeling.<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36-38)</a> While less prevalent than inhibition modeling, recent attempts have also been made to model the metabolic clearance of compounds by P450 enzymes.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The development of both inhibition and metabolism pharmacophore models was achieved for the current set of compounds. We have successfully developed both an inhibition (<i>r</i><sup>2</sup> = 0.958) as well as a metabolism pharmacophore model (<i>r</i><sup>2</sup> = 0.857) for the omeprazole-based series of compounds. As would be expected from the correlation of our data with lipophilic properties, both models took into account the aromaticity of the benzimidazole rings as well as multiple hydrophobic binding interactions. Interestingly, the metabolism model appeared to be more dependent on the hydrogen bond donating and accepting properties of the compounds than the inhibition model was, possibly indicating more rigid criteria for a compound to be a substrate of CYP2C19 as compared to an inhibitor of CYP2C19. In addition, substitution off of the sulfur atom appeared to affect both the metabolism and inhibition properties of the compounds in a manner more amenable to structure–activity relationships, whereas substitution at the 5-position of the benzimidazole moiety appeared to exert more influence on the observed site of metabolism.</div><div class="NLM_p last">As P450 crystal structures become more readily available, the use of docking and homology modeling has also increased and been used to predict and explore select enzyme–ligand interactions.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44">(40-44)</a> As the crystal structure of CYP2C19 has not been solved yet, a homology model based on the CYP2C9 crystal structure was used for active site docking studies. Two compounds were docked into the active site of CYP2C19, compounds <b>6</b> and <b>30</b>, as representatives of analogues containing an aliphatic moiety or heterocycle off of the sulfur linker. Consistent with the observed primary sites of metabolism on each molecule, the ω-1 position of compound <b>6</b> and the 5-methyl group of compound <b>30</b> were nearly superimposed approximately 3 Å from the heme iron. As both the physicochemical properties and the pharmacophore models indicated the importance of lipophilicity in predicting both the metabolism and inhibition for these compounds, it is not surprising that the closest amino acid residues to both compounds all have the potential for hydrophobic interactions. The 5-methoxy moiety of compound <b>6</b> and the pyridine nitrogen of compound <b>30</b>, which also occupied similar positions in the active site of CYP2C19, were both located within 2 Å of Ala477, indicating a potentially important role of hydrogen binding interactions with this residue in the positioning of these analogues in a catalytically favorable position within the active site of CYP2C19. Previous studies have also implicated Phe114, Ile362, and Leu 366 in the binding of hydrophobic molecules within the CYP2C19 active site.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42163" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42163" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a highly potent set of CYP2C19 inhibitors that are also metabolized by CYP2C19 have been synthesized and used for pharmacophore and homology modeling studies with CYP2C19. Compound <b>30</b> represents the most potent CYP2C19 inhibitor currently reported in the literature. Assessing the metabolism of the compound set indicates that the primary site of metabolism is on the hydrophobic side chain off of the sulfur atom for those compounds with an aliphatic or phenyl group off of the sulfur linker and on the benzimidazole portion of the molecule for those compounds with a heterocycle adjacent to the sulfur linker. Finally, the data points to the dynamic interplay of binding affinity and metabolic stability in properly defining a <i>K</i><sub>i</sub> value for enzyme inhibitors that may also be metabolized by the same enzyme that they inhibit.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37508" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37508" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Materials</h3><div class="NLM_p last">Recombinant CYP2C19 Supersomes and 3-<i>O</i>-methylfluorescein were purchased from Becton Dickinson (San Jose, CA). NADPH was obtained from EMD Chemicals (Gibbstown, NJ). Fluorescein, magnesium sulfate, and all fine chemicals were purchased from Sigma-Aldrich (St. Louis, MO). All solvents were from J. T. Baker (Phillipsburg, NJ). Deuterated DMSO was purchased from Cambridge Isotope Laboratories (Andover, MA).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis</h3><div class="NLM_p last">The appropriate mercapto-benzimidazole analogue (unsubstituted, methoxy, ethoxy, amino, methyl, or difluoromethoxy; 1.1 equiv) was dissolved in 15 mL of methanol with 3 mL of 2N sodium hydroxide and heated to 70 °C (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Upon complete dissolution, 1 equiv of a bromo- or chloro-alkylating agent was added to the reaction and stirred at 70 °C for 12 h, at which point the reactions were checked for completion using thin layer chromatography and subsequently evaporated to dryness under a stream of nitrogen. Reactions were reconstituted in 2.5% aqueous sodium hydroxide and extracted twice with methylene chloride. The organic layers were combined, dried over magnesium sulfate, and evaporated to dryness prior to LC-MS/MS and NMR characterization. Preparative thin layer chromatography was carried out as warranted to ensure the purity of the final products (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). All final products were ≥95% pure as determined by HPLC/UV/mass spectrometry.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> NMR Analysis</h3><div class="NLM_p">Compounds were characterized using a 500 MHz Varian NMR spectrometer (Varian, Palo Alto, CA) using DMSO-<i>d</i><sub>6</sub> as the solvent. Additional confirmation was obtained using electrospray ionization mass spectrometry (ESI-MS) on a ThermoFisher LTQ ion trap mass spectrometer (ThermoFisher Scientific, Waltham, MA).</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Compound <b>1</b> (115.4 mg, 47.4% yield)</h4><div class="NLM_p last">δ 1.34 (t, <i>J</i> = 7.8, 3H), 3.23 (q, <i>J</i> = 5.8, 2H), 3.76 (s, 3H), 6.73 (d, <i>J</i> = 9.8, 1H), 6.97 (d, <i>J</i> = 7.8, 1H), 7.30 (dd, <i>J</i> = 5.8, 7.8, 1H), 12.34 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 209.0615; calculated for C<sub>10</sub>H<sub>12</sub>N<sub>2</sub>OS, 209.0670.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Compound <b>2</b> (207.5 mg, 70.5% yield)</h4><div class="NLM_p last">δ 0.99 (t, <i>J</i> = 7.8, 3H), 1.70 (t, <i>J</i> = 7.8, 2H), 3.20 (m, <i>J</i> = 7.8, 2H) 3.76 (s, 3H), 6.72 (d, <i>J</i> = 7.8, 1H), 6.96 (d, <i>J</i> = 7.8, 1H), 7.31 (dd, <i>J</i> = 5.8, 7.8, 1H), 12.34 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 223.0800; calculated for C<sub>11</sub>H<sub>14</sub>N<sub>2</sub>OS, 223.0827.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Compound <b>3</b> (184.1 mg, 70.4% yield)</h4><div class="NLM_p last">δ 0.90 (t, <i>J</i> = 7.8, 3H), 1.42 (m, <i>J</i> = 7.8, 2H), 1.67 (m, <i>J</i> = 7.8, 2H), 3.23 (t, <i>J</i> = 5.8, 2H), 3.76 (s, <i>3</i>H), 6.72 (d, <i>J</i> = 7.8, 1H), 6.96 (d, <i>J</i> = 7.8, 1H), 7.32 (dd, <i>J</i> = 5.8, 7.8, 1H), 12.34 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 237.0984; calculated for C<sub>12</sub>H<sub>16</sub>N<sub>2</sub>OS, 237.0983.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Compound <b>4</b> (255.7 mg, 77.2% yield)</h4><div class="NLM_p last">δ 0.86 (t, <i>J</i> = 7.8, 3H), 1.31 (m, <i>J</i> = 7.8, 2H), 1.38 (m, <i>J</i> = 7.8, 2H), 1.68 (m, <i>J</i> = 7.8, 2H), 3.22 (t, <i>J</i> = 7.8, 2H), 3.76 (s, 3H), 6.72 (d, <i>J</i> = 5.8, 1H), 6.94 (s, 1H), 7.30 (d, <i>J</i> = 9.8, 1H), 12.34 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 251.1196; calculated for C<sub>13</sub>H<sub>18</sub>N<sub>2</sub>OS, 251.1140.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Compound <b>5</b> (259.8 mg, 78.3% yield)</h4><div class="NLM_p last">δ 0.86 (t, <i>J</i> = 7.3, 3H), 1.27 (m, <i>J</i> = 4.9, 4H), 1.40 (m, <i>J</i> = 7.3, 2H), 1.67 (m, <i>J</i> = 7.3, 2H), 3.22 (t, <i>J</i> = 7.3, 2H), 3.76 (s, 3H), 6.73 (d, <i>J</i> = 7.3, 1H), 6.94 (s, 1H), 7.30 (d, <i>J</i> = 9.8, 1H), 12.34 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 265.1283; calculated for C<sub>14</sub>H<sub>20</sub>N<sub>2</sub>OS, 265.1296.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Compound <b>6</b> (221.7 mg, 79.1% yield)</h4><div class="NLM_p last">δ 0.85 (m, <i>J</i> = 12.2, 3H), 1.25 (m, <i>J</i> = 12.2, 7H), 1.39 (m, <i>J</i> = 7.3, 2H), 1.68 (m, <i>J</i> = 7.3, 2H), 3.22 (t, <i>J</i> = 7.3, 2H), 3.75 (s, 3H), 6.72 (d, <i>J</i> = 7.3, 1H), 6.94 (s, 1H), 7.31 (d, <i>J</i> = 7.3, 1H), 12.34 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 279.1466; calculated for C<sub>15</sub>H<sub>22</sub>N<sub>2</sub>OS, 279.1453.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Compound <b>7</b> (126.1 mg, 47.3% yield)</h4><div class="NLM_p last">δ 1.00 (d, <i>J</i> = 7.8, 6H), 1.93 (m, <i>J</i> = 5.8, 1H), 3.15 (d, <i>J</i> = 3.9, 2H), 3.76 (s, 3H), 6.73 (d, <i>J</i> = 7.8, 1H), 6.92 (d, <i>J</i> = 5.8, 1H), 7.30 (dd, <i>J</i> = 7.8, 5.8, 1H), 12.50 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 237.0911; calculated for C<sub>12</sub>H<sub>16</sub>N<sub>2</sub>OS, 237.0983.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Compound <b>8</b> (17.1 mg, 5.7% yield)</h4><div class="NLM_p last">δ 1.06 (s, 9H), 2.85 (s, 2H), 3.76 (s, 3H), 6.72 (d, <i>J</i> = 7.3, 1H), 6.94 (s, 1H), 7.31 (d, <i>J</i> = 7.3, 1H), 12.50 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 251.1127; calculated for C<sub>13</sub>H<sub>18</sub>N<sub>2</sub>OS, 251.1140.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Compound <b>9</b> (194.2 mg, 74.4% yield)</h4><div class="NLM_p last">δ 0.31 (t, <i>J</i> = 5.8, 2H), 0.53 (t, <i>J</i> = 7.8, 2H), 1.18 (m, <i>J</i> = 3.9, 1H), 3.51 (d, <i>J</i> = 5.8, 2H), 3.76 (s, 3H), 6.73 (d, <i>J</i> = 7.8, 1H), 6.92 (d, <i>J</i> = 7.8, 1H), 7.30 (dd, <i>J</i> = 7.8, 5.8, 1H), 12.50 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 235.0868; calculated for C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>OS, 235.0827.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Compound <b>10</b> (54.7 mg, 16.4% yield)</h4><div class="NLM_p last">δ 1.01 (m, <i>J</i> = 11.7, 4H), 1.15 (m, <i>J</i> = 11.7, 2H), 1.60 (d, <i>J</i> = 7.8, 4H), 1.67 (m, <i>J</i> = 11.7, 1H), 1.83 (d, <i>J</i> = 11.7, 2H), 3.75 (s, 3H), 6.72 (d, <i>J</i> = 9.8, 1H), 6.94 (s, 1H), 7.30 (d, <i>J</i> = 9.8, 1H), 12.33 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 277.1288; calculated for C<sub>15</sub>H<sub>20</sub>N<sub>2</sub>OS, 277.1296.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Compound <b>11</b> (28.0 mg, 8.8% yield)</h4><div class="NLM_p last">δ 1.03 (t, <i>J</i> = 5.8, 2H), 3.27 (m, <i>J</i> = 5.8, 2H), 3.51 (t, <i>J</i> = 5.8, 2H), 3.76 (s, 3H), 4.69 (t, <i>J</i> = 5.8, 1H), 6.72 (d, <i>J</i> = 9.8, 1H), 6.94 (s, 1H), 7.30 (d, <i>J</i> = 9.8, 1H), 12.33 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 239.0786; calculated for C<sub>11</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>S, 239.0776.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Compound <b>12</b> (32.1 mg, 10.2% yield)</h4><div class="NLM_p last">δ 1.03 (t, <i>J</i> = 5.86, 2H), 3.27 (m, <i>J</i> = 5.8, 2H), 3.51 (t, <i>J</i> = 5.8, 2H), 3.76 (s, 3H), 6.72 (d, <i>J</i> = 9.8, 1H), 6.94 (s, 1H), 7.30 (d, <i>J</i> = 9.8, 1H), 10.94 (s, 1H), 12.33 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 267.0824; calculated for C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub>S, 267.0725.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Compound <b>13</b> (115.2 mg, 55.3% yield)</h4><div class="NLM_p last">δ 3.76 (s, 3H), 4.19 (s, 2H), 6.93 (d, <i>J</i> = 7.8, 1H), 7.10 (d, <i>J</i> = 7.8, 2H), 7.20 (s, 1H), 7.30 (m, <i>J</i> = 7.1, 2H), 7.51 (d, <i>J</i> = 7.8, 1H), 7.80 (m, J=7.8, 1H), 12.33 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 271.0865; calculated for C<sub>15</sub>H<sub>14</sub>N<sub>2</sub>OS, 271.0827.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Compound <b>14</b> (291.7 mg, 85.3% yield)</h4><div class="NLM_p last">δ 2.25 (s, <i>3</i>H), 3.76 (s, 3H), 4.47 (s, 2H), 6.74 (d, <i>J</i> = 5.8, 1H), 6.96 (s, 1H), 7.11 (d, <i>J</i> = 7.8, 2H), 7.30 (m, <i>J</i> = 5.8, 3H), 12.34 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 285.0949; calculated for C<sub>16</sub>H<sub>16</sub>N<sub>2</sub>OS, 285.0983.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Compound <b>15</b> (340.8 mg, 85.8% yield)</h4><div class="NLM_p last">δ 1.19 (d, <i>J</i> = 5.8, 6H), 2.86 (m, <i>J</i> = 5.8, 1H), 3.76 (s, 3H), 4.19 (s, 2H), 6.72 (d, <i>J</i> = 9.8, 1H), 6.94 (s, 1H), 6.98 (m, <i>J</i> = 5.8, 2H), 7.19 (d, <i>J</i> = 5.8, 2H), 7.30 (d, <i>J</i> = 9.8, 1H), 12.33 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 313.1234; calculated for C<sub>18</sub>H<sub>20</sub>N<sub>2</sub>OS, 313.1296.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Compound <b>16</b> (275.6 mg, 64.1% yield)</h4><div class="NLM_p last">δ 1.33 (s, 9H), 3.76 (s, 3H), 4.19 (s, 2H), 6.72 (d, <i>J</i> = 9.8, 1H), 6.94 (s, 1H), 6.98 (m, <i>J</i> = 5.8, 2H), 7.19 (d, <i>J</i> = 5.8, 2H), 7.30 (d, <i>J</i> = 9.8, 1H), 12.33 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 327.1401; calculated for C<sub>19</sub>H<sub>22</sub>N<sub>2</sub>OS, 327.1453.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Compound <b>17</b> (156.3 mg, 42.9% yield)</h4><div class="NLM_p last">δ 3.76 (s, 3H), 4.51 (s, 2H), 6.76 (d, <i>J</i> = 5.8, 1H), 6.88 (m, <i>J</i> = 5.8, 1H), 7.10 (m, <i>J</i> = 5.8, 1H), 7.36 (d, <i>J</i> = 7.8, 2H), 7.45 (d, <i>J</i> = 9.8, 2H), 12.43 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 305.0476; calculated for C<sub>15</sub>H<sub>13</sub>ClN<sub>2</sub>OS, 305.0437.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Compound <b>18</b> (210.3 mg, 46.6% yield)</h4><div class="NLM_p last">δ 3.76 (s, 3H), 4.51 (s, 2H), 6.74 (d, <i>J</i> = 5.8, 1H), 6.86 (m, <i>J</i> = 5.8, 1H), 7.12 (m, <i>J</i> = 5.8, 1H), 7.38 (d, <i>J</i> = 7.8, 2H), 7.47 (d, <i>J</i> = 9.8, 2H), 12.34 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 349.0092; calculated for C<sub>15</sub>H<sub>13</sub>BrN<sub>2</sub>OS, 348.9932.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Compound <b>19</b> (365.9 mg, 78.5% yield)</h4><div class="NLM_p last">δ 3.76 (s, 3H), 4.47 (s, 2H), 6.65 (d, <i>J</i> = 11.7, 1H), 6.95 (m, <i>J</i> = 7.8, 1H), 7.23 (d, <i>J</i> = 7.8, 2H), 7.33 (m, <i>J</i> = 7.8, 1H), 7.66 (d, <i>J</i> = 7.8, 2H), 12.43 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 396.9782; calculated for C<sub>15</sub>H<sub>13</sub>IN<sub>2</sub>OS, 396.9793.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Compound <b>20</b> (36.4 mg, 12.5% yield)</h4><div class="NLM_p last">δ 3.87 (s, 3H), 4.19 (s, 2H), 6.65 (d, <i>J</i> = 11.7, 1H), 6.95 (m, <i>J</i> = 7.8, 1H), 7.23 (d, <i>J</i> = 7.8, 2H), 7.33 (m, <i>J</i> = 7.8, 1H), 7.66 (d, <i>J</i> = 7.8, 2H), 12.58 (s, 1H), 12.78 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 315.0752; calculated for C<sub>16</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub>S, 315.0725.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Compound <b>21</b> (230.7 mg, 59.5% yield)</h4><div class="NLM_p last">δ 3.63 (s, 6H), 3.76 (s, 3H), 4.19 (s, 2H), 6.13 (s, 2H), 6.18 (s, 1H) 6.72 (d, <i>J</i> = 9.8, 1H), 6.94 (s, 1H), 7.30 (d, <i>J</i> = 9.8, 1H), 12.34 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 331.0888; calculated for C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>S, 331.1038.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Compound <b>22</b> (296.2 mg, 70.8% yield)</h4><div class="NLM_p last">δ 3.75 (s, 3H), 4.45 (s, 2H), 6.73 (d, <i>J</i> = 5.8, 1H), 6.93 (m, <i>J</i> = 5.8, 1H), 7.25 (d, <i>J</i> = 5.8, 1H), 7.30 (m, <i>J</i> = 9.8, 1H), 7.37 (m, <i>J</i> = 5.8, 2H), 7.42 (m, <i>J</i> = 5.8, 2H), 7.46 (m, <i>J</i> = 5.8, 2H), 7.60 (d, <i>J</i> = 5.8, 1H), 12.36 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 347.0996; calculated for C<sub>21</sub>H<sub>18</sub>N<sub>2</sub>OS, 347.1140.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Compound <b>23</b> (194.1 mg, 57.0% yield)</h4><div class="NLM_p last">δ 3.76 (s, 3H), 4.50 (s, 2H), 6.94 (d, <i>J</i> = 7.8, 1H), 7.12 (s, 1H), 7.18 (d, 1H), 7.55 (m, <i>J</i> = 7.8, 6H), 8.02 (d, <i>J</i> = 5.8, 1H), 12.33 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 321.0957; calculated for C<sub>19</sub>H<sub>16</sub>N<sub>2</sub>OS, 321.0983.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Compound <b>24</b> (175.4 mg, 67.2% yield)</h4><div class="NLM_p last">δ 3.76 (s, 3H), 4.56 (s, 2H), 6.72 (d, <i>J</i> = 9.8, 1H), 6.94 (s, 1H), 7.30 (m, <i>J</i> = 9.8, 2H), 7.54 (t, <i>J</i> = 7.8, 1H), 7.73 (t, <i>J</i> = 7.8, 1H), 7.94 (m, <i>J</i> = 5.8, 2H), 8.02 (d, <i>J</i> = 5.8, 1H), 12.33 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 322.1072; calculated for C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>OS, 322.0936.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Compound <b>25</b> (428.6 mg, 91.0% yield)</h4><div class="NLM_p last">δ 3.76 (s, 3H), 4.50 (d, <i>J</i> = 11.7, 2H), 6.74 (d, <i>J</i> = 5.8, 1H), 6.87 (d, <i>J</i> = 7.8, 1H), 6.95 (d, <i>J</i> = 7.8, 2H), 7.07 (d, <i>J</i> = 9.8, 1H), 7.12 (t, <i>J</i> = 7.7, 1H), 7.19 (d, <i>J</i> = 5.8, 1H), 7.23 (d, <i>J</i> = 7.8, 1H), 7.31 (m, <i>J</i> = 7.8, 1H), 7.38 (d, <i>J</i> = 7.8, 3H), 12.34 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 363.1063; calculated for C<sub>21</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>S, 363.1089.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Compound <b>26</b> (403.1 mg, 80.5% yield)</h4><div class="NLM_p last">δ 3.76 (s, 3H), 4.29 (s, 2H), 5.14 (s, 2H), 6.65 (d, <i>J</i> = 7.8, 2H), 6.87 (d, <i>J</i> = 7.8, 2H), 6.72 (d, <i>J</i> = 9.8, 1H), 6.94 (s, 1H), 7.30 (d, <i>J</i> = 9.8, 1H), 7.37 (t, <i>J</i> = 7.8, 1H), 7.41 (t, <i>J</i> = 5.8, 2H), 7.48 (d, <i>J</i> = 5.8, 2H), 12.43 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 376.9986; calculated for C<sub>22</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>S, 377.1245.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Compound <b>27</b> (114.2 mg, 57.6% yield)</h4><div class="NLM_p last">δ 3.76 (s, 3H), 4.51 (s, 2H), 6.93 (d, <i>J</i> = 7.8, 1H), 7.12 (s, 1H), 7.15 (t, <i>J</i> = 7.8, 1H), 7.30 (d, <i>J</i> = 9.8, 1H), 7.56 (d, <i>J</i> = 7.8, 1H), 7.74 (t, <i>J</i> = 7.8, 1H), 8.67 (d, <i>J</i> = 7.8, 1H), 12.43 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 272.0748; calculated for C<sub>14</sub>H<sub>13</sub>N<sub>3</sub>OS, 272.0779.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Compound <b>28</b> (132.2 mg, 64.2% yield)</h4><div class="NLM_p last">δ 1.33 (t, <i>J</i> = 7.8, 3H), 4.01 (m, <i>J</i> = 7.8, 2H), 4.63 (d, <i>J</i> = 11.7, 2H), 6.74 (t, <i>J</i> = 7.8, 1H), 6.87 (s, 1H), 7.27 (m, <i>J</i> = 3.8, 1H), 7.39 (d, <i>J</i> = 7.8, 1H), 7.51 (t, <i>J</i> = 7.8, 1H), 7.78 (t, <i>J</i> = 7.8, 1H), 8.51 (d, <i>J</i> = 3.9, 1H), 12.47 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 286.0978; calculated for C<sub>15</sub>H<sub>15</sub>N<sub>3</sub>OS, 286.0936.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Compound <b>29</b> (146.3 mg, 66.4% yield)</h4><div class="NLM_p last">δ 4.52 (s, 2H), 7.15 (t, <i>J</i> = 9.8, 1H), 7.21 (t, <i>J</i> = 7.8, 2H), 7.27 (d, <i>J</i> = 9.8, 1H), 7.45 (d, <i>J</i> = 7.8, 2H), 7.74 (t, <i>J</i> = 7.8, 1H), 8.67 (d, <i>J</i> = 7.8, 1H), 12.43 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 242.0643; calculated for C<sub>13</sub>H<sub>11</sub>N<sub>3</sub>S, 242.0674.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Compound <b>30</b> (283.9 mg, 86.7% yield)</h4><div class="NLM_p last">δ 2.38 (s, 3H), 4.65 (s, 2H), 6.91 (s, 1H), 6.96 (d, <i>J</i> = 8.8, 1H), 7.29 (m, <i>J</i> = 5.8, 2H), 7.51 (d, <i>J</i> = 8.8, 1H), 7.75 (t, <i>J</i> = 8.8, 1H), 8.52 (d, <i>J</i> = 5.8, 1H), 12.33 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 256.0803; calculated for C<sub>14</sub>H<sub>13</sub>N<sub>3</sub>S, 256.0830.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Compound <b>31</b> (292.3 mg, 74.4% yield)</h4><div class="NLM_p last">δ 4.67 (s, 2H), 6.97 (d, <i>J</i> = 9.8, 1H), 7.02 (s, 1H), 7.17 (s, 1H), 7.24 (t, <i>J</i> = 72.6, 1H), 7.30 (m, <i>J</i> = 3.9, 1H), 7.40 (d, <i>J</i> = 7.8, 1H), 7.53 (d, <i>J</i> = 7.8, 1H), 8.52 (d, <i>J</i> = 5.8, 1H), 12.33 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 308.0608; calculated for C<sub>14</sub>H<sub>11</sub>F<sub>2</sub>N<sub>3</sub>OS, 308.0591.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Compound <b>32</b> (75.6 mg, 32.5% yield)</h4><div class="NLM_p last">δ 4.52 (s, 2H), 5.85 (s, 2H), 6.72 (d, <i>J</i> = 9.8, 1H), 6.94 (s, 1H), 7.15 (t, <i>J</i> = 7.8, 1H), 7.27 (d, <i>J</i> = 7.8, 1H), 7.30 (d, <i>J</i> = 9.8, 1H), 7.74 (t, <i>J</i> = 7.8, 1H), 8.67 (d, <i>J</i> = 7.8, 1H), 12.43 (s, 1H). ESI-MS (M + H)<sup>+</sup> found, 257.0792; calculated for C<sub>13</sub>H<sub>12</sub>N<sub>4</sub>S, 257.0783.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> P450 Inhibition Assay</h3><div class="NLM_p">Inhibition of recombinant CYP2C19 microsomes was determined for each analogue using 3-<i>O</i>-methylfluorescein as a probe substrate. Initial experiments were performed to ensure reaction linearity with respect to protein and time. Each incubation (<i>n</i> = 2) consisted of 2 pmol recombinant protein in 100 mM potassium phosphate buffer (pH 7.4) containing 3 mM MgCl<sub>2</sub>. Following a 3 min preincubation period, reactions were initiated with the addition of 1 mM NADPH (final concentration). Organic solvent concentrations were the same for all incubations and did not exceed 0.5% (v/v). IC<sub>50</sub> values for each analogue were determined for CYP2C19 using a final test compound concentration range of 0–50 μM. 3-<i>O</i>-methylfluorescein was run at 1 μM (approximate <i>K</i><sub>m</sub>). All incubations were allowed to proceed at 37 °C for 5 min and quenched with 50 μL of 2N NaOH. Samples were vortex-mixed for 5 min prior to analysis.</div><div class="NLM_p">Once IC<sub>50</sub> values were estimated, a <i>K</i><sub>i</sub> was determined for each test compound against CYP2C19 catalyzed 3-<i>O</i>-methylfluorescein metabolism. <i>K</i><sub>i</sub> experiments were run under similar conditions as the IC<sub>50</sub> determination except that the probe substrate was run at 0.5, 1, 2, and 4 μM corresponding to concentrations equal to 0.5<i> K</i><sub>m</sub>, <i>K</i><sub>m</sub>, 2<i>K</i><sub>m</sub>, and 4<i>K</i><sub>m</sub>, respectively. Each test compound was run at 0IC<sub>50</sub>, 0.5IC<sub>50</sub>, IC<sub>50</sub>, 2IC<sub>50</sub>, and 4IC<sub>50</sub>. Incubations were allowed to proceed at 37 °C for 5 min and quenched with 50 μL of 2N NaOH. All <i>K</i><sub>i</sub> determinations were performed in duplicate.</div><div class="NLM_p">Sample analysis was performed on a Tecan Safire<sup>2</sup> microplate reader (Männedorf, Switzerland). Fluorescein formation was monitored using an excitation wavelength of 485 nm (10 nm bandwidth) and an emission wavelength of 530 nm (20 nm bandwidth). A manual gain of 40 (arbitrary units) was utilized with no lag time and an integration time of 40 μs. Each sample was read twice and the average response used in IC<sub>50</sub> and <i>K</i><sub>i</sub> calculations.</div><div class="NLM_p">To determine the selectivity of the omeprazole analogues versus other P450 isoforms, IC<sub>50</sub> determinations were carried out in human liver microsomes with P450-selective substrate probes. Briefly, 0.1 mg/mL human liver microsomes, 3 mM MgCl<sub>2</sub>, 100 mM potassium phosphate buffer (pH 7.4), and the P450-selective substrate probe at previously determined <i>K</i><sub>m</sub> value (CYP1A2, 85 μM phenacetin; CYP2B6, 75 μM bupropion; CYP2C8, 7 μM paclitaxel; CYP2C9, 17 μM diclofenac; CYP2C19, 10 μM (<i>S</i>)-mephenytoin; CYP2D6, 5 μM dextromethorphan; CYP2E1, 75 μM chlorzoxazone; CYP3A4, 2.5 μM midazolam) were combined with each omeprazole analogue (0–50 μM, final concentration) and preincubated for 5 min at 37 °C. Reactions were initiated via addition of 1 mM NADPH (final concentration) and quenched after 10 min (5 min for midazolam) with 2 volumes of ice cold acetonitrile containing 1 μM tolbutamide as an internal standard.</div><div class="NLM_p last">LC-MS/MS analysis for the inhibition assay was carried out using multiple reaction monitoring on an Applied Biosystems API 4000 Q-Trap (operated in triple quadrupole mode) equipped with an electrospray ionization source (Applied Biosystems, Foster City, CA). Prior to analysis, mass spectrometry parameters were optimized for each test compound. Global mass spectrometry settings included the curtain gas (40 arbitrary units), ion spray voltage (4700 V), source temperature (550 °C), and collision-assisted dissociation gas (set to medium). Chromatographic separation was achieved using a rapid gradient with a Gemini C18 30 mm × 2.0 mm (5 μm) column (Phenomenex, Torrace, CA) coupled to two LC-20AD pumps with an in-line CBM-20A controller and DGU-20A<sub>5</sub> solvent degasser (Shimadzu, Columbia, MD) and a LEAP CTC HTS PAL autosampler equipped with a dual-solvent self-washing system (CTC Analytics, Carrboro, NC).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Statistical Analysis</h3><div class="NLM_p last">Inhibition data (IC<sub>50</sub> and <i>K</i><sub>i</sub>) was calculated using Graphpad Prism (version 5.01; Graphpad Software Inc., San Diego, CA). For fluorescence assays, all parameters were calculated after first subtracting out background fluorescence from 3-<i>O</i>-methylfluorescein. Inhibition curves were fit to a standard four-site eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> to estimate an IC<sub>50</sub> value.<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/jm-2011-01346g_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span><i>K</i><sub>i</sub> estimates were determined using nonlinear regression analysis. The mechanism of inhibition and inhibitory model selection was determined through visual inspection of the Dixon ([<i>I</i>] vs 1/<i>v</i>) and Lineweaver–Burke (1/<i>S</i> vs 1/<i>v</i>) plots and through comparison of the Akaike information criteria. All data were subsequently fit to a competitive inhibition model (2), where [<i>S</i>] is the probe substrate concentration, <i>K</i><sub>m</sub> is equal to the probe substrate concentration at half-maximum reaction velocity, [<i>I</i>] is the test compound concentration in the incubation, and <i>K</i><sub>i</sub> is the dissociation constant for the enzyme–inhibitor complex. For <i>K</i><sub>i</sub> determinations, <i>K</i><sub>m</sub>, <i>K</i><sub>i</sub>, and <i>V</i><sub>max</sub> were treated as global parameters. Goodness of fit was determined using global <i>r</i><sup>2</sup> values.<span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/jm-2011-01346g_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Intrinsic Clearance Determination</h3><div class="NLM_p last">To support the generation of a pharmacophore model and assess the stability of the omeprazole analogues, intrinsic clearance determinations were carried out in recombinant CYP2C19 and human liver microsomes. Incubations in recombinant CYP2C19 included 2 pmol CYP2C19, 2 mM MgCl<sub>2</sub>, and 0.5 μM substrate in 100 mM potassium phosphate buffer (pH 7.4). Incubations were initiated with the addition of 1 mM NADPH (final concentration) and aliquots removed at 0, 2.5, 5, 10, 20, and 40 min. Reactions were quenched with 1 volume (v/v) of ice-cold acetonitrile containing 1 μM tolbutamide as an internal standard. Human liver microsomal clearance determinations were carried out in a similar fashion and contained 0.1 mg/mL human liver microsomes, 3 mM MgCl<sub>2</sub>, and 0.5 μM substrate in 100 mM potassium phosphate buffer (pH 7.4). LC-MS/MS analysis of the omeprazole analogues was performed using a similar instrumental protocol to that described for the CYP inhibition assays.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Pharmacophore Model Generation</h3><div class="NLM_p last">Ligands (compounds <b>1</b> through <b>26</b>) were prepared using LigPrep (Ligprep 2.0 (2006) Schrodinger, LLC, New York, NY), which attached hydrogen atoms and converted two-dimensional .sdf files to three-dimensional structures with proper stereocenters. The ligands were generated as a neutral series. Ligand conformations were submitted to a pre-energy minimization using the OPLS_2005 force field with a distance dependent dielectric model. A maximum of 200 initial conformers were examined. Minimized structures within 1 kcal energy and rmsd of 1 Å or less were eliminated. Each ligand was examined against the six default pharmacophore features: hydrogen bond acceptor (A), hydrogen bond donor (D), hydrophobic (H), negative charge (N), positive ionization (P), and aromatic ring (R). The pharmacophore model was generated using feature-based pharmacophore model. Four ligands were chosen as active ligands for the model. Active compounds were chosen based upon two criteria: (1) active compounds must reside within the top 15% with respect to inhibitor potency and (2) must contain some sense of structural diversity from one another. The number of pharmacophore features was varied from a minimum of three to a maximum of six features during the alignment process with a limit of three hydrophobic sites allowed. Common pharmacophores features were required to match at least 3 of the 4 active compounds. Upon the basis of the size of pharmacophore set, a maximum of three principal features were allowed. During pharmacophore hypothesis testing, 50% of ligands were randomly assigned to the training set, while the remainder was included as the test set. The remaining model criteria were set to PHASE default parameters.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Metabolite Identification in rCYP2C19</h3><div class="NLM_p last">To elucidate the sites of metabolism of the omeprazole analogues, metabolite identification studies were performed in recombinant CYP2C19. Briefly, incubations contained 20 pmol CYP2C19, 3 mM MgCl<sub>2</sub>, and 20 μM substrate in 100 mM potassium phosphate buffer (pH 7.4). Incubations were allowed to proceed for 20 min before being quenched with 2 volumes of ice-cold acetonitrile containing 0.1% formic acid (v/v). Samples were centrifuged, and the resulting supernatant collected and evaporated under nitrogen. Prior to mass spectral/UV analysis, samples were reconstituted in water:acetonitrile:formic acid (50:50:0.1). Analysis of metabolite formation was performed on a ThermoFisher LTQ ion trap mass spectrometer. Chromatographic separation was achieved using a Luna C18 150 μm × 2.0 5 μm column (Phenomenex, Torrance, CA) and a 20 min linear gradient from 95:5 A:B to 5:95 A:B (A, water containing 0.1% formic acid; B, acetonitrile containing 0.1% formic acid) at a flow rate of 250 μL/min.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> CYP2C19 Homology Model Studies</h3><div class="NLM_p">A three-dimensional homology model of CYP2C19 was built using Prime (Schrodinger, LLC, New York, NY) and was based on the crystal structure of CYP2C9 with flurbiprofen bound (PDB file <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R9O">1R9O</a>). The crystal structure of CYP2C9 was chosen due to its sequence homology with CYP2C19 and because it did not contain any amino acid modifications. The amino acid sequence of CYP2C19 was obtained from GenBank (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=CAH73444.1">CAH73444.1</a>). Ramachandran plots confirmed the structural plausibility of the homology model. Visual evaluation of the model detected no odd bond angles or bond lengths.</div><div class="NLM_p last">SiteMap (Schrodinger, LLC) located and defined the P450 2C19 active site using a series of adjacent dummy atoms that estimated the size and boundary of the active site. The SiteMap-defined active site was employed to generate the docking grid for subsequent docking experiments. The docking grid was defined by a 14 × 14 × 14 Å<sup>3</sup> box whereby the mass center of the each docked ligand was centered. The remaining algorithm parameters were set to the default settings. Ligands were docked using the Ligand Docking algorithm within Glide (Schrodinger, LLC). Individual ligand poses were examined either by GlideScore or eModel. Prior to docking, ligands were prepared in a similar fashion to that described for the pharmacophore model.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm201346g" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan L. Wahlstrom</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics and Drug Metabolism, Amgen Inc., Seattle, Washington 98119, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#600a010e1720010d07050e4e030f0d"><span class="__cf_email__" data-cfemail="87ede6e9f0c7e6eae0e2e9a9e4e8ea">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert S. Foti</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics and Drug Metabolism, Amgen Inc., Seattle, Washington 98119, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan A. Rock</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics and Drug Metabolism, Amgen Inc., Seattle, Washington 98119, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaogang Han</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics and Drug Metabolism Biomarkers, Pfizer, Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert A. Flowers</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Lehigh University, Bethlehem, Pennsylvania 18015, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Larry C. Wienkers</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics and Drug Metabolism, Amgen Inc., Seattle, Washington 98119, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2776e3803-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Dr. Brooke M. VandenBrink for valuable assistance in preparing the pharmacophore and homology model figures.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> Abbreviations Used</h2><tr><td class="NLM_term">P450</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">QSAR</td><td class="NLM_def"><p class="first last">quantitative structure–activity relationship</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">inhibition constant</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">LC-MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography-tandem mass spectrometry</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Ortiz de Montellano, P. R.; De Voss, J. J.</span><span> </span><span class="NLM_article-title">Substrate Oxidation by Cytochrome P450 Enzymes</span>. In  <span class="citation_source-book">Cytochrome P450: Structure, Mechanism, and Biochemistry</span>, <span class="NLM_edition">3rd</span> ed.; <span class="NLM_contrib-group">Ortiz de Montellano, P. R.</span>, Ed.; <span class="NLM_publisher-name">Kluwer Academic/Plenum Publishers</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1007%2F0-387-27447-2_6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=183-245&author=P.+R.+Ortiz+de+Montellano&author=J.+J.+De+Vossauthor=P.+R.+Ortiz+de+Montellano&title=Cytochrome+P450%3A+Structure%2C+Mechanism%2C+and+Biochemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2F0-387-27447-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F0-387-27447-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DP.%2BR.%26atitle%3DSubstrate%2520Oxidation%2520by%2520Cytochrome%2520P450%2520Enzymes%26btitle%3DCytochrome%2520P450%253A%2520Structure%252C%2520Mechanism%252C%2520and%2520Biochemistry%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DP.%2BR.%26pub%3DKluwer%2520Academic%252FPlenum%2520Publishers%26date%3D2005%26spage%3D183%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Guengerich, F. P.</span><span> </span><span class="NLM_article-title">Human Cytochrome P450 Enzymes</span>. In  <span class="citation_source-book">Cytochrome P450: Structure, Mechanism, and Biochemistry</span>, <span class="NLM_edition">3rd</span> ed.; <span class="NLM_contrib-group">Ortiz de Montellano, P. R.</span>, Ed.; <span class="NLM_publisher-name">Kluwer Academic/Plenum Publishers</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1007%2F0-387-27447-2_10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=377-530&author=F.+P.+Guengerichauthor=P.+R.+Ortiz+de+Montellano&title=Cytochrome+P450%3A+Structure%2C+Mechanism%2C+and+Biochemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F0-387-27447-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F0-387-27447-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DHuman%2520Cytochrome%2520P450%2520Enzymes%26btitle%3DCytochrome%2520P450%253A%2520Structure%252C%2520Mechanism%252C%2520and%2520Biochemistry%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DP.%2BR.%26pub%3DKluwer%2520Academic%252FPlenum%2520Publishers%26date%3D2005%26spage%3D377%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Guengerich, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, J. S.</span><span> </span><span class="NLM_article-title">Applying mechanisms of chemical toxicity to predict drug safety</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx600260a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhslahsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=344-369&author=F.+P.+Guengerichauthor=J.+S.+MacDonald&title=Applying+mechanisms+of+chemical+toxicity+to+predict+drug+safety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Applying Mechanisms of Chemical Toxicity to Predict Drug Safety</span></div><div class="casAuthors">Guengerich, F. Peter; MacDonald, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-369</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Toxicol. can no longer be used only as a science that reacts to problems but must be more proactive in predicting potential human safety issues with new drug candidates.  Success in this area must be based on an understanding of the mechanisms of toxicity.  This review summarizes and extends some of the concepts of an American Chem. Society ProSpectives meeting on the title subject held in June 2006.  One important area is the discernment of the exact nature of the most common problems in drug toxicity.  Knowledge of chem. structure alerts and relevant biol. pathways are important.  Biol. activation to reactive products and off-target pharmacol. are considered to be major contexts of drug toxicity, although defining exactly what the contributions are is not trivial.  Some newer approaches to screening for both have been developed.  A goal in predictive toxicol. is the use of in vitro methods and database development to make predictions concerning potential modes of toxicity and to stratify drug candidates for further development.  Such predictions are desirable for several economic and other reasons but are certainly not routine yet.  However, progress has been made using several approaches.  Some examples of the application of studies of wide-scale biol. responses are now available, with incorporation into development paradigms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxyWz1mKS0h7Vg90H21EOLACvtfcHk0li7VdAyXiUi8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhslahsrk%253D&md5=d1ef7299d11c39d0ff3b031779915e54</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Ftx600260a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx600260a%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DMacDonald%26aufirst%3DJ.%2BS.%26atitle%3DApplying%2520mechanisms%2520of%2520chemical%2520toxicity%2520to%2520predict%2520drug%2520safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D344%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Denton, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashman, J. R.</span><span> </span><span class="NLM_article-title">5-Substituted, 6-Substituted, and Unsubstituted 3-Heteroaromatic Pyridine Analogues of Nicotine as Selective Inhibitors of Cytochrome P-450 2A6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=224-239&author=T.+T.+Dentonauthor=X.+Zhangauthor=J.+R.+Cashman&title=5-Substituted%2C+6-Substituted%2C+and+Unsubstituted+3-Heteroaromatic+Pyridine+Analogues+of+Nicotine+as+Selective+Inhibitors+of+Cytochrome+P-450+2A6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDenton%26aufirst%3DT.%2BT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCashman%26aufirst%3DJ.%2BR.%26atitle%3D5-Substituted%252C%25206-Substituted%252C%2520and%2520Unsubstituted%25203-Heteroaromatic%2520Pyridine%2520Analogues%2520of%2520Nicotine%2520as%2520Selective%2520Inhibitors%2520of%2520Cytochrome%2520P-450%25202A6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D48%26spage%3D224%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Gomaa, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridgens, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboraia, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfern, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, C.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26): Synthesis and Biological Evaluation of Imidazole Methyl 3-(4-(Aryl-2-ylamino)phenyl)propanoates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6803</span><span class="NLM_x">–</span> <span class="NLM_lpage">6811</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200695m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6803-6811&author=M.+S.+Gomaaauthor=C.+E.+Bridgensauthor=A.+S.+Aboraiaauthor=G.+J.+Vealauthor=C.+P.+Redfernauthor=A.+Brancaleauthor=J.+L.+Armstrongauthor=C.+Simons&title=Small+Molecule+Inhibitors+of+Retinoic+Acid+4-Hydroxylase+%28CYP26%29%3A+Synthesis+and+Biological+Evaluation+of+Imidazole+Methyl+3-%284-%28Aryl-2-ylamino%29phenyl%29propanoates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm200695m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200695m%26sid%3Dliteratum%253Aachs%26aulast%3DGomaa%26aufirst%3DM.%2BS.%26aulast%3DBridgens%26aufirst%3DC.%2BE.%26aulast%3DAboraia%26aufirst%3DA.%2BS.%26aulast%3DVeal%26aufirst%3DG.%2BJ.%26aulast%3DRedfern%26aufirst%3DC.%2BP.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DArmstrong%26aufirst%3DJ.%2BL.%26aulast%3DSimons%26aufirst%3DC.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520Retinoic%2520Acid%25204-Hydroxylase%2520%2528CYP26%2529%253A%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Imidazole%2520Methyl%25203-%25284-%2528Aryl-2-ylamino%2529phenyl%2529propanoates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6803%26epage%3D6811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, Y.-J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Discovery of Novel <i>trans</i>-Stilbene Analogues as Potent and Selective Human Cytochrome P450 1B1 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=160-164&author=S.+Kimauthor=H.+Koauthor=J.+E.+Parkauthor=S.+Jungauthor=S.+K.+Leeauthor=Y.-J.+Chun&title=Design%2C+Synthesis%2C+and+Discovery+of+Novel+trans-Stilbene+Analogues+as+Potent+and+Selective+Human+Cytochrome+P450+1B1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKo%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DJung%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DChun%26aufirst%3DY.-J.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Discovery%2520of%2520Novel%2520trans-Stilbene%2520Analogues%2520as%2520Potent%2520and%2520Selective%2520Human%2520Cytochrome%2520P450%25201B1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D45%26spage%3D160%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Paine, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludington, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haining, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettie, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeldin, D. C.</span><span> </span><span class="NLM_article-title">The human intestinal cytochrome P450 “pie”</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=880-886&author=M.+F.+Paineauthor=H.+L.+Hartauthor=S.+S.+Ludingtonauthor=R.+L.+Hainingauthor=A.+E.+Rettieauthor=D.+C.+Zeldin&title=The+human+intestinal+cytochrome+P450+%E2%80%9Cpie%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaine%26aufirst%3DM.%2BF.%26aulast%3DHart%26aufirst%3DH.%2BL.%26aulast%3DLudington%26aufirst%3DS.%2BS.%26aulast%3DHaining%26aufirst%3DR.%2BL.%26aulast%3DRettie%26aufirst%3DA.%2BE.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26atitle%3DThe%2520human%2520intestinal%2520cytochrome%2520P450%2520%25E2%2580%259Cpie%25E2%2580%259D%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D880%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VandenBranden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Identification of the human cytochromes p450 responsible for in vitro formation of <i>R</i>- and <i>S</i>-norfluoxetine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">1044</span><span class="NLM_x">–</span> <span class="NLM_lpage">1050</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=11356927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvVShsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2001&pages=1044-1050&author=B.+J.+Ringauthor=J.+A.+Ecksteinauthor=J.+S.+Gillespieauthor=S.+N.+Binkleyauthor=M.+VandenBrandenauthor=S.+A.+Wrighton&title=Identification+of+the+human+cytochromes+p450+responsible+for+in+vitro+formation+of+R-+and+S-norfluoxetine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the human cytochromes P450 responsible for in vitro formation of R- and S-norfluoxetine</span></div><div class="casAuthors">Ring, Barbara J.; Eckstein, James A.; Gillespie, Jennifer S.; Binkley, Shelly N.; Vandenbranden, Mark; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1044-1050</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The formation of R- and S-norfluoxetine was analyzed in vitro in human liver microsomes.  Low apparent Km values for R-norfluoxetine formation of ≤8 μM and S-norfluoxetine of <0.2 μM were detd.  R-Norfluoxetine formation rates in a characterized microsomal bank correlated with the catalytic activities for cytochrome P 450 (CYP) 2D6, CYP2C9, and CYP2C8.  Expressed CYP2C9, CYP2C19, and CYP2D6 formed R-norfluoxetine following incubation with 1 μM R-fluoxetine and exhibited apparent Km values of 9.7, 8.5, and 1.8 μM, resp.  Multivariate correlation anal. identified CYP2C9 and CYP2D6 as significant regressors with R-norfluoxetine formation.  Antibodies to the CYP2C subfamily and CYP2D6 each exhibited moderate inhibition of R-norfluoxetine formation.  Therefore, CYP2D6 and CYP2C9 contribute to this biotransformation.  At pharmacol. concns. of S-fluoxetine, S-norfluoxetine formation rates in the bank of microsomes were found to correlate only with CYP2D6 catalytic activity and only expressed CYP2D6 was found to be capable of forming S-norfluoxetine.  Thus, it would appear that both CYP2D6 and CYP2C9 contribute to the formation of R-norfluoxetine, whereas only CYP2D6 is responsible for the conversion to S-norfluoxetine.  Since the enantiomers of fluoxetine and norfluoxetine are inhibitors of CYP2D6, upon chronic dosing, the CYP2D6-mediated metab. of the fluoxetine enantiomers would likely be inhibited, resulting in R-norfluoxetine formation being mediated by CYP2C9 and S-norfluoxetine formation being mediated by multiple high Km enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW2MTE7_3w6bVg90H21EOLACvtfcHk0lhrb_lVsrtevQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvVShsrs%253D&md5=9ec662cbf6111a1c27ca073f8670a8b1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DEckstein%26aufirst%3DJ.%2BA.%26aulast%3DGillespie%26aufirst%3DJ.%2BS.%26aulast%3DBinkley%26aufirst%3DS.%2BN.%26aulast%3DVandenBranden%26aufirst%3DM.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DIdentification%2520of%2520the%2520human%2520cytochromes%2520p450%2520responsible%2520for%2520in%2520vitro%2520formation%2520of%2520R-%2520and%2520S-norfluoxetine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D297%26spage%3D1044%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Feng, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H. H.</span><span> </span><span class="NLM_article-title">The induction effect of rifampicin on activity of mephenytoin 4′-hydroxylase related to M1 mutation of CYP2C19 and gene dose</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1046%2Fj.1365-2125.1998.00643.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=9489590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK1cXpslehuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1998&pages=27-29&author=H.+J.+Fengauthor=S.+L.+Huangauthor=W.+Wangauthor=H.+H.+Zhou&title=The+induction+effect+of+rifampicin+on+activity+of+mephenytoin+4%E2%80%B2-hydroxylase+related+to+M1+mutation+of+CYP2C19+and+gene+dose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The induction effect of rifampicin on activity of mephenytoin 4'-hydroxylase related to M1 mutation of CYP2C19 and gene dose</span></div><div class="casAuthors">Feng, Hua-Jun; Huang, Song-Lin; Wang, Wei; Zhou, Hong-Hao</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-29</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">To det. the induction effect of rifampicin on the activity of 4'-hydroxylase in poor metabolizers (PMs) with m1 mutation of S-mephenytoin 4'-hydroxylation and the relationship of the effect with gene dose.  Seven extensive metabolizers (EMs) of S-mephenytoin 4'-hydroxylation and five PMs with m1 mutation were chosen to take rifampicin 300 mg day-1 orally for 22 days.  Prior to and after rifampicin treatment, each subject was given racemic mephenytoin 100 mg.  The 4'-hydroxymephenytoin (4'-OH-MP) excreted in the 0-24 h urine and mephenytoin S/R ratio in the 0-8 h urine were detd. by h.p.l.c. and GC, resp.  In all EMs, the excretion of 4'-OH-MP in the 0-24 h urine was increased by 146.4±17.9%, 0-8 h urinary mephenytoin S/R ratio was decreased by 77.3±8.8%, the percentage increase in the 0-24 h excretion of 4'-OH-MP in those CYP2C19 homozygous (wt/wt) was greater than that in those heterozygous (wt/m1 and wt/m2) (203.9±42.5% vs 69.6±4.1%).  0-8 H urinary mephenytoin S/R ratio of those PMs with m1 mutation was decreased by 9.6%, the amt. of 4'-OH-MP excreted in the 0-24 h urine was increased by 80.1±48.0%.  The activity of 4'-hydroxylase of PMs with m1 mutation of S-mephenytoin 4'-hydroxylation can be induced by rifampicin and the inducing effect of rifampicin on 4'-hydroxylase is gene dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI8JXivrVyRbVg90H21EOLACvtfcHk0lhrb_lVsrtevQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXpslehuw%253D%253D&md5=7dddb83db34051b0e099ab9bbde661b9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2125.1998.00643.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2125.1998.00643.x%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DH.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DH.%2BH.%26atitle%3DThe%2520induction%2520effect%2520of%2520rifampicin%2520on%2520activity%2520of%2520mephenytoin%25204%25E2%2580%25B2-hydroxylase%2520related%2520to%2520M1%2520mutation%2520of%2520CYP2C19%2520and%2520gene%2520dose%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1998%26volume%3D45%26spage%3D27%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Raucy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasker, J. M.</span><span> </span><span class="NLM_article-title">Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1124%2Fjpet.102.033837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=12130704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Ogsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=475-482&author=J.+L.+Raucyauthor=L.+Muellerauthor=K.+Duanauthor=S.+W.+Allenauthor=S.+Stromauthor=J.+M.+Lasker&title=Expression+and+induction+of+CYP2C+P450+enzymes+in+primary+cultures+of+human+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes</span></div><div class="casAuthors">Raucy, Judy L.; Mueller, Lisa; Duan, Kui; Allen, Scott W.; Strom, Stephen; Lasker, Jerome M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">475-482</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Although CYP2C8, CYP2C9, and CYP2C19 play an important role in drug biotransformation, factors influencing the expression and activity of these CYP2C P450s in human liver remain largely undefined.  We used primary cultures of human hepatocytes from 15 subjects to assess the inducibility of CYP2C enzyme expression by prototypical inducer agents, including rifampicin, dexamethasone, and phenobarbital.  After culture for 72 h in serum-free medium on collagen, Western blotting revealed that CYP2C9 was the only CYP2C enzyme expressed at appreciable levels in untreated hepatocytes.  Subsequent treatment with 25 μM rifampicin for 48 h elicited marked increases in CYP2C8 (700 ± 761%), CYP2C19 (854%), and CYP2C9 (209 ± 176%) protein content vs. a 550 ± 170% enhancement of CYP3A4 enzyme levels.  Parallel increases in CYP2C mRNAs, measured by Northern blotting and/or RNase protection, were found in rifampicin-treated hepatocytes, with CYP2C8, CYP2C9, and CYP2C19 transcripts exhibiting increases of 688 ± 635, 207 ± 49, and 230 ± 60%, resp., vs. an 8.8-fold enhancement of CYP3A4 mRNA levels.  Dexamethasone (10 μM) treatment enhanced CYP2C8 mRNA (360 ± 100%) and protein (274%) content, although this steroid had less effect on CYP2C9 and CYP2C19 transcripts (23 ± 21% and 21 ± 36%, resp.) and enzyme levels (55 and 143%, resp.).  Phenobarbital (100 μM) was a powerful inducer of CYP2C9 (850%) and CYP2C19 (735%) mRNA content, and also increased CYP2C8 (610%) and CYP3A4 (205%) transcripts.  Our results show that CYP2C enzyme expression in human hepatocytes is highly inducible by rifampicin, dexamethasone, and phenobarbital.  Because these xenobiotics are ligands and/or activators of the pregnane X receptor and/or constitutive androstane receptor, such orphan nuclear receptors and their response elements may partake in regulating CYP2C gene expression in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0l1hH2pJopbVg90H21EOLACvtfcHk0lhrb_lVsrtevQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Ogsb8%253D&md5=a9c9e8674bb318bdddf621f3cf4ebc3d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.033837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.033837%26sid%3Dliteratum%253Aachs%26aulast%3DRaucy%26aufirst%3DJ.%2BL.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DDuan%26aufirst%3DK.%26aulast%3DAllen%26aufirst%3DS.%2BW.%26aulast%3DStrom%26aufirst%3DS.%26aulast%3DLasker%26aufirst%3DJ.%2BM.%26atitle%3DExpression%2520and%2520induction%2520of%2520CYP2C%2520P450%2520enzymes%2520in%2520primary%2520cultures%2520of%2520human%2520hepatocytes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D475%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Foti, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlstrom, J. L.</span><span> </span><span class="NLM_article-title">CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=523-528&author=R.+S.+Fotiauthor=J.+L.+Wahlstrom&title=CYP2C19+inhibition%3A+the+impact+of+substrate+probe+selection+on+in+vitro+inhibition+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DWahlstrom%26aufirst%3DJ.%2BL.%26atitle%3DCYP2C19%2520inhibition%253A%2520the%2520impact%2520of%2520substrate%2520probe%2520selection%2520on%2520in%2520vitro%2520inhibition%2520profiles%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D523%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Wang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, W. W.</span><span> </span><span class="NLM_article-title">Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population</span> <span class="citation_source-journal">Clin. Exp. Pharmacol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1111%2Fj.1440-1681.2007.04583.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=17439410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvVels7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=421-424&author=J.+H.+Wangauthor=P.+Q.+Liauthor=Q.+Y.+Fuauthor=Q.+X.+Liauthor=W.+W.+Cai&title=Cyp2c19+genotype+and+omeprazole+hydroxylation+phenotype+in+Chinese+Li+population"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">CYP2C19 genotype and omeprazole hydroxylation phenotype in Chinese Li population</span></div><div class="casAuthors">Wang, Jiu-Hui; Li, Pei-Qiong; Fu, Qiong-Yao; Li, Qiu-Xiang; Cai, Wang-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">421-424</span>CODEN:
                <span class="NLM_cas:coden">CEXPB9</span>;
        ISSN:<span class="NLM_cas:issn">0305-1870</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">1. CYP2C19 is a polymorphism of cytochrome P 450, which is responsible for the metab. of many drugs.  The genetic polymorphism shows interethnic variation and it has been demonstrated that the frequency of poor metabolizers (PM) and the distribution of alleles of CYP2C19 vary among Chinese ethnic nationalities.  The aim of the present study was to investigate the incidence of CYP2C19 polymorphism in the Chinese Li population.  2. One hundred and sixty-five unrelated healthy Li subjects were identified with respect to CYP2C19 by genotype and phenotype anal.  A polymerase chain reaction-restriction fragment length polymorphism method was performed for genotyping.  The plasma concns. of omeprazole and 5-hydroxyomeprazole were assayed by reversed-phase high-performance liq. chromatog. and the omeprazole hydroxylation index (HI) was detd.  3. The frequency distribution of omeprazole HI is bimodal and the antimode for HI was estd. to be 5.6.  The prevalence of phenotypic PM in the Li population was 16.6% (13.7-19.5; 95% CI).  Genotype anal. revealed that the frequencies of the CYP2C19*1, *2 and *3 alleles in the Li population were 0.617 (0.590-0.644; 95% CI), 0.353 (0.327-0.379; 95% CI) and 0.031 (0.021-0.041; 95% CI), resp.  The frequency of genotypic PM was 14.7% (11.9-17.5; 95% CI), which almost agreed with the frequency of phenotypic PM.  Omeprazole HI was significantly different among the different genotype groups (P < 0.05).  4. The present study revealed that the incidence of the CYP2C19*1, *2 and *3 alleles in Chinese Li population is different to that in other ethnic populations of China.  There was an obvious relationship between CYP2C19 genotype and omeprazole hydroxylation phenotype, and about 90% of phenotypic PM can be explained by the CYP2C19*2 and *3 alleles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpElTo-oIWQI7Vg90H21EOLACvtfcHk0ljtQitzURZ_nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvVels7w%253D&md5=42a5dd941df5e3ebfefe9986fcc4d262</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1681.2007.04583.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1681.2007.04583.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DP.%2BQ.%26aulast%3DFu%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DQ.%2BX.%26aulast%3DCai%26aufirst%3DW.%2BW.%26atitle%3DCyp2c19%2520genotype%2520and%2520omeprazole%2520hydroxylation%2520phenotype%2520in%2520Chinese%2520Li%2520population%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D2007%26volume%3D34%26spage%3D421%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Holt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howden, C. W.</span><span> </span><span class="NLM_article-title">Omeprazole. Overview and opinion</span> <span class="citation_source-journal">Digestive Dis. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1007%2FBF01298864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=2007354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK3MXkt1Wntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1991&pages=385-393&author=S.+Holtauthor=C.+W.+Howden&title=Omeprazole.+Overview+and+opinion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Omeprazole.  Overview and opinion</span></div><div class="casAuthors">Holt, S.; Howden, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Digestive Diseases and Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">385-93</span>CODEN:
                <span class="NLM_cas:coden">DDSCDJ</span>;
        ISSN:<span class="NLM_cas:issn">0163-2116</span>.
    </div><div class="casAbstract">Review with 93 refs. on the pharmacol. of omeprazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprdad08GwDi7Vg90H21EOLACvtfcHk0ljtQitzURZ_nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkt1Wntr0%253D&md5=08322f1d6a10fddddb93b1d8127db132</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2FBF01298864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01298864%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DS.%26aulast%3DHowden%26aufirst%3DC.%2BW.%26atitle%3DOmeprazole.%2520Overview%2520and%2520opinion%26jtitle%3DDigestive%2520Dis.%2520Sci.%26date%3D1991%26volume%3D36%26spage%3D385%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Howden, C. W.</span><span> </span><span class="NLM_article-title">Clinical pharmacology of omeprazole</span> <span class="citation_source-journal">Clin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.2165%2F00003088-199120010-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A280%3ADyaK3M3jtVyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1991&pages=38-49&author=C.+W.+Howden&title=Clinical+pharmacology+of+omeprazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacology of omeprazole</span></div><div class="casAuthors">Howden C W</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacokinetics</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-49</span>
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    </div><div class="casAbstract">Omeprazole is a specific inhibitor of H+,K(+)-ATPase or 'proton pump' in parietal cells.  This enzyme is responsible for the final step in the process of acid secretion; omeprazole blocks acid secretion in response to all stimuli.  Single doses produce dose-dependent inhibition with increasing effect over the first few days, reaching a maximum after about 5 days.  Doses of omeprazole 20mg daily or greater are able to virtually abolish intragastric acidity in most individuals, although lower doses have a much more variable effect.  Omeprazole causes a dose-dependent increase in gastrin levels.  Omeprazole must be protected from intragastric acid when given orally, and is therefore administered as encapsulated enteric-coated granules.  Absorption can be erratic but is generally rapid, and initially the drug is widely distributed.  It is highly protein-bound and extensively metabolised.  Its elimination half-life is about 1h but its pharmacological effect lasts much longer, since it is preferentially concentrated in parietal cells where it forms a covalent linkage with H+,K(+)-ATPase, which it irreversibly inhibits.  Omeprazole binds to hepatic cytochrome P450 and inhibits oxidative metabolism of some drugs, the most important being phenytoin.  Omeprazole has produced short term healing rates superior to the histamine H2-receptor antagonists in duodenal ulcer, gastric ulcer and reflux oesophagitis.  It has also been shown to be highly effective in healing ulcers which have failed to respond to H2-receptor antagonists, and has been extremely valuable in treating patients with Zollinger-Ellison syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrsomvQl8SZQwxfk_AGB-EfW6udTcc2eYnEXNXzuPA0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3jtVyjug%253D%253D&md5=06d5803c938aeeec08d12c50ef33b452</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2165%2F00003088-199120010-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199120010-00003%26sid%3Dliteratum%253Aachs%26aulast%3DHowden%26aufirst%3DC.%2BW.%26atitle%3DClinical%2520pharmacology%2520of%2520omeprazole%26jtitle%3DClin.%2520Pharm.%26date%3D1991%26volume%3D20%26spage%3D38%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Spencer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulds, D.</span><span> </span><span class="NLM_article-title">Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1994&pages=404-430&author=C.+M.+Spencerauthor=D.+Faulds&title=Lansoprazole.+A+reappraisal+of+its+pharmacodynamic+and+pharmacokinetic+properties%2C+and+its+therapeutic+efficacy+in+acid-related+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpencer%26aufirst%3DC.%2BM.%26aulast%3DFaulds%26aufirst%3DD.%26atitle%3DLansoprazole.%2520A%2520reappraisal%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%252C%2520and%2520its%2520therapeutic%2520efficacy%2520in%2520acid-related%2520disorders%26jtitle%3DDrugs%26date%3D1994%26volume%3D48%26spage%3D404%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Meyer, U. A.</span><span> </span><span class="NLM_article-title">Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs</span> <span class="citation_source-journal">Eur. J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S21</span><span class="NLM_x">–</span> <span class="NLM_lpage">S25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=S21-S25&issue=Suppl+1&author=U.+A.+Meyer&title=Metabolic+interactions+of+the+proton-pump+inhibitors+lansoprazole%2C+omeprazole+and+pantoprazole+with+other+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DU.%2BA.%26atitle%3DMetabolic%2520interactions%2520of%2520the%2520proton-pump%2520inhibitors%2520lansoprazole%252C%2520omeprazole%2520and%2520pantoprazole%2520with%2520other%2520drugs%26jtitle%3DEur.%2520J.%2520Gastroenterol.%2520Hepatol.%26date%3D1996%26volume%3D8%26issue%3DSuppl%25201%26spage%3DS21%26epage%3DS25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Meyer, U. A.</span><span> </span><span class="NLM_article-title">Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions</span> <span class="citation_source-journal">Yale J. biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=9165689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Cht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1996&pages=203-209&author=U.+A.+Meyer&title=Interaction+of+proton+pump+inhibitors+with+cytochromes+P450%3A+consequences+for+drug+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions</span></div><div class="casAuthors">Meyer, Urs A.</div><div class="citationInfo"><span class="NLM_cas:title">Yale Journal of Biology and Medicine</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-209</span>CODEN:
                <span class="NLM_cas:coden">YJBMAU</span>;
        ISSN:<span class="NLM_cas:issn">0044-0086</span>.
    
            (<span class="NLM_cas:orgname">Yale Journal of Biology and Medicine</span>)
        </div><div class="casAbstract">A review, with 38 refs.  Omeprazole, lansoprazole and pantoprazole are metabolized by several human cytochromes P 450, most prominently by CYP2C19 and CYP3A4.  Only pantoprazole is also metabolized by a sulfotransferase.  Differences in the quant. contribution of these enzymes and in the relative affinities of the substrates explain some of the obsd. interactions with carbamazepin, diazepam, phenytoin and theophylline and of the impact of the CYP2C19 (mephenytoin) genetic polymorphism.  Of these drugs, pantoprazole has the lowest potential for interactions, both in vitro and in human volunteer studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobcNjcXY2JxbVg90H21EOLACvtfcHk0lgCAENYprzdIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Cht7Y%253D&md5=02fd323a07201b8743eba7d0665fa6a8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DU.%2BA.%26atitle%3DInteraction%2520of%2520proton%2520pump%2520inhibitors%2520with%2520cytochromes%2520P450%253A%2520consequences%2520for%2520drug%2520interactions%26jtitle%3DYale%2520J.%2520biol.%2520Med.%26date%3D1996%26volume%3D69%26spage%3D203%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ko, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thacker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flockhart, D. A.</span><span> </span><span class="NLM_article-title">Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=9224780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFCgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=853-862&author=J.+W.+Koauthor=N.+Sukhovaauthor=D.+Thackerauthor=P.+Chenauthor=D.+A.+Flockhart&title=Evaluation+of+omeprazole+and+lansoprazole+as+inhibitors+of+cytochrome+P450+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms</span></div><div class="casAuthors">Ko, Jae-Wook; Sukhova, Nadia; Thacker, David; Chen, Patricia; Flockhart, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">853-862</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The human clearance of omeprazole and lansoprazole is conducted primarily by the hepatic cytochrome P 450 (CYP) system.  Efficacy data indicate few differences between these two drugs, but they may exhibit discrete drug interaction profiles.  To compare the potency and specificity of these drugs as inhibitors of CYP isoforms, we performed in vitro studies with human liver microsomal prepns.  Both drugs were potent, competitive inhibitors of CYP2C19, as measured by the conversion of S-mephenytoin to 4-hydroxymephenytoin (ki = 3.1±2.2 μM for omeprazole, Ki = 3.2±1.3 μM for lansoprazole).  For omeprazole, the highest concn. at which >70% inhibition of CYP2C19 was obsd. with no significant inhibitory effect on other isoforms was at least 20 times greater than Ki.  Both drugs were competitive inhibitors of CYP2C9-catalyzed conversion of tolbutamide to 4-hydroxytolbutamide (Ki = 40.1±14.8 μM for omeprazole, Ki = 52.1±1.4 μM for lansoprazole) and were noncompetitive inhibitors of CYP3A-catalyzed conversion of dextromethorphan to 3-methoxymorphinan (Ki = 84.4±4.0 μM for omeprazole, Ki = 170.4±7.1 μM for lansoprazole).  Lansoprazole was at least 5 times more potent (Ki = 44.7±22.0 μM) than omeprazole (ki = 240.7±102.0 μM) as an inhibitor of CYP2D6-mediated conversion of dextromethorphan to dextrorphan.  No inhibition of CYP1A2, assessed by measuring the conversion of phenacetin to acetaminophen, was noted.  Our data suggest that whereas the inhibitory profiles of these two drugs are similar, lansoprazole may be the more important in vitro inhibitor of CYP2D6.  Since its inhibition is very potent and has a broad "window of selectivity," omeprazole seems to be a useful, selective inhibitor of CYP2C19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-xV8zsJrbQLVg90H21EOLACvtfcHk0lgCAENYprzdIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFCgurs%253D&md5=0b24590f62f88d1eb4287efecd1fadf2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DJ.%2BW.%26aulast%3DSukhova%26aufirst%3DN.%26aulast%3DThacker%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DFlockhart%26aufirst%3DD.%2BA.%26atitle%3DEvaluation%2520of%2520omeprazole%2520and%2520lansoprazole%2520as%2520inhibitors%2520of%2520cytochrome%2520P450%2520isoforms%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1997%26volume%3D25%26spage%3D853%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Andersson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cederberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edvardsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heggelund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundborg, P.</span><span> </span><span class="NLM_article-title">Effect of omeprazole and cimetidine on plasma diazepam levels</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1990&pages=51-54&author=T.+Anderssonauthor=K.+Andrenauthor=C.+Cederbergauthor=G.+Edvardssonauthor=A.+Heggelundauthor=P.+Lundborg&title=Effect+of+omeprazole+and+cimetidine+on+plasma+diazepam+levels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DT.%26aulast%3DAndren%26aufirst%3DK.%26aulast%3DCederberg%26aufirst%3DC.%26aulast%3DEdvardsson%26aufirst%3DG.%26aulast%3DHeggelund%26aufirst%3DA.%26aulast%3DLundborg%26aufirst%3DP.%26atitle%3DEffect%2520of%2520omeprazole%2520and%2520cimetidine%2520on%2520plasma%2520diazepam%2520levels%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1990%26volume%3D39%26spage%3D51%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Andersson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cederberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edvardsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heggelund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundborg, P.</span><span> </span><span class="NLM_article-title">Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1038%2Fclpt.1990.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=2104790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK3cXhtFWmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1990&pages=79-85&author=T.+Anderssonauthor=C.+Cederbergauthor=G.+Edvardssonauthor=A.+Heggelundauthor=P.+Lundborg&title=Effect+of+omeprazole+treatment+on+diazepam+plasma+levels+in+slow+versus+normal+rapid+metabolizers+of+omeprazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole</span></div><div class="casAuthors">Andersson, Tommy; Cederberg, Christer; Edvardsson, Gunilla; Heggelund, Asger; Lundborg, Per</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-85</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">The effect of omeprazole treatment on diazepam plasma levels was studied in four slow and six rapid metabolizers of omeprazole.  Single i.v. doses of diazepam (0.1 mg/kg) were administered after 1 wk of oral treatment with omeprazole (20 mg) and placebo.  This was a double-blind crossover study with randomized placebo and omeprazole treatments.  Blood was collected up to 120 h after diazepam dosing (still during one-daily omeprazole and placebo administration) for measurement of diazepam and its major metabolite desmethyldiazepam.  The slow metabolizers of omeprazole also metabolized diazepam slowly, exhibiting only half the diazepam plasma clearance of the others.  The mean clearance of diazepam was decreased 26% after omeprazole in the rapid metabolizers, whereas the slow group showed no apparent interaction.  The mean plasma concns. of desmethyldiazepam showed a more rapid formation in the rapid compared with the slow metabolizers, which is a logical consequence of the rate of diazepam metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxfkdIz5fL8rVg90H21EOLACvtfcHk0lgCAENYprzdIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtFWmsbs%253D&md5=e41ea5d2bfe4a391ea37bfaaa14518db</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fclpt.1990.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.1990.12%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DT.%26aulast%3DCederberg%26aufirst%3DC.%26aulast%3DEdvardsson%26aufirst%3DG.%26aulast%3DHeggelund%26aufirst%3DA.%26aulast%3DLundborg%26aufirst%3DP.%26atitle%3DEffect%2520of%2520omeprazole%2520treatment%2520on%2520diazepam%2520plasma%2520levels%2520in%2520slow%2520versus%2520normal%2520rapid%2520metabolizers%2520of%2520omeprazole%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1990%26volume%3D47%26spage%3D79%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Enderle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grass, U.</span><span> </span><span class="NLM_article-title">Drug interaction: omeprazole and phenprocoumon</span> <span class="citation_source-journal">BMC Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1186%2F1471-230X-1-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=11313000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A280%3ADC%252BD38nnslCksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=2&author=C.+Enderleauthor=W.+Mullerauthor=U.+Grass&title=Drug+interaction%3A+omeprazole+and+phenprocoumon"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Drug interaction: omeprazole and phenprocoumon</span></div><div class="casAuthors">Enderle C; Muller W; Grass U</div><div class="citationInfo"><span class="NLM_cas:title">BMC gastroenterology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Oral anticoagulants like the coumarin derivatives are characterised by a particularly narrow therapeutic range.  Any interfering co-medication can pose a challenge to establishing a stable anticoagulant dosage regimen and thus present a serious risk for the patient.  Here we describe two cases of patients on anticoagulant therapy that suggest possible drug interactions between phenprocoumon and the proton pump inhibitor omeprazole.  RESULTS:  In both patients, the International Normalised Ratio (INR) increased beyond the therapeutic range after they were given omeprazole for the treatment of gastrointestinal symptoms.  The INR returned to therapeutic levels after the phenprocoumon dose was reduced (Case 1) and omeprazole discontinued (Case 2).  CONCLUSIONS:  The increased anticoagulant activity of phenprocoumon observed in the two described cases and the known interaction potential of omeprazole suggest that the clearance of phenprocoumon may have been reduced due to competitive inhibition of its degradation by omeprazole.  Drug interactions may be one of the reasons for the difficulties encountered with some patients in establishing a stable anticoagulant therapy.  Physicians should carefully review any concurrently used medication and if possible opt for drugs with a low interaction potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDx4aM5th5G3thwrmtH4OBfW6udTcc2eYkpmojpoV18bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nnslCksw%253D%253D&md5=756db98333a605ce5d265892b2a9ffd5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1471-230X-1-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-230X-1-2%26sid%3Dliteratum%253Aachs%26aulast%3DEnderle%26aufirst%3DC.%26aulast%3DMuller%26aufirst%3DW.%26aulast%3DGrass%26aufirst%3DU.%26atitle%3DDrug%2520interaction%253A%2520omeprazole%2520and%2520phenprocoumon%26jtitle%3DBMC%2520Gastroenterol.%26date%3D2001%26volume%3D1%26spage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Pearson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahal, U. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig-Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">The kinetic mechanism for cytochrome P450 metabolism of type II binding compounds: evidence supporting direct reduction</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">511</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1016%2Fj.abb.2011.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=21530484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVWms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2011&pages=69-79&author=J.+Pearsonauthor=U.+P.+Dahalauthor=D.+Rockauthor=C.+C.+Pengauthor=J.+O.+Schenkauthor=C.+Joswig-Jonesauthor=J.+P.+Jones&title=The+kinetic+mechanism+for+cytochrome+P450+metabolism+of+type+II+binding+compounds%3A+evidence+supporting+direct+reduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetic mechanism for cytochrome P450 metabolism of Type II binding compounds: Evidence supporting direct reduction</span></div><div class="casAuthors">Pearson, Joshua; Dahal, Upendra P.; Rock, Daniel; Peng, Chi-Chi; Schenk, James O.; Joswig-Jones, Carolyn; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">69-79</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The metabolic stability of a drug is an important property that should be optimized during drug design and development.  Nitrogen incorporation is hypothesized to increase the stability by coordination of nitrogen to the heme iron of cytochrome P 450, a binding mode that is referred to as type II binding.  However, we noticed that the type II binding compd. has less metabolic stability at sub-satg. conditions than a closely related type I binding compd.  Three kinetic models will be presented for type II binder metab.; (1) Dead-end type II binding, (2) a rapid equil. between type I and II binding modes before redn., and (3) a direct redn. of the type II coordinated heme.  Data will be presented on redn. rates of iron, the off rates of substrate (using surface plasmon resonance) and the catalytic rate consts.  These data argue against the dead-end, and rapid equil. models, leaving the direct redn. kinetic mechanism for metab. of the type II binding compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsVJoIl9O74rVg90H21EOLACvtfcHk0lg1VxfvtJDj6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVWms74%253D&md5=6f4cd09fe694d8e5cf766654a77a7f4b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2011.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2011.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DJ.%26aulast%3DDahal%26aufirst%3DU.%2BP.%26aulast%3DRock%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DC.%2BC.%26aulast%3DSchenk%26aufirst%3DJ.%2BO.%26aulast%3DJoswig-Jones%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520kinetic%2520mechanism%2520for%2520cytochrome%2520P450%2520metabolism%2520of%2520type%2520II%2520binding%2520compounds%253A%2520evidence%2520supporting%2520direct%2520reduction%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2011%26volume%3D511%26spage%3D69%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Peng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig-Jones, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">The effects of type II binding on metabolic stability and binding affinity in cytochrome P450 CYP3A4</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">497</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2010&pages=68-81&author=C.+C.+Pengauthor=J.+T.+Pearsonauthor=D.+A.+Rockauthor=C.+A.+Joswig-Jonesauthor=J.+P.+Jones&title=The+effects+of+type+II+binding+on+metabolic+stability+and+binding+affinity+in+cytochrome+P450+CYP3A4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DC.%2BC.%26aulast%3DPearson%26aufirst%3DJ.%2BT.%26aulast%3DRock%26aufirst%3DD.%2BA.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520effects%2520of%2520type%2520II%2520binding%2520on%2520metabolic%2520stability%2520and%2520binding%2520affinity%2520in%2520cytochrome%2520P450%2520CYP3A4%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2010%26volume%3D497%26spage%3D68%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Chiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tata, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">P450 interaction with HIV protease inhibitors: relationship between metabolic stability, inhibitory potency, and P450 binding spectra</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">3</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=1-3&author=M.+Chibaauthor=L.+Jinauthor=W.+Newayauthor=J.+P.+Vaccaauthor=J.+R.+Tataauthor=K.+Chapmanauthor=J.+H.+Lin&title=P450+interaction+with+HIV+protease+inhibitors%3A+relationship+between+metabolic+stability%2C+inhibitory+potency%2C+and+P450+binding+spectra"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DP450%2520interaction%2520with%2520HIV%2520protease%2520inhibitors%253A%2520relationship%2520between%2520metabolic%2520stability%252C%2520inhibitory%2520potency%252C%2520and%2520P450%2520binding%2520spectra%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2001%26volume%3D29%26spage%3D1%26epage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span> </span><span class="NLM_article-title">Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=843-855&author=H.+Liauthor=J.+Sunauthor=X.+Fanauthor=X.+Suiauthor=L.+Zhangauthor=Y.+Wangauthor=Z.+He&title=Considerations+and+recent+advances+in+QSAR+models+for+cytochrome+P450-mediated+drug+metabolism+prediction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DX.%26aulast%3DSui%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DZ.%26atitle%3DConsiderations%2520and%2520recent%2520advances%2520in%2520QSAR%2520models%2520for%2520cytochrome%2520P450-mediated%2520drug%2520metabolism%2520prediction%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2008%26volume%3D22%26spage%3D843%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Locuson, C. W.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettie, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">Charge and substituent effects on affinity and metabolism of benzbromarone-based CYP2C19 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6768</span><span class="NLM_x">–</span> <span class="NLM_lpage">6776</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049605m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6768-6776&author=C.+W.+Locusonauthor=H.+Suzukiauthor=A.+E.+Rettieauthor=J.+P.+Jones&title=Charge+and+substituent+effects+on+affinity+and+metabolism+of+benzbromarone-based+CYP2C19+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm049605m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049605m%26sid%3Dliteratum%253Aachs%26aulast%3DLocuson%26aufirst%3DC.%2BW.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DRettie%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DCharge%2520and%2520substituent%2520effects%2520on%2520affinity%2520and%2520metabolism%2520of%2520benzbromarone-based%2520CYP2C19%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6768%26epage%3D6776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ridderstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamora, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fjellstrom, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, T. B.</span><span> </span><span class="NLM_article-title">Analysis of selective regions in the active sites of human cytochromes P450, 2C8, 2C9, 2C18, and 2C19 homology models using GRID/CPCA</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4072</span><span class="NLM_x">–</span> <span class="NLM_lpage">4081</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0109107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4072-4081&author=M.+Ridderstromauthor=I.+Zamoraauthor=O.+Fjellstromauthor=T.+B.+Andersson&title=Analysis+of+selective+regions+in+the+active+sites+of+human+cytochromes+P450%2C+2C8%2C+2C9%2C+2C18%2C+and+2C19+homology+models+using+GRID%2FCPCA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0109107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0109107%26sid%3Dliteratum%253Aachs%26aulast%3DRidderstrom%26aufirst%3DM.%26aulast%3DZamora%26aufirst%3DI.%26aulast%3DFjellstrom%26aufirst%3DO.%26aulast%3DAndersson%26aufirst%3DT.%2BB.%26atitle%3DAnalysis%2520of%2520selective%2520regions%2520in%2520the%2520active%2520sites%2520of%2520human%2520cytochromes%2520P450%252C%25202C8%252C%25202C9%252C%25202C18%252C%2520and%25202C19%2520homology%2520models%2520using%2520GRID%252FCPCA%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4072%26epage%3D4081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, D. F.</span><span> </span><span class="NLM_article-title">The metabolism of CYP2C9 and CYP2C19 for gliclazide by homology modeling and docking study</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">854</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=854-861&author=Y.+Yaoauthor=W.+W.+Hanauthor=Y.+H.+Zhouauthor=Z.+S.+Liauthor=Q.+Liauthor=X.+Y.+Chenauthor=D.+F.+Zhong&title=The+metabolism+of+CYP2C9+and+CYP2C19+for+gliclazide+by+homology+modeling+and+docking+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DW.%2BW.%26aulast%3DZhou%26aufirst%3DY.%2BH.%26aulast%3DLi%26aufirst%3DZ.%2BS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DX.%2BY.%26aulast%3DZhong%26aufirst%3DD.%2BF.%26atitle%3DThe%2520metabolism%2520of%2520CYP2C9%2520and%2520CYP2C19%2520for%2520gliclazide%2520by%2520homology%2520modeling%2520and%2520docking%2520study%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D854%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kneller, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haining, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trager, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettie, A. E.</span><span> </span><span class="NLM_article-title">(+)-<i>N</i>-3-Benzyl-nirvanol and (−)-<i>N</i>-3-Benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=235-239&author=H.+Suzukiauthor=M.+B.+Knellerauthor=R.+L.+Hainingauthor=W.+F.+Tragerauthor=A.+E.+Rettie&title=%28%2B%29-N-3-Benzyl-nirvanol+and+%28%E2%88%92%29-N-3-Benzyl-phenobarbital%3A+new+potent+and+selective+in+vitro+inhibitors+of+CYP2C19"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DKneller%26aufirst%3DM.%2BB.%26aulast%3DHaining%26aufirst%3DR.%2BL.%26aulast%3DTrager%26aufirst%3DW.%2BF.%26aulast%3DRettie%26aufirst%3DA.%2BE.%26atitle%3D%2528%252B%2529-N-3-Benzyl-nirvanol%2520and%2520%2528%25E2%2588%2592%2529-N-3-Benzyl-phenobarbital%253A%2520new%2520potent%2520and%2520selective%2520in%2520vitro%2520inhibitors%2520of%2520CYP2C19%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D235%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Houston, J. B.; Kenworthy, K. E.; Galetin, A.</span><span> </span><span class="NLM_article-title">Typical and Atypical Enzyme Kinetics</span>. In  <span class="citation_source-book">Drug Metabolizing Enzymes: Cytochrome P450 and Other Enzymes in Drug Discovery and Development</span>; <span class="NLM_contrib-group">Lee, J. S.; Obach, R. S.; Fisher, M. B.</span>, Eds.; <span class="NLM_publisher-name">Marcel Dekker</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1201%2F9781420028485.ch7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=211-254&author=J.+B.+Houston&author=K.+E.+Kenworthy&author=A.+Galetinauthor=J.+S.+Lee&author=R.+S.+Obach&author=M.+B.+Fisher&title=Drug+Metabolizing+Enzymes%3A+Cytochrome+P450+and+Other+Enzymes+in+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1201%2F9781420028485.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1201%252F9781420028485.ch7%26sid%3Dliteratum%253Aachs%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26atitle%3DTypical%2520and%2520Atypical%2520Enzyme%2520Kinetics%26btitle%3DDrug%2520Metabolizing%2520Enzymes%253A%2520Cytochrome%2520P450%2520and%2520Other%2520Enzymes%2520in%2520Drug%2520Discovery%2520and%2520Development%26aulast%3DLee%26aufirst%3DJ.%2BS.%26pub%3DMarcel%2520Dekker%26date%3D2003%26spage%3D211%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M.</span><span> </span><span class="NLM_article-title">Role of CYP3A4 in human hepatic diltiazem <i>N</i>-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=9223567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK2sXksFyitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1997&pages=294-300&author=D.+Suttonauthor=A.+M.+Butlerauthor=L.+Nadinauthor=M.+Murray&title=Role+of+CYP3A4+in+human+hepatic+diltiazem+N-demethylation%3A+inhibition+of+CYP3A4+activity+by+oxidized+diltiazem+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites</span></div><div class="casAuthors">Sutton, Dylan; Butler, Alison M.; Nadin, Louise; Murray, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">294-300</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The antihypertensive agent diltiazem (DTZ) impairs hepatic drug metab. by inhibition of cytochrome P 450 (CYP).  The accumulation of DTZ metabolites in serum occurs during prolonged therapy and leads to decreased DTZ elimination.  Thus, DTZ metabolites may contribute to CYP inhibition.  This study assessed the role of human CYPs in microsomal DTZ oxidn. and the capacity of DTZ metabolites to inhibit specific CYP activities.  DTZ N-demethylation varied 10-fold in microsomal fractions from 17 livers (0.33-3.31 nmol/mg of protein/min).  DTZ oxidn. was correlated with testosterone 6β-hydroxylation (r = 0.82) and, to a lesser extent, tolbutamide hydroxylation (r = 0.59) but not with activities mediated by CYP1A2 or CYP2E1.  CYP3A4 in lymphoblastoid cell microsomes catalyzed DTZ N-demethylation but CYP2C8 and CYP2C9 were also active (∼20% and 10% of the activity supported by CYP3A4); seven other CYPs produced little or no N-desmethyl DTZ from DTZ.  The CYP3A4 inhibitors ketoconazole and troleandomycin decreased microsomal DTZ oxidn., but inhibitors or substrates of CYP2C, CYP2D and CYP2E1 produced no inhibition.  Some inhibition was produced by α-naphthoflavone, a chem. that inhibits CYP1As and also interacts with CYP3A4.  In further expts., the capacities of DTZ and three metabolites to modulate human CYP 1A2, 1A2, 2E1, 2C9 and 3A4 activities were evaluated in vitro.  DTZ and its N-desmethyl and N,N-didesmethyl metabolites selectively inhibited CYP3A4 activity, whereas O-desmethyl DTZ was not inhibitory.  The IC50 value of DTZ against CYP3A4-mediated testosterone 6β-hydroxylation (substrate concn., 50 μM) was 120 μM.  The N-desmethyl (IC50 = 11 μM) and N,N-didesmethyl (IC50 = 0.6 μM) metabolites were 11 and 200 times, resp., more potent.  From kinetic studies, N-desmethyl DTZ and N,N-didesmethyl DTZ were potent competitive inhibitors of CYP3A4 (Ki = ∼2 and 0.1 μM, resp.).  CYP3A4 inhibition was enhanced when DTZ and N-desmethyl DTZ underwent biotransformation in NADPH-supplemented hepatic microsomes in vitro, supporting the contention that inhibitory metabolites may be generated in situ.  These findings suggest that N-demethylation metabolites of DTZ may contribute to CYP3A4 inhibition in vivo, esp. under conditions in which N-desmethyl DTZ accumulates, such as during prolonged DTZ therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIL8o2n_0Da7Vg90H21EOLACvtfcHk0lj6_Hctv0aXfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFyitb0%253D&md5=1b1cb145c6246ca57f1455963adc721c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DButler%26aufirst%3DA.%2BM.%26aulast%3DNadin%26aufirst%3DL.%26aulast%3DMurray%26aufirst%3DM.%26atitle%3DRole%2520of%2520CYP3A4%2520in%2520human%2520hepatic%2520diltiazem%2520N-demethylation%253A%2520inhibition%2520of%2520CYP3A4%2520activity%2520by%2520oxidized%2520diltiazem%2520metabolites%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D282%26spage%3D294%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Fukushima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushimaru, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, S.</span><span> </span><span class="NLM_article-title">On the error of the dixon plot for estimating the inhibition constant between enzyme and inhibitor</span> <span class="citation_source-journal">Biochem. Mol. Biol. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1002%2Fbmb.2002.494030020022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Wrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=90-92&author=Y.+Fukushimaauthor=M.+Ushimaruauthor=S.+Takahara&title=On+the+error+of+the+dixon+plot+for+estimating+the+inhibition+constant+between+enzyme+and+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">On the error of the Dixon plot for estimating the inhibition constant between enzyme and inhibitor</span></div><div class="casAuthors">Fukushima, Yoshihiro; Ushimaru, Makoto; Takahara, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Molecular Biology Education</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">90-92</span>CODEN:
                <span class="NLM_cas:coden">BMBECE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8175</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">In textbook treatments of enzyme inhibition kinetics, adjustment of the initial inhibitor concn. for inhibitor bound to enzyme is often neglected.  A specific example is the graphical plots such as the Dixon plot for estn. of an inhibition const., wherein the initial concn. of inhibitor is usually plotted instead of the true inhibitor concn.  Justification for this approxn. should be presented to students because, under certain conditions, it can be inaccurate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0VACMt3YGvbVg90H21EOLACvtfcHk0lj6_Hctv0aXfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Wrs7g%253D&md5=139fbc08827730873c2457169958a8f4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fbmb.2002.494030020022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbmb.2002.494030020022%26sid%3Dliteratum%253Aachs%26aulast%3DFukushima%26aufirst%3DY.%26aulast%3DUshimaru%26aufirst%3DM.%26aulast%3DTakahara%26aufirst%3DS.%26atitle%3DOn%2520the%2520error%2520of%2520the%2520dixon%2520plot%2520for%2520estimating%2520the%2520inhibition%2520constant%2520between%2520enzyme%2520and%2520inhibitor%26jtitle%3DBiochem.%2520Mol.%2520Biol.%2520Ed.%26date%3D2002%26volume%3D30%26spage%3D90%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Carter, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leighton-Davies, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, S. J.</span><span> </span><span class="NLM_article-title">Miniaturized receptor binding assays: complications arising from ligand depletion</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1177%2F1087057106297788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=17259589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=255-266&author=C.+M.+Carterauthor=J.+R.+Leighton-Daviesauthor=S.+J.+Charlton&title=Miniaturized+receptor+binding+assays%3A+complications+arising+from+ligand+depletion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Miniaturized receptor binding assays: complications arising from ligand depletion</span></div><div class="casAuthors">Carter, Clare M. Scaramellini; Leighton-Davies, Juliet R.; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-266</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The advent of miniaturized assay formats has made possible the screening of large nos. of compds. against a single target, known as high-throughput screening.  Despite this clear advantage, assay miniaturization also increases the risk of ligand depletion, where the actual concn. of free ligand is significantly lower than that added.  This, in turn, complicates the interpretation of data from such assays, potentially introducing significant error if not recognized.  In this study, the effects of reducing assay vol. on radioligand Kd and competitor Ki values have been investigated, using the muscarinic M3 receptor as a model system.  It was found that assay miniaturization caused dramatic effects, with up to a 30-fold underestimation of ligand affinity.  A theor. model was developed and shown to accurately predict both the degree of ligand depletion in any given assay vol. and the effect of this depletion on affinity ests. for competing ligands.  Importantly, it was found that in most cases, errors introduced by ligand depletion could be largely cor. for by the use of appropriate anal. methods.  In addn. to those previously described by others, the authors propose a simple method capable of correcting errors in competition binding expts. performed in conditions of ligand depletion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGKpq8YM5oA7Vg90H21EOLACvtfcHk0ljglZU8XXFk2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFOhtb8%253D&md5=b198ce18b79c32cb5fccc20ebd54296e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1177%2F1087057106297788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057106297788%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DC.%2BM.%26aulast%3DLeighton-Davies%26aufirst%3DJ.%2BR.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DMiniaturized%2520receptor%2520binding%2520assays%253A%2520complications%2520arising%2520from%2520ligand%2520depletion%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2007%26volume%3D12%26spage%3D255%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lewis, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lake, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickins, M.</span><span> </span><span class="NLM_article-title">Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1080%2F14756360600703313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=17059170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=385-389&author=D.+F.+Lewisauthor=B.+G.+Lakeauthor=Y.+Itoauthor=M.+Dickins&title=Lipophilicity+relationships+in+inhibitors+of+CYP2C9+and+CYP2C19+enzymes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes</span></div><div class="casAuthors">Lewis, David F. V.; Lake, Brian G.; Ito, Yuko; Dickins, Maurice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">385-389</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Quant. structure-activity relationships (QSARs) within a series of cytochrome P 450 2C9 (CYP2C9) and cytochrome P 450 2C19 (CYP2C19) inhibitors are reported.  In particular, it is noted that compd. lipophilicity, in the form of log P values (where P is the octanol/water partition coeff.), is an important factor in explaining the variation in inhibitory potency within these series of compds., many of which also act as substrates for the resp. enzymes.  In addn., there is a role for hydrogen bonding and π-π stacking interactions within the P 450 active site which represent secondary factors in the binding processes of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNFMf7Q5FnTrVg90H21EOLACvtfcHk0ljglZU8XXFk2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqsLbP&md5=39391ac9ab130651bc962437d49489a9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1080%2F14756360600703313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360600703313%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BF.%26aulast%3DLake%26aufirst%3DB.%2BG.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DDickins%26aufirst%3DM.%26atitle%3DLipophilicity%2520relationships%2520in%2520inhibitors%2520of%2520CYP2C9%2520and%2520CYP2C19%2520enzymes%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2006%26volume%3D21%26spage%3D385%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kneller, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trager, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettie, A. E.</span><span> </span><span class="NLM_article-title">Active-site characteristics of CYP2C19 and CYP2C9 probed with hydantoin and barbiturate inhibitors</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">429</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2004&pages=1-15&author=H.+Suzukiauthor=M.+B.+Knellerauthor=D.+A.+Rockauthor=J.+P.+Jonesauthor=W.+F.+Tragerauthor=A.+E.+Rettie&title=Active-site+characteristics+of+CYP2C19+and+CYP2C9+probed+with+hydantoin+and+barbiturate+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DKneller%26aufirst%3DM.%2BB.%26aulast%3DRock%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DTrager%26aufirst%3DW.%2BF.%26aulast%3DRettie%26aufirst%3DA.%2BE.%26atitle%3DActive-site%2520characteristics%2520of%2520CYP2C19%2520and%2520CYP2C9%2520probed%2520with%2520hydantoin%2520and%2520barbiturate%2520inhibitors%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2004%26volume%3D429%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Three and four dimensional-quantitative structure–activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span> <span class="citation_source-journal">Pharmacogenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=10780267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=477-489&author=S.+Ekinsauthor=G.+Braviauthor=S.+Binkleyauthor=J.+S.+Gillespieauthor=B.+J.+Ringauthor=J.+H.+Wikelauthor=S.+A.+Wrighton&title=Three+and+four+dimensional-quantitative+structure%E2%80%93activity+relationship+%283D%2F4D-QSAR%29+analyses+of+CYP2D6+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span></div><div class="casAuthors">Ekins, Sean; Bravi, Gianpaolo; Binkley, Shelly; Gillespie, Jennifer S.; Ring, Barbara J.; Wikel, James H.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-489</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Three- and four-dimensional quant. structure activity relationship (3D/4D-QSAR) pharmacophore models of competitive inhibitors of CYP2D6 were constructed using data from our lab. or the literature.  The 3D-QSAR pharmacophore models of the common structural features of CYP2D6 inhibitors were built using the program Catalyst (Mol. Simulations, San Diego, CA, USA).  These 3D-QSAR models were compared with 3D and 4D-QSAR partial least squares (PLS) models which were constructed using mol. surface-weighted holistic invariant mol. (MS-WHIM) descriptors of size and shape of inhibitors.  The first Catalyst model was generated from multiple conformers of competitive inhibitors (n = 20) of CYP2D6 mediated bufurolol 1'-hydroxylation.  This model demonstrated a correlation of obsd. and predicted Ki (apparent) values of r = 0.75.  A second Catalyst model was constructed from literature derived Ki (apparent) values (n = 31) for the inhibition of CYP2D6.  This model provided a correlation of obsd. and predicted inhibition for CYP2D6 of r = 0.91.  Both Catalyst Ki pharmacophores were then validated by predicting the Ki (apparent) of a test set of known CYP2D6 inhibitors (n = 15).  Ten out of 15 of these Ki (apparent) values were predicted to be within one log residual of the obsd. value using our CYP2D6 inhibitor model, while the literature model predicted nine out of 15 values.  Similarly, 3D- and 4D-QSARs derived from PLS MS-WHIM for our dataset yielded predictable models as assessed using cross-validation.  The corresponding cross-validated PLS MS-WHIM model for the literature dataset yielded a comparable 3D-QSAR and improved 4D-QSAR value.  Such computational models will aid in future prediction of drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcRiE7XUQvY7Vg90H21EOLACvtfcHk0ljglZU8XXFk2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D&md5=b714320963218c19c858e31376b9b528</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DBravi%26aufirst%3DG.%26aulast%3DBinkley%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BS.%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DWikel%26aufirst%3DJ.%2BH.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThree%2520and%2520four%2520dimensional-quantitative%2520structure%25E2%2580%2593activity%2520relationship%2520%25283D%252F4D-QSAR%2529%2520analyses%2520of%2520CYP2D6%2520inhibitors%26jtitle%3DPharmacogenetics%26date%3D1999%26volume%3D9%26spage%3D477%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Three- and four-dimensional quantitative structure–activity relationship analyses of cytochrome P-450 3A4 inhibitors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=10381809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK1MXktFKit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1999&pages=429-438&author=S.+Ekinsauthor=G.+Braviauthor=S.+Binkleyauthor=J.+S.+Gillespieauthor=B.+J.+Ringauthor=J.+H.+Wikelauthor=S.+A.+Wrighton&title=Three-+and+four-dimensional+quantitative+structure%E2%80%93activity+relationship+analyses+of+cytochrome+P-450+3A4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors</span></div><div class="casAuthors">Ekins, Sean; Bravi, Gianpaolo; Binkley, Shelly; Gillespie, Jennifer S.; Ring, Barbara J.; Wikel, James H.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">429-438</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The program Catalyst was used to build three-dimensional quant. structure activity relationship (3D-QSAR) pharmacophore models of the structural features common to competitive-type inhibitors of cytochrome P 450 (CYP) 3A4.  These were compared with 3D- and four-dimensional (4D)-QSAR partial least-squares (PLS) models built using mol. surface-weighted holistic invariant mol. (MS-WHIM) descriptors for size and shape of the inhibitor.  The Catalyst pharmacophore model generated from multiple conformers of competitive inhibitors of CYP3A4-mediated midazolam 1'-hydroxylation (n = 14) yielded a high correlation of obsd. and predicted Ki values of r = 0.91.  Similarly, PLS MS-WHIM was used to produce 3D- and 4D-QSARs for this data set and produced models that were statistically predictable after cross-validation.  Two addnl. Catalyst pharmacophores were constructed from literature Ki values (n = 32) derived from the inhibition of CYP3A-mediated cyclosporin A metab. and IC50 data (n = 22) from the inhibition of CYP3A4-mediated quinine 3-hydroxylation.  These Catalyst pharmacophores illustrated correlations of obsd. and predicted inhibition for CYP3A4 of r = 0.77 and 0.92, resp.  The corresponding 4D-QSARs generated by PLS MS-WHIM for these data sets were of comparable quality as judged by cross-validation.  Both Ki pharmacophores generated with Catalyst were also validated by predicting the Ki(apparent) values of a test set of eight CYP3A4 inhibitors not included in either model.  In seven of eight cases, the residuals of the predicted Ki(apparent) values were within 1 log unit of the obsd. values.  The 3D- and 4D-QSAR models produced in this study suggest the utility of future in silico prediction of CYP3A4-mediated drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNq8OnkSOfqbVg90H21EOLACvtfcHk0lh5M05F-dj85g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFKit7s%253D&md5=3b298a468a1544616bffad2cf5f1344a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DBravi%26aufirst%3DG.%26aulast%3DBinkley%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BS.%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DWikel%26aufirst%3DJ.%2BH.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThree-%2520and%2520four-dimensional%2520quantitative%2520structure%25E2%2580%2593activity%2520relationship%2520analyses%2520of%2520cytochrome%2520P-450%25203A4%2520inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D290%26spage%3D429%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">Pharmacophore and three-dimensional quantitative structure–activity relationship methods for modeling cytochrome p450 active sites</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=936-944&author=S.+Ekinsauthor=M.+J.+de+Grootauthor=J.+P.+Jones&title=Pharmacophore+and+three-dimensional+quantitative+structure%E2%80%93activity+relationship+methods+for+modeling+cytochrome+p450+active+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DPharmacophore%2520and%2520three-dimensional%2520quantitative%2520structure%25E2%2580%2593activity%2520relationship%2520methods%2520for%2520modeling%2520cytochrome%2520p450%2520active%2520sites%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2001%26volume%3D29%26spage%3D936%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Sciabola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morao, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M. J.</span><span> </span><span class="NLM_article-title">Pharmacophoric fingerprint method (TOPP) for 3D-QSAR modeling: application to CYP2D6 metabolic stability</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci060143q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2it7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=76-84&author=S.+Sciabolaauthor=I.+Moraoauthor=M.+J.+de+Groot&title=Pharmacophoric+fingerprint+method+%28TOPP%29+for+3D-QSAR+modeling%3A+application+to+CYP2D6+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophoric Fingerprint Method (TOPP) for 3D-QSAR Modeling: Application to CYP2D6 Metabolic Stability</span></div><div class="casAuthors">Sciabola, Simone; Morao, Inaki; de Groot, Marcel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-84</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The application of a new 3-point pharmacophore-fingerprinting package (TOPP, Triplets Of Pharmacophoric Points) to develop QSAR models is discussed.  In the CYP2D6 metabolic stability case, these 3D pharmacophoric fingerprints have shown to be as valid as other 3D descriptors and 2D features.  Interestingly, it was found in the 3D models that the use of more realistic substrate conformations, by an addnl. docking step, did not improve the statistical results significantly.  A detailed anal. of the generated pharmacophoric hypotheses is consistent with the previously proposed dual interaction mode of substrates within the active site of CYP2D6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZRgg9XUktNbVg90H21EOLACvtfcHk0lh5M05F-dj85g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2it7fP&md5=5e15dc4e7bd371ca4b7e92dc32cec393</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fci060143q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci060143q%26sid%3Dliteratum%253Aachs%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DMorao%26aufirst%3DI.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26atitle%3DPharmacophoric%2520fingerprint%2520method%2520%2528TOPP%2529%2520for%25203D-QSAR%2520modeling%253A%2520application%2520to%2520CYP2D6%2520metabolic%2520stability%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D76%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leydon, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxbrow, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenery, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. M.</span><span> </span><span class="NLM_article-title">Crystal structure of human cytochrome P450 2D6</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7614</span><span class="NLM_x">–</span> <span class="NLM_lpage">7622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1074%2Fjbc.M511232200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=16352597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ygtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7614-7622&author=P.+Rowlandauthor=F.+E.+Blaneyauthor=M.+G.+Smythauthor=J.+J.+Jonesauthor=V.+R.+Leydonauthor=A.+K.+Oxbrowauthor=C.+J.+Lewisauthor=M.+G.+Tennantauthor=S.+Modiauthor=D.+S.+Egglestonauthor=R.+J.+Cheneryauthor=A.+M.+Bridges&title=Crystal+structure+of+human+cytochrome+P450+2D6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human cytochrome P 450 2D6</span></div><div class="casAuthors">Rowland, Paul; Blaney, Frank E.; Smyth, Martin G.; Jones, Jo J.; Leydon, Vaughan R.; Oxbrow, Amanda K.; Lewis, Ceri J.; Tennant, Mike G.; Modi, Sandeep; Eggleston, Drake S.; Chenery, Richard J.; Bridges, Angela M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7614-7622</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 2D6 is a heme-contg. enzyme that is responsible for the metab. of at least 20% of known drugs.  Substrates of 2D6 typically contain a basic N atom and a planar arom. ring.  Here, the crystal structure of human 2D6 was solved and refined to 3.0Å resoln.  The structure showed the characteristic P 450 fold as seen in other members of the family, with the lengths and orientations of the individual secondary structural elements being very similar to those seen in 2C9.  There were, however, several important differences, the most notable involving the F helix, the F-G loop, the B' helix, β-sheet 4, and part of β-sheet 1, all of which were situated on the distal face of the protein.  The 2D6 structure had a well-defined active site cavity above the heme group, contg. many important residues that have been implicated in substrate recognition and binding, including Asp-301, Glu-216, Phe-483, and Phe-120.  The crystal structure helped to explain how Asp-301, Glu-216, and Phe-483 could act as substrate-binding residues and suggested that the role of Phe-120 is to control the orientation of the arom. ring found in most substrates with respect to the heme.  The structure was compared with published homol. models and has been used to explain much of the reported site-directed mutagenesis data and to help understand the metab. of several compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon7FdjHI2WD7Vg90H21EOLACvtfcHk0lh5M05F-dj85g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ygtbg%253D&md5=f31403bf56fadab86a694b1add06859c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M511232200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M511232200%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DSmyth%26aufirst%3DM.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BJ.%26aulast%3DLeydon%26aufirst%3DV.%2BR.%26aulast%3DOxbrow%26aufirst%3DA.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DChenery%26aufirst%3DR.%2BJ.%26aulast%3DBridges%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520human%2520cytochrome%2520P450%25202D6%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7614%26epage%3D7622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Schoch, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span> </span><span class="NLM_article-title">Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">9497</span><span class="NLM_x">–</span> <span class="NLM_lpage">9503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1074%2Fjbc.M312516200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=14676196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Omt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=9497-9503&author=G.+A.+Schochauthor=J.+K.+Yanoauthor=M.+R.+Westerauthor=K.+J.+Griffinauthor=C.+D.+Stoutauthor=E.+F.+Johnson&title=Structure+of+human+microsomal+cytochrome+P450+2C8.+Evidence+for+a+peripheral+fatty+acid+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Human Microsomal Cytochrome P450 2C8: evidence for a peripheral fatty acid binding site</span></div><div class="casAuthors">Schoch, Guillaume A.; Yano, Jason K.; Wester, Michael R.; Griffin, Keith J.; Stout, C. David; Johnson, Eric F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">9497-9503</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A 2.7-Å mol. structure of human microsomal cytochrome P 450 2C8 (CYP2C8) was detd. by x-ray crystallog.  The membrane protein was modified for crystn. by replacement of the hydrophobic N-terminal transmembrane domain with a short hydrophilic sequence before residue 28.  The structure of the native sequence is complete from residue 28 to the beginning of a C-terminal histidine tag used for purifn.  CYP2C8 is one of the principal hepatic drug-metabolizing enzymes that oxidizes therapeutic drugs such as taxol and cerivastatin and endobiotics such as retinoic acid and arachidonic acid.  Consistent with the relatively large size of its preferred substrates, the active site vol. is twice that obsd. for the structure of CYP2C5.  The extended active site cavity is bounded by the β1 sheet and helix F' that have not previously been implicated in substrate recognition by mammalian P450s.  CYP2C8 crystd. as a sym. dimer formed by the interaction of helixes F, F', G', and G.  Two mols. of palmitic acid are bound in the dimer interface.  The dimer is obsd. in soln., and mass spectrometry confirmed the assocn. of palmitic acid with the enzyme.  This novel finding identifies a peripheral binding site in P450s that may contribute to drug-drug interactions in P 450 metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM_mLgb6K1XrVg90H21EOLACvtfcHk0ljzL7yJjNoYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Omt78%253D&md5=433aca9f612b396ff3cc6f30291200a2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M312516200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M312516200%26sid%3Dliteratum%253Aachs%26aulast%3DSchoch%26aufirst%3DG.%2BA.%26aulast%3DYano%26aufirst%3DJ.%2BK.%26aulast%3DWester%26aufirst%3DM.%2BR.%26aulast%3DGriffin%26aufirst%3DK.%2BJ.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26atitle%3DStructure%2520of%2520human%2520microsomal%2520cytochrome%2520P450%25202C8.%2520Evidence%2520for%2520a%2520peripheral%2520fatty%2520acid%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D9497%26epage%3D9503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Wester, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span> </span><span class="NLM_article-title">The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">35630</span><span class="NLM_x">–</span> <span class="NLM_lpage">35637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=35630-35637&author=M.+R.+Westerauthor=J.+K.+Yanoauthor=G.+A.+Schochauthor=C.+Yangauthor=K.+J.+Griffinauthor=C.+D.+Stoutauthor=E.+F.+Johnson&title=The+structure+of+human+cytochrome+P450+2C9+complexed+with+flurbiprofen+at+2.0-A+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWester%26aufirst%3DM.%2BR.%26aulast%3DYano%26aufirst%3DJ.%2BK.%26aulast%3DSchoch%26aufirst%3DG.%2BA.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DGriffin%26aufirst%3DK.%2BJ.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26atitle%3DThe%2520structure%2520of%2520human%2520cytochrome%2520P450%25202C9%2520complexed%2520with%2520flurbiprofen%2520at%25202.0-A%2520resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D35630%26epage%3D35637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Williams, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angove, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matak Vinkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Crystal structure of human cytochrome P450 2C9 with bound warfarin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">424</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1038%2Fnature01862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=12861225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1aqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2003&pages=464-468&author=P.+A.+Williamsauthor=J.+Cosmeauthor=A.+Wardauthor=H.+C.+Angoveauthor=D.+Matak+Vinkovicauthor=H.+Jhoti&title=Crystal+structure+of+human+cytochrome+P450+2C9+with+bound+warfarin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human cytochrome P450 2C9 with bound warfarin</span></div><div class="casAuthors">Williams, Pamela A.; Cosme, Jose; Ward, Alison; Angove, Hayley C.; Vinkovic, Dijana Matak; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">424</span>
        (<span class="NLM_cas:issue">6947</span>),
    <span class="NLM_cas:pages">464-468</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cytochrome P 450 proteins (CYP450s) are membrane-assocd. heme proteins that metabolize physiol. important compds. in many species of microorganisms, plants and animals.  Mammalian CYP450s recognize and metabolize diverse xenobiotics such as drug mols., environmental compds. and pollutants.  Human CYP450 proteins CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 are the major drug-metabolizing isoforms, and contribute to the oxidative metab. of more than 90% of the drugs in current clin. use.  Polymorphic variants have also been reported for some CYP450 isoforms, which has implications for the efficacy of drugs in individuals, and for the co-administration of drugs.  The mol. basis of drug recognition by human CYP450s, however, has remained elusive.  Here the authors describe the crystal structure of a human CYP450, CYP2C9, both unliganded and in complex with the anti-coagulant drug warfarin.  The structure defines unanticipated interactions between CYP2C9 and warfarin, and reveals a new binding pocket.  The binding mode of warfarin suggests that CYP2C9 may undergo an allosteric mechanism during its function.  The newly discovered binding pocket also suggests that CYP2C9 may simultaneously accommodate multiple ligands during its biol. function, and provides a possible mol. basis for understanding complex drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogGWLKcJNO47Vg90H21EOLACvtfcHk0ljzL7yJjNoYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1aqtrk%253D&md5=f5bcc91bd3c7c1332506f7671a09da6f</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature01862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01862%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DCosme%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DA.%26aulast%3DAngove%26aufirst%3DH.%2BC.%26aulast%3DMatak%2BVinkovic%26aufirst%3DD.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520human%2520cytochrome%2520P450%25202C9%2520with%2520bound%2520warfarin%26jtitle%3DNature%26date%3D2003%26volume%3D424%26spage%3D464%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Yano, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span> </span><span class="NLM_article-title">The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">38091</span><span class="NLM_x">–</span> <span class="NLM_lpage">38094</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1074%2Fjbc.C400293200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=15258162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1Oqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=38091-38094&author=J.+K.+Yanoauthor=M.+R.+Westerauthor=G.+A.+Schochauthor=K.+J.+Griffinauthor=C.+D.+Stoutauthor=E.+F.+Johnson&title=The+structure+of+human+microsomal+cytochrome+P450+3A4+determined+by+X-ray+crystallography+to+2.05-A+resolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution</span></div><div class="casAuthors">Yano, Jason K.; Wester, Michael R.; Schoch, Guillaume A.; Griffin, Keith J.; Stout, C. David; Johnson, Eric F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">38091-38094</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The structure of P 450 3A4 was detd. by x-ray crystallog. to 2.05-Å resoln.  P 450 3A4 catalyzes the metabolic clearance of a large no. of clin. used drugs, and a no. of adverse drug-drug interactions reflect the inhibition or induction of the enzyme.  P 450 3A4 exhibits a relatively large substrate-binding cavity that is consistent with its capacity to oxidize bulky substrates such as cyclosporin, statins, taxanes, and macrolide antibiotics.  Family 3A P450s also exhibit unusual kinetic characteristics that suggest simultaneous occupancy by smaller substrates.  Although the active site vol. is similar to that of P 450 2C8 (PDB code: 1PQ2), the shape of the active site cavity differs considerably due to differences in the folding and packing of portions of the protein that form the cavity.  Compared with P 450 2C8, the active site cavity of 3A4 is much larger near the heme iron.  The lower constraints on the motions of small substrates near the site of oxygen activation may diminish the efficiency of substrate oxidn., which may in turn be improved by space restrictions imposed by the presence of a second substrate mol.  The structure of P 450 3A4 should facilitate a better understanding of the substrate selectivity of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpOI8NmLt-drVg90H21EOLACvtfcHk0ljzL7yJjNoYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1Oqs7c%253D&md5=59a8fa760069d365165ddeeb9e4081d4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C400293200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C400293200%26sid%3Dliteratum%253Aachs%26aulast%3DYano%26aufirst%3DJ.%2BK.%26aulast%3DWester%26aufirst%3DM.%2BR.%26aulast%3DSchoch%26aufirst%3DG.%2BA.%26aulast%3DGriffin%26aufirst%3DK.%2BJ.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26atitle%3DThe%2520structure%2520of%2520human%2520microsomal%2520cytochrome%2520P450%25203A4%2520determined%2520by%2520X-ray%2520crystallography%2520to%25202.05-A%2520resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D38091%26epage%3D38094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Na Ye, Bang Li, Qi Mao, Eric A. Wold, Sheng Tian, John A. Allen, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 190-200. <a href="https://doi.org/10.1021/acschemneuro.8b00572" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00572%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DOrphan%252BReceptor%252BGPR88%252Bas%252Ban%252BEmerging%252BNeurotherapeutic%252BTarget%26aulast%3DYe%26aufirst%3DNa%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D23102018%26date%3D12122018%26date%3D20122018%26date%3D12122018%26volume%3D10%26issue%3D1%26spage%3D190%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tzuen-Yang  Ye</span>, <span class="hlFld-ContribAuthor ">Manikandan  Selvaraju</span>, and <span class="hlFld-ContribAuthor ">Chung-Ming  Sun</span>  . </span><span class="cited-content_cbyCitation_article-title">Cascade Synthesis of Benzimidazole-Linked Pyrroles via Copper Catalyzed Oxidative Cyclization and Ketonization. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (12)
                                     , 3103-3106. <a href="https://doi.org/10.1021/acs.orglett.7b01224" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b01224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b01224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b01224%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCascade%252BSynthesis%252Bof%252BBenzimidazole-Linked%252BPyrroles%252Bvia%252BCopper%252BCatalyzed%252BOxidative%252BCyclization%252Band%252BKetonization%26aulast%3DYe%26aufirst%3DTzuen-Yang%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23042017%26date%3D05062017%26date%3D16062017%26volume%3D19%26issue%3D12%26spage%3D3103%26epage%3D3106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip  Dhole</span>, <span class="hlFld-ContribAuthor ">Manikandan  Selvaraju</span>, <span class="hlFld-ContribAuthor ">Barnali  Maiti</span>, <span class="hlFld-ContribAuthor ">Kaushik  Chanda</span>, and <span class="hlFld-ContribAuthor ">Chung-Ming  Sun</span>  . </span><span class="cited-content_cbyCitation_article-title">Microwave Controlled Reductive Cyclization: A Selective Synthesis of Novel Benzimidazole-alkyloxypyrrolo[1,2-a]quinoxalinones. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2015,</strong> <em>17 </em>
                                    (5)
                                     , 310-316. <a href="https://doi.org/10.1021/acscombsci.5b00010" title="DOI URL">https://doi.org/10.1021/acscombsci.5b00010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.5b00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.5b00010%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DMicrowave%252BControlled%252BReductive%252BCyclization%25253A%252BA%252BSelective%252BSynthesis%252Bof%252BNovel%252BBenzimidazole-alkyloxypyrrolo%25255B1%25252C2-a%25255Dquinoxalinones%26aulast%3DDhole%26aufirst%3DSandip%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D2015%26date%3D15042014%26date%3D12042015%26date%3D21042015%26date%3D11052015%26volume%3D17%26issue%3D5%26spage%3D310%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xun  Ji</span>, <span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jinfang  Wang</span>, <span class="hlFld-ContribAuthor ">Linxiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Au(I)/Ag(I)-Catalyzed Cascade Approach for the Synthesis of Benzo[4,5]imidazo[1,2-c]pyrrolo[1,2-a]quinazolinones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (9)
                                     , 4312-4318. <a href="https://doi.org/10.1021/jo400228g" title="DOI URL">https://doi.org/10.1021/jo400228g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo400228g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo400228g%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAu%252528I%252529%25252FAg%252528I%252529-Catalyzed%252BCascade%252BApproach%252Bfor%252Bthe%252BSynthesis%252Bof%252BBenzo%25255B4%25252C5%25255Dimidazo%25255B1%25252C2-c%25255Dpyrrolo%25255B1%25252C2-a%25255Dquinazolinones%26aulast%3DJi%26aufirst%3DXun%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08022013%26date%3D19042013%26date%3D03052013%26date%3D04042013%26volume%3D78%26issue%3D9%26spage%3D4312%26epage%3D4318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eun  Gong</span>, <span class="hlFld-ContribAuthor ">Satya  Chea</span>, <span class="hlFld-ContribAuthor ">Anand  Balupuri</span>, <span class="hlFld-ContribAuthor ">Nam  Kang</span>, <span class="hlFld-ContribAuthor ">Young-Won  Chin</span>, <span class="hlFld-ContribAuthor ">Young  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (3)
                                     , 555. <a href="https://doi.org/10.3390/molecules23030555" title="DOI URL">https://doi.org/10.3390/molecules23030555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23030555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23030555%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEnzyme%252BKinetics%252Band%252BMolecular%252BDocking%252BStudies%252Bon%252BCytochrome%252B2B6%25252C%252B2C19%25252C%252B2E1%25252C%252Band%252B3A4%252BActivities%252Bby%252BSauchinone%26aulast%3DGong%26aufirst%3DEun%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junhao  Li</span>, <span class="hlFld-ContribAuthor ">Hanwen  Du</span>, <span class="hlFld-ContribAuthor ">Zengrui  Wu</span>, <span class="hlFld-ContribAuthor ">Haixia  Su</span>, <span class="hlFld-ContribAuthor ">Guixia  Liu</span>, <span class="hlFld-ContribAuthor ">Yun  Tang</span>, <span class="hlFld-ContribAuthor ">Weihua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Interactions of omeprazole-based analogues with cytochrome P450 2C19: a computational study. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2016,</strong> <em>12 </em>
                                    (6)
                                     , 1913-1921. <a href="https://doi.org/10.1039/C6MB00139D" title="DOI URL">https://doi.org/10.1039/C6MB00139D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MB00139D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MB00139D%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DInteractions%252Bof%252Bomeprazole-based%252Banalogues%252Bwith%252Bcytochrome%252BP450%252B2C19%25253A%252Ba%252Bcomputational%252Bstudy%26aulast%3DLi%26aufirst%3DJunhao%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D6%26spage%3D1913%26epage%3D1921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaisa A.  Salminen</span>, <span class="hlFld-ContribAuthor ">Minna  Rahnasto-Rilla</span>, <span class="hlFld-ContribAuthor ">Raija  Väänänen</span>, <span class="hlFld-ContribAuthor ">Peter  Imming</span>, <span class="hlFld-ContribAuthor ">Achim  Meyer</span>, <span class="hlFld-ContribAuthor ">Aline  Horling</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">Hannu  Raunio</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>. </span><span class="cited-content_cbyCitation_article-title">Time-Dependent Inhibition of CYP2C19 by Isoquinoline Alkaloids: In Vitro and In Silico Analysis. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2015,</strong> <em>43 </em>
                                    (12)
                                     , 1891-1904. <a href="https://doi.org/10.1124/dmd.115.065755" title="DOI URL">https://doi.org/10.1124/dmd.115.065755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.115.065755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.115.065755%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DTime-Dependent%252BInhibition%252Bof%252BCYP2C19%252Bby%252BIsoquinoline%252BAlkaloids%25253A%252BIn%252BVitro%252Band%252BIn%252BSilico%252BAnalysis%26aulast%3DSalminen%26aufirst%3DKaisa%2BA.%26date%3D2015%26date%3D2015%26volume%3D43%26issue%3D12%26spage%3D1891%26epage%3D1904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teresa  Kaserer</span>, <span class="hlFld-ContribAuthor ">Veronika  Temml</span>, <span class="hlFld-ContribAuthor ">Daniela  Schuster</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore‐Based Methods for Predicting the Inhibition and Induction of Metabolic Enzymes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 351-372. <a href="https://doi.org/10.1002/9783527673261.ch14" title="DOI URL">https://doi.org/10.1002/9783527673261.ch14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527673261.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527673261.ch14%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacophore%2525E2%252580%252590Based%252BMethods%252Bfor%252BPredicting%252Bthe%252BInhibition%252Band%252BInduction%252Bof%252BMetabolic%252BEnzymes%26aulast%3DKaserer%26aufirst%3DTeresa%26date%3D2014%26date%3D2014%26spage%3D351%26epage%3D372%26pub%3DWiley%26atitle%3DDrug%252BMetabolism%252BPrediction%26aulast%3DKirchmair%26aufirst%3DJohannes%26date%3D2014%26date%3D2014%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica H.  Hartman</span>, <span class="hlFld-ContribAuthor ">Steven D.  Cothren</span>, <span class="hlFld-ContribAuthor ">Sun-Ha  Park</span>, <span class="hlFld-ContribAuthor ">Chul-Ho  Yun</span>, <span class="hlFld-ContribAuthor ">Jerry A.  Darsey</span>, <span class="hlFld-ContribAuthor ">Grover P.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Predicting CYP2C19 catalytic parameters for enantioselective oxidations using artificial neural networks and a chirality code. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (13)
                                     , 3749-3759. <a href="https://doi.org/10.1016/j.bmc.2013.04.044" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.04.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.04.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.04.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPredicting%252BCYP2C19%252Bcatalytic%252Bparameters%252Bfor%252Benantioselective%252Boxidations%252Busing%252Bartificial%252Bneural%252Bnetworks%252Band%252Ba%252Bchirality%252Bcode%26aulast%3DHartman%26aufirst%3DJessica%2BH.%26date%3D2013%26volume%3D21%26issue%3D13%26spage%3D3749%26epage%3D3759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Tactics to Avoid Inhibition of Cytochrome P450s. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 107-158. <a href="https://doi.org/10.1007/7355_2013_25" title="DOI URL">https://doi.org/10.1007/7355_2013_25</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2013_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2013_25%26sid%3Dliteratum%253Aachs%26atitle%3DTactics%252Bto%252BAvoid%252BInhibition%252Bof%252BCytochrome%252BP450s%26aulast%3DLeach%26aufirst%3DAndrew%2BG.%26date%3D2013%26date%3D2013%26spage%3D107%26epage%3D158%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTactics%252Bin%252BContemporary%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. General synthetic route for the omeprazole-based analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CYP2C19 inhibition pharmacophore model for the omeprazole-based analogues. The features for this five-feature model corresponded to the hydrogen bond accepting (blue) and donating (pink) features of the benzimidazole nitrogens, the hydrophobicity of the side chains off of the sulfur atom and the benzimidazole moiety (green), and the aromaticity of the benzimidazole rings (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CYP2C19 metabolism pharmacophore model for the omeprazole-based analogues. The five features for the metabolism pharmacophore model corresponded to the hydrogen bond accepting properties of a benzimidazole nitrogen and the oxygen atom of the benzimidazole methoxy moiety (pink), the hydrogen bond donating properties of the second benzimidazole nitrogen (blue), the hydrophobicity of the side chains off of the sulfur atom (green), and the aromaticity of the benzimidazole rings (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Three-dimensional correlation between inhibition potency (<i>K</i><sub>i</sub>), intrinsic clearance (Cl<sub>int</sub>), and LogD<sub>7.4</sub>. Calculated <i>r</i><sup>2</sup> values were 0.78 (<i>K</i><sub>i</sub> versus LogD<sub>7.4</sub>), 0.64 (Cl<sub>int</sub> versus LogD<sub>7.4</sub>), and 0.87 (<i>K</i><sub>i</sub> versus Cl<sub>int</sub>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Identification of the primary sites of metabolism for this series of compounds. Compounds with a methoxy group at the 5-position of the benzimidazole ring and an aliphatic chain off of the sulfur were oxidatively metabolized at the ω-1 carbon of the aliphatic side chain, while compounds lacking the methoxy group and containing a heterocyclic ring off of the sulfur atom were primarily metabolized on the substituent at the 5-position of the benzimidazole ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/medium/jm-2011-01346g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Active-site docking of compounds <b>6</b> (green) and <b>30</b> (orange) into a homology model of CYP2C19 (I-helix shown in red). Primary sites of metabolism were located approximately 3 Å from the heme iron, with the 5-methoxy group of compound <b>6</b> and the pyridine nitrogen of compound <b>30</b> occupying a similar space in the active site within approximately 2 Å of Ala477.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201346g/production/images/large/jm-2011-01346g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201346g&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07777" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07777" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Ortiz de Montellano, P. R.; De Voss, J. J.</span><span> </span><span class="NLM_article-title">Substrate Oxidation by Cytochrome P450 Enzymes</span>. In  <span class="citation_source-book">Cytochrome P450: Structure, Mechanism, and Biochemistry</span>, <span class="NLM_edition">3rd</span> ed.; <span class="NLM_contrib-group">Ortiz de Montellano, P. R.</span>, Ed.; <span class="NLM_publisher-name">Kluwer Academic/Plenum Publishers</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1007%2F0-387-27447-2_6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=183-245&author=P.+R.+Ortiz+de+Montellano&author=J.+J.+De+Vossauthor=P.+R.+Ortiz+de+Montellano&title=Cytochrome+P450%3A+Structure%2C+Mechanism%2C+and+Biochemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2F0-387-27447-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F0-387-27447-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DP.%2BR.%26atitle%3DSubstrate%2520Oxidation%2520by%2520Cytochrome%2520P450%2520Enzymes%26btitle%3DCytochrome%2520P450%253A%2520Structure%252C%2520Mechanism%252C%2520and%2520Biochemistry%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DP.%2BR.%26pub%3DKluwer%2520Academic%252FPlenum%2520Publishers%26date%3D2005%26spage%3D183%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Guengerich, F. P.</span><span> </span><span class="NLM_article-title">Human Cytochrome P450 Enzymes</span>. In  <span class="citation_source-book">Cytochrome P450: Structure, Mechanism, and Biochemistry</span>, <span class="NLM_edition">3rd</span> ed.; <span class="NLM_contrib-group">Ortiz de Montellano, P. R.</span>, Ed.; <span class="NLM_publisher-name">Kluwer Academic/Plenum Publishers</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1007%2F0-387-27447-2_10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=377-530&author=F.+P.+Guengerichauthor=P.+R.+Ortiz+de+Montellano&title=Cytochrome+P450%3A+Structure%2C+Mechanism%2C+and+Biochemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F0-387-27447-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F0-387-27447-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DHuman%2520Cytochrome%2520P450%2520Enzymes%26btitle%3DCytochrome%2520P450%253A%2520Structure%252C%2520Mechanism%252C%2520and%2520Biochemistry%26aulast%3DOrtiz%2Bde%2BMontellano%26aufirst%3DP.%2BR.%26pub%3DKluwer%2520Academic%252FPlenum%2520Publishers%26date%3D2005%26spage%3D377%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Guengerich, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, J. S.</span><span> </span><span class="NLM_article-title">Applying mechanisms of chemical toxicity to predict drug safety</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx600260a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhslahsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=344-369&author=F.+P.+Guengerichauthor=J.+S.+MacDonald&title=Applying+mechanisms+of+chemical+toxicity+to+predict+drug+safety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Applying Mechanisms of Chemical Toxicity to Predict Drug Safety</span></div><div class="casAuthors">Guengerich, F. Peter; MacDonald, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-369</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Toxicol. can no longer be used only as a science that reacts to problems but must be more proactive in predicting potential human safety issues with new drug candidates.  Success in this area must be based on an understanding of the mechanisms of toxicity.  This review summarizes and extends some of the concepts of an American Chem. Society ProSpectives meeting on the title subject held in June 2006.  One important area is the discernment of the exact nature of the most common problems in drug toxicity.  Knowledge of chem. structure alerts and relevant biol. pathways are important.  Biol. activation to reactive products and off-target pharmacol. are considered to be major contexts of drug toxicity, although defining exactly what the contributions are is not trivial.  Some newer approaches to screening for both have been developed.  A goal in predictive toxicol. is the use of in vitro methods and database development to make predictions concerning potential modes of toxicity and to stratify drug candidates for further development.  Such predictions are desirable for several economic and other reasons but are certainly not routine yet.  However, progress has been made using several approaches.  Some examples of the application of studies of wide-scale biol. responses are now available, with incorporation into development paradigms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxyWz1mKS0h7Vg90H21EOLACvtfcHk0li3Akx_cuxnuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhslahsrk%253D&md5=d1ef7299d11c39d0ff3b031779915e54</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Ftx600260a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx600260a%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DMacDonald%26aufirst%3DJ.%2BS.%26atitle%3DApplying%2520mechanisms%2520of%2520chemical%2520toxicity%2520to%2520predict%2520drug%2520safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D344%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Denton, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashman, J. R.</span><span> </span><span class="NLM_article-title">5-Substituted, 6-Substituted, and Unsubstituted 3-Heteroaromatic Pyridine Analogues of Nicotine as Selective Inhibitors of Cytochrome P-450 2A6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=224-239&author=T.+T.+Dentonauthor=X.+Zhangauthor=J.+R.+Cashman&title=5-Substituted%2C+6-Substituted%2C+and+Unsubstituted+3-Heteroaromatic+Pyridine+Analogues+of+Nicotine+as+Selective+Inhibitors+of+Cytochrome+P-450+2A6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDenton%26aufirst%3DT.%2BT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCashman%26aufirst%3DJ.%2BR.%26atitle%3D5-Substituted%252C%25206-Substituted%252C%2520and%2520Unsubstituted%25203-Heteroaromatic%2520Pyridine%2520Analogues%2520of%2520Nicotine%2520as%2520Selective%2520Inhibitors%2520of%2520Cytochrome%2520P-450%25202A6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D48%26spage%3D224%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Gomaa, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridgens, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboraia, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfern, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, C.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26): Synthesis and Biological Evaluation of Imidazole Methyl 3-(4-(Aryl-2-ylamino)phenyl)propanoates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6803</span><span class="NLM_x">–</span> <span class="NLM_lpage">6811</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200695m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6803-6811&author=M.+S.+Gomaaauthor=C.+E.+Bridgensauthor=A.+S.+Aboraiaauthor=G.+J.+Vealauthor=C.+P.+Redfernauthor=A.+Brancaleauthor=J.+L.+Armstrongauthor=C.+Simons&title=Small+Molecule+Inhibitors+of+Retinoic+Acid+4-Hydroxylase+%28CYP26%29%3A+Synthesis+and+Biological+Evaluation+of+Imidazole+Methyl+3-%284-%28Aryl-2-ylamino%29phenyl%29propanoates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm200695m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200695m%26sid%3Dliteratum%253Aachs%26aulast%3DGomaa%26aufirst%3DM.%2BS.%26aulast%3DBridgens%26aufirst%3DC.%2BE.%26aulast%3DAboraia%26aufirst%3DA.%2BS.%26aulast%3DVeal%26aufirst%3DG.%2BJ.%26aulast%3DRedfern%26aufirst%3DC.%2BP.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DArmstrong%26aufirst%3DJ.%2BL.%26aulast%3DSimons%26aufirst%3DC.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520Retinoic%2520Acid%25204-Hydroxylase%2520%2528CYP26%2529%253A%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Imidazole%2520Methyl%25203-%25284-%2528Aryl-2-ylamino%2529phenyl%2529propanoates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6803%26epage%3D6811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, Y.-J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Discovery of Novel <i>trans</i>-Stilbene Analogues as Potent and Selective Human Cytochrome P450 1B1 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=160-164&author=S.+Kimauthor=H.+Koauthor=J.+E.+Parkauthor=S.+Jungauthor=S.+K.+Leeauthor=Y.-J.+Chun&title=Design%2C+Synthesis%2C+and+Discovery+of+Novel+trans-Stilbene+Analogues+as+Potent+and+Selective+Human+Cytochrome+P450+1B1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKo%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DJung%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DChun%26aufirst%3DY.-J.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Discovery%2520of%2520Novel%2520trans-Stilbene%2520Analogues%2520as%2520Potent%2520and%2520Selective%2520Human%2520Cytochrome%2520P450%25201B1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D45%26spage%3D160%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Paine, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludington, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haining, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettie, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeldin, D. C.</span><span> </span><span class="NLM_article-title">The human intestinal cytochrome P450 “pie”</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=880-886&author=M.+F.+Paineauthor=H.+L.+Hartauthor=S.+S.+Ludingtonauthor=R.+L.+Hainingauthor=A.+E.+Rettieauthor=D.+C.+Zeldin&title=The+human+intestinal+cytochrome+P450+%E2%80%9Cpie%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaine%26aufirst%3DM.%2BF.%26aulast%3DHart%26aufirst%3DH.%2BL.%26aulast%3DLudington%26aufirst%3DS.%2BS.%26aulast%3DHaining%26aufirst%3DR.%2BL.%26aulast%3DRettie%26aufirst%3DA.%2BE.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26atitle%3DThe%2520human%2520intestinal%2520cytochrome%2520P450%2520%25E2%2580%259Cpie%25E2%2580%259D%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D880%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VandenBranden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Identification of the human cytochromes p450 responsible for in vitro formation of <i>R</i>- and <i>S</i>-norfluoxetine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">1044</span><span class="NLM_x">–</span> <span class="NLM_lpage">1050</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=11356927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvVShsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2001&pages=1044-1050&author=B.+J.+Ringauthor=J.+A.+Ecksteinauthor=J.+S.+Gillespieauthor=S.+N.+Binkleyauthor=M.+VandenBrandenauthor=S.+A.+Wrighton&title=Identification+of+the+human+cytochromes+p450+responsible+for+in+vitro+formation+of+R-+and+S-norfluoxetine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the human cytochromes P450 responsible for in vitro formation of R- and S-norfluoxetine</span></div><div class="casAuthors">Ring, Barbara J.; Eckstein, James A.; Gillespie, Jennifer S.; Binkley, Shelly N.; Vandenbranden, Mark; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1044-1050</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The formation of R- and S-norfluoxetine was analyzed in vitro in human liver microsomes.  Low apparent Km values for R-norfluoxetine formation of ≤8 μM and S-norfluoxetine of <0.2 μM were detd.  R-Norfluoxetine formation rates in a characterized microsomal bank correlated with the catalytic activities for cytochrome P 450 (CYP) 2D6, CYP2C9, and CYP2C8.  Expressed CYP2C9, CYP2C19, and CYP2D6 formed R-norfluoxetine following incubation with 1 μM R-fluoxetine and exhibited apparent Km values of 9.7, 8.5, and 1.8 μM, resp.  Multivariate correlation anal. identified CYP2C9 and CYP2D6 as significant regressors with R-norfluoxetine formation.  Antibodies to the CYP2C subfamily and CYP2D6 each exhibited moderate inhibition of R-norfluoxetine formation.  Therefore, CYP2D6 and CYP2C9 contribute to this biotransformation.  At pharmacol. concns. of S-fluoxetine, S-norfluoxetine formation rates in the bank of microsomes were found to correlate only with CYP2D6 catalytic activity and only expressed CYP2D6 was found to be capable of forming S-norfluoxetine.  Thus, it would appear that both CYP2D6 and CYP2C9 contribute to the formation of R-norfluoxetine, whereas only CYP2D6 is responsible for the conversion to S-norfluoxetine.  Since the enantiomers of fluoxetine and norfluoxetine are inhibitors of CYP2D6, upon chronic dosing, the CYP2D6-mediated metab. of the fluoxetine enantiomers would likely be inhibited, resulting in R-norfluoxetine formation being mediated by CYP2C9 and S-norfluoxetine formation being mediated by multiple high Km enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW2MTE7_3w6bVg90H21EOLACvtfcHk0ljPuSMzTjAVKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvVShsrs%253D&md5=9ec662cbf6111a1c27ca073f8670a8b1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DEckstein%26aufirst%3DJ.%2BA.%26aulast%3DGillespie%26aufirst%3DJ.%2BS.%26aulast%3DBinkley%26aufirst%3DS.%2BN.%26aulast%3DVandenBranden%26aufirst%3DM.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DIdentification%2520of%2520the%2520human%2520cytochromes%2520p450%2520responsible%2520for%2520in%2520vitro%2520formation%2520of%2520R-%2520and%2520S-norfluoxetine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D297%26spage%3D1044%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Feng, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H. H.</span><span> </span><span class="NLM_article-title">The induction effect of rifampicin on activity of mephenytoin 4′-hydroxylase related to M1 mutation of CYP2C19 and gene dose</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1046%2Fj.1365-2125.1998.00643.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=9489590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK1cXpslehuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1998&pages=27-29&author=H.+J.+Fengauthor=S.+L.+Huangauthor=W.+Wangauthor=H.+H.+Zhou&title=The+induction+effect+of+rifampicin+on+activity+of+mephenytoin+4%E2%80%B2-hydroxylase+related+to+M1+mutation+of+CYP2C19+and+gene+dose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The induction effect of rifampicin on activity of mephenytoin 4'-hydroxylase related to M1 mutation of CYP2C19 and gene dose</span></div><div class="casAuthors">Feng, Hua-Jun; Huang, Song-Lin; Wang, Wei; Zhou, Hong-Hao</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-29</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">To det. the induction effect of rifampicin on the activity of 4'-hydroxylase in poor metabolizers (PMs) with m1 mutation of S-mephenytoin 4'-hydroxylation and the relationship of the effect with gene dose.  Seven extensive metabolizers (EMs) of S-mephenytoin 4'-hydroxylation and five PMs with m1 mutation were chosen to take rifampicin 300 mg day-1 orally for 22 days.  Prior to and after rifampicin treatment, each subject was given racemic mephenytoin 100 mg.  The 4'-hydroxymephenytoin (4'-OH-MP) excreted in the 0-24 h urine and mephenytoin S/R ratio in the 0-8 h urine were detd. by h.p.l.c. and GC, resp.  In all EMs, the excretion of 4'-OH-MP in the 0-24 h urine was increased by 146.4±17.9%, 0-8 h urinary mephenytoin S/R ratio was decreased by 77.3±8.8%, the percentage increase in the 0-24 h excretion of 4'-OH-MP in those CYP2C19 homozygous (wt/wt) was greater than that in those heterozygous (wt/m1 and wt/m2) (203.9±42.5% vs 69.6±4.1%).  0-8 H urinary mephenytoin S/R ratio of those PMs with m1 mutation was decreased by 9.6%, the amt. of 4'-OH-MP excreted in the 0-24 h urine was increased by 80.1±48.0%.  The activity of 4'-hydroxylase of PMs with m1 mutation of S-mephenytoin 4'-hydroxylation can be induced by rifampicin and the inducing effect of rifampicin on 4'-hydroxylase is gene dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI8JXivrVyRbVg90H21EOLACvtfcHk0ljPuSMzTjAVKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXpslehuw%253D%253D&md5=7dddb83db34051b0e099ab9bbde661b9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2125.1998.00643.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2125.1998.00643.x%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DH.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DH.%2BH.%26atitle%3DThe%2520induction%2520effect%2520of%2520rifampicin%2520on%2520activity%2520of%2520mephenytoin%25204%25E2%2580%25B2-hydroxylase%2520related%2520to%2520M1%2520mutation%2520of%2520CYP2C19%2520and%2520gene%2520dose%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1998%26volume%3D45%26spage%3D27%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Raucy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasker, J. M.</span><span> </span><span class="NLM_article-title">Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1124%2Fjpet.102.033837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=12130704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Ogsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=475-482&author=J.+L.+Raucyauthor=L.+Muellerauthor=K.+Duanauthor=S.+W.+Allenauthor=S.+Stromauthor=J.+M.+Lasker&title=Expression+and+induction+of+CYP2C+P450+enzymes+in+primary+cultures+of+human+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes</span></div><div class="casAuthors">Raucy, Judy L.; Mueller, Lisa; Duan, Kui; Allen, Scott W.; Strom, Stephen; Lasker, Jerome M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">475-482</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Although CYP2C8, CYP2C9, and CYP2C19 play an important role in drug biotransformation, factors influencing the expression and activity of these CYP2C P450s in human liver remain largely undefined.  We used primary cultures of human hepatocytes from 15 subjects to assess the inducibility of CYP2C enzyme expression by prototypical inducer agents, including rifampicin, dexamethasone, and phenobarbital.  After culture for 72 h in serum-free medium on collagen, Western blotting revealed that CYP2C9 was the only CYP2C enzyme expressed at appreciable levels in untreated hepatocytes.  Subsequent treatment with 25 μM rifampicin for 48 h elicited marked increases in CYP2C8 (700 ± 761%), CYP2C19 (854%), and CYP2C9 (209 ± 176%) protein content vs. a 550 ± 170% enhancement of CYP3A4 enzyme levels.  Parallel increases in CYP2C mRNAs, measured by Northern blotting and/or RNase protection, were found in rifampicin-treated hepatocytes, with CYP2C8, CYP2C9, and CYP2C19 transcripts exhibiting increases of 688 ± 635, 207 ± 49, and 230 ± 60%, resp., vs. an 8.8-fold enhancement of CYP3A4 mRNA levels.  Dexamethasone (10 μM) treatment enhanced CYP2C8 mRNA (360 ± 100%) and protein (274%) content, although this steroid had less effect on CYP2C9 and CYP2C19 transcripts (23 ± 21% and 21 ± 36%, resp.) and enzyme levels (55 and 143%, resp.).  Phenobarbital (100 μM) was a powerful inducer of CYP2C9 (850%) and CYP2C19 (735%) mRNA content, and also increased CYP2C8 (610%) and CYP3A4 (205%) transcripts.  Our results show that CYP2C enzyme expression in human hepatocytes is highly inducible by rifampicin, dexamethasone, and phenobarbital.  Because these xenobiotics are ligands and/or activators of the pregnane X receptor and/or constitutive androstane receptor, such orphan nuclear receptors and their response elements may partake in regulating CYP2C gene expression in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0l1hH2pJopbVg90H21EOLACvtfcHk0ljPuSMzTjAVKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Ogsb8%253D&md5=a9c9e8674bb318bdddf621f3cf4ebc3d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.033837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.033837%26sid%3Dliteratum%253Aachs%26aulast%3DRaucy%26aufirst%3DJ.%2BL.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DDuan%26aufirst%3DK.%26aulast%3DAllen%26aufirst%3DS.%2BW.%26aulast%3DStrom%26aufirst%3DS.%26aulast%3DLasker%26aufirst%3DJ.%2BM.%26atitle%3DExpression%2520and%2520induction%2520of%2520CYP2C%2520P450%2520enzymes%2520in%2520primary%2520cultures%2520of%2520human%2520hepatocytes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D475%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Foti, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlstrom, J. L.</span><span> </span><span class="NLM_article-title">CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=523-528&author=R.+S.+Fotiauthor=J.+L.+Wahlstrom&title=CYP2C19+inhibition%3A+the+impact+of+substrate+probe+selection+on+in+vitro+inhibition+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DWahlstrom%26aufirst%3DJ.%2BL.%26atitle%3DCYP2C19%2520inhibition%253A%2520the%2520impact%2520of%2520substrate%2520probe%2520selection%2520on%2520in%2520vitro%2520inhibition%2520profiles%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D523%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Wang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, W. W.</span><span> </span><span class="NLM_article-title">Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population</span> <span class="citation_source-journal">Clin. Exp. Pharmacol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1111%2Fj.1440-1681.2007.04583.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=17439410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvVels7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=421-424&author=J.+H.+Wangauthor=P.+Q.+Liauthor=Q.+Y.+Fuauthor=Q.+X.+Liauthor=W.+W.+Cai&title=Cyp2c19+genotype+and+omeprazole+hydroxylation+phenotype+in+Chinese+Li+population"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">CYP2C19 genotype and omeprazole hydroxylation phenotype in Chinese Li population</span></div><div class="casAuthors">Wang, Jiu-Hui; Li, Pei-Qiong; Fu, Qiong-Yao; Li, Qiu-Xiang; Cai, Wang-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">421-424</span>CODEN:
                <span class="NLM_cas:coden">CEXPB9</span>;
        ISSN:<span class="NLM_cas:issn">0305-1870</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">1. CYP2C19 is a polymorphism of cytochrome P 450, which is responsible for the metab. of many drugs.  The genetic polymorphism shows interethnic variation and it has been demonstrated that the frequency of poor metabolizers (PM) and the distribution of alleles of CYP2C19 vary among Chinese ethnic nationalities.  The aim of the present study was to investigate the incidence of CYP2C19 polymorphism in the Chinese Li population.  2. One hundred and sixty-five unrelated healthy Li subjects were identified with respect to CYP2C19 by genotype and phenotype anal.  A polymerase chain reaction-restriction fragment length polymorphism method was performed for genotyping.  The plasma concns. of omeprazole and 5-hydroxyomeprazole were assayed by reversed-phase high-performance liq. chromatog. and the omeprazole hydroxylation index (HI) was detd.  3. The frequency distribution of omeprazole HI is bimodal and the antimode for HI was estd. to be 5.6.  The prevalence of phenotypic PM in the Li population was 16.6% (13.7-19.5; 95% CI).  Genotype anal. revealed that the frequencies of the CYP2C19*1, *2 and *3 alleles in the Li population were 0.617 (0.590-0.644; 95% CI), 0.353 (0.327-0.379; 95% CI) and 0.031 (0.021-0.041; 95% CI), resp.  The frequency of genotypic PM was 14.7% (11.9-17.5; 95% CI), which almost agreed with the frequency of phenotypic PM.  Omeprazole HI was significantly different among the different genotype groups (P < 0.05).  4. The present study revealed that the incidence of the CYP2C19*1, *2 and *3 alleles in Chinese Li population is different to that in other ethnic populations of China.  There was an obvious relationship between CYP2C19 genotype and omeprazole hydroxylation phenotype, and about 90% of phenotypic PM can be explained by the CYP2C19*2 and *3 alleles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpElTo-oIWQI7Vg90H21EOLACvtfcHk0ljEwszS8jAA1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvVels7w%253D&md5=42a5dd941df5e3ebfefe9986fcc4d262</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1681.2007.04583.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1681.2007.04583.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DP.%2BQ.%26aulast%3DFu%26aufirst%3DQ.%2BY.%26aulast%3DLi%26aufirst%3DQ.%2BX.%26aulast%3DCai%26aufirst%3DW.%2BW.%26atitle%3DCyp2c19%2520genotype%2520and%2520omeprazole%2520hydroxylation%2520phenotype%2520in%2520Chinese%2520Li%2520population%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D2007%26volume%3D34%26spage%3D421%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Holt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howden, C. W.</span><span> </span><span class="NLM_article-title">Omeprazole. Overview and opinion</span> <span class="citation_source-journal">Digestive Dis. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1007%2FBF01298864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=2007354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK3MXkt1Wntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1991&pages=385-393&author=S.+Holtauthor=C.+W.+Howden&title=Omeprazole.+Overview+and+opinion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Omeprazole.  Overview and opinion</span></div><div class="casAuthors">Holt, S.; Howden, C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Digestive Diseases and Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">385-93</span>CODEN:
                <span class="NLM_cas:coden">DDSCDJ</span>;
        ISSN:<span class="NLM_cas:issn">0163-2116</span>.
    </div><div class="casAbstract">Review with 93 refs. on the pharmacol. of omeprazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprdad08GwDi7Vg90H21EOLACvtfcHk0ljEwszS8jAA1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkt1Wntr0%253D&md5=08322f1d6a10fddddb93b1d8127db132</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2FBF01298864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01298864%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DS.%26aulast%3DHowden%26aufirst%3DC.%2BW.%26atitle%3DOmeprazole.%2520Overview%2520and%2520opinion%26jtitle%3DDigestive%2520Dis.%2520Sci.%26date%3D1991%26volume%3D36%26spage%3D385%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Howden, C. W.</span><span> </span><span class="NLM_article-title">Clinical pharmacology of omeprazole</span> <span class="citation_source-journal">Clin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.2165%2F00003088-199120010-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A280%3ADyaK3M3jtVyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1991&pages=38-49&author=C.+W.+Howden&title=Clinical+pharmacology+of+omeprazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacology of omeprazole</span></div><div class="casAuthors">Howden C W</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacokinetics</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-49</span>
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    </div><div class="casAbstract">Omeprazole is a specific inhibitor of H+,K(+)-ATPase or 'proton pump' in parietal cells.  This enzyme is responsible for the final step in the process of acid secretion; omeprazole blocks acid secretion in response to all stimuli.  Single doses produce dose-dependent inhibition with increasing effect over the first few days, reaching a maximum after about 5 days.  Doses of omeprazole 20mg daily or greater are able to virtually abolish intragastric acidity in most individuals, although lower doses have a much more variable effect.  Omeprazole causes a dose-dependent increase in gastrin levels.  Omeprazole must be protected from intragastric acid when given orally, and is therefore administered as encapsulated enteric-coated granules.  Absorption can be erratic but is generally rapid, and initially the drug is widely distributed.  It is highly protein-bound and extensively metabolised.  Its elimination half-life is about 1h but its pharmacological effect lasts much longer, since it is preferentially concentrated in parietal cells where it forms a covalent linkage with H+,K(+)-ATPase, which it irreversibly inhibits.  Omeprazole binds to hepatic cytochrome P450 and inhibits oxidative metabolism of some drugs, the most important being phenytoin.  Omeprazole has produced short term healing rates superior to the histamine H2-receptor antagonists in duodenal ulcer, gastric ulcer and reflux oesophagitis.  It has also been shown to be highly effective in healing ulcers which have failed to respond to H2-receptor antagonists, and has been extremely valuable in treating patients with Zollinger-Ellison syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrsomvQl8SZQwxfk_AGB-EfW6udTcc2eZbeSWpNkvRrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3jtVyjug%253D%253D&md5=06d5803c938aeeec08d12c50ef33b452</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2165%2F00003088-199120010-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199120010-00003%26sid%3Dliteratum%253Aachs%26aulast%3DHowden%26aufirst%3DC.%2BW.%26atitle%3DClinical%2520pharmacology%2520of%2520omeprazole%26jtitle%3DClin.%2520Pharm.%26date%3D1991%26volume%3D20%26spage%3D38%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Spencer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulds, D.</span><span> </span><span class="NLM_article-title">Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1994&pages=404-430&author=C.+M.+Spencerauthor=D.+Faulds&title=Lansoprazole.+A+reappraisal+of+its+pharmacodynamic+and+pharmacokinetic+properties%2C+and+its+therapeutic+efficacy+in+acid-related+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpencer%26aufirst%3DC.%2BM.%26aulast%3DFaulds%26aufirst%3DD.%26atitle%3DLansoprazole.%2520A%2520reappraisal%2520of%2520its%2520pharmacodynamic%2520and%2520pharmacokinetic%2520properties%252C%2520and%2520its%2520therapeutic%2520efficacy%2520in%2520acid-related%2520disorders%26jtitle%3DDrugs%26date%3D1994%26volume%3D48%26spage%3D404%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Meyer, U. A.</span><span> </span><span class="NLM_article-title">Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs</span> <span class="citation_source-journal">Eur. J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S21</span><span class="NLM_x">–</span> <span class="NLM_lpage">S25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=S21-S25&issue=Suppl+1&author=U.+A.+Meyer&title=Metabolic+interactions+of+the+proton-pump+inhibitors+lansoprazole%2C+omeprazole+and+pantoprazole+with+other+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DU.%2BA.%26atitle%3DMetabolic%2520interactions%2520of%2520the%2520proton-pump%2520inhibitors%2520lansoprazole%252C%2520omeprazole%2520and%2520pantoprazole%2520with%2520other%2520drugs%26jtitle%3DEur.%2520J.%2520Gastroenterol.%2520Hepatol.%26date%3D1996%26volume%3D8%26issue%3DSuppl%25201%26spage%3DS21%26epage%3DS25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Meyer, U. A.</span><span> </span><span class="NLM_article-title">Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions</span> <span class="citation_source-journal">Yale J. biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=9165689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Cht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1996&pages=203-209&author=U.+A.+Meyer&title=Interaction+of+proton+pump+inhibitors+with+cytochromes+P450%3A+consequences+for+drug+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions</span></div><div class="casAuthors">Meyer, Urs A.</div><div class="citationInfo"><span class="NLM_cas:title">Yale Journal of Biology and Medicine</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-209</span>CODEN:
                <span class="NLM_cas:coden">YJBMAU</span>;
        ISSN:<span class="NLM_cas:issn">0044-0086</span>.
    
            (<span class="NLM_cas:orgname">Yale Journal of Biology and Medicine</span>)
        </div><div class="casAbstract">A review, with 38 refs.  Omeprazole, lansoprazole and pantoprazole are metabolized by several human cytochromes P 450, most prominently by CYP2C19 and CYP3A4.  Only pantoprazole is also metabolized by a sulfotransferase.  Differences in the quant. contribution of these enzymes and in the relative affinities of the substrates explain some of the obsd. interactions with carbamazepin, diazepam, phenytoin and theophylline and of the impact of the CYP2C19 (mephenytoin) genetic polymorphism.  Of these drugs, pantoprazole has the lowest potential for interactions, both in vitro and in human volunteer studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobcNjcXY2JxbVg90H21EOLACvtfcHk0lhih25JZn1ITA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Cht7Y%253D&md5=02fd323a07201b8743eba7d0665fa6a8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DU.%2BA.%26atitle%3DInteraction%2520of%2520proton%2520pump%2520inhibitors%2520with%2520cytochromes%2520P450%253A%2520consequences%2520for%2520drug%2520interactions%26jtitle%3DYale%2520J.%2520biol.%2520Med.%26date%3D1996%26volume%3D69%26spage%3D203%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ko, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thacker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flockhart, D. A.</span><span> </span><span class="NLM_article-title">Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=9224780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFCgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=853-862&author=J.+W.+Koauthor=N.+Sukhovaauthor=D.+Thackerauthor=P.+Chenauthor=D.+A.+Flockhart&title=Evaluation+of+omeprazole+and+lansoprazole+as+inhibitors+of+cytochrome+P450+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms</span></div><div class="casAuthors">Ko, Jae-Wook; Sukhova, Nadia; Thacker, David; Chen, Patricia; Flockhart, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">853-862</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The human clearance of omeprazole and lansoprazole is conducted primarily by the hepatic cytochrome P 450 (CYP) system.  Efficacy data indicate few differences between these two drugs, but they may exhibit discrete drug interaction profiles.  To compare the potency and specificity of these drugs as inhibitors of CYP isoforms, we performed in vitro studies with human liver microsomal prepns.  Both drugs were potent, competitive inhibitors of CYP2C19, as measured by the conversion of S-mephenytoin to 4-hydroxymephenytoin (ki = 3.1±2.2 μM for omeprazole, Ki = 3.2±1.3 μM for lansoprazole).  For omeprazole, the highest concn. at which >70% inhibition of CYP2C19 was obsd. with no significant inhibitory effect on other isoforms was at least 20 times greater than Ki.  Both drugs were competitive inhibitors of CYP2C9-catalyzed conversion of tolbutamide to 4-hydroxytolbutamide (Ki = 40.1±14.8 μM for omeprazole, Ki = 52.1±1.4 μM for lansoprazole) and were noncompetitive inhibitors of CYP3A-catalyzed conversion of dextromethorphan to 3-methoxymorphinan (Ki = 84.4±4.0 μM for omeprazole, Ki = 170.4±7.1 μM for lansoprazole).  Lansoprazole was at least 5 times more potent (Ki = 44.7±22.0 μM) than omeprazole (ki = 240.7±102.0 μM) as an inhibitor of CYP2D6-mediated conversion of dextromethorphan to dextrorphan.  No inhibition of CYP1A2, assessed by measuring the conversion of phenacetin to acetaminophen, was noted.  Our data suggest that whereas the inhibitory profiles of these two drugs are similar, lansoprazole may be the more important in vitro inhibitor of CYP2D6.  Since its inhibition is very potent and has a broad "window of selectivity," omeprazole seems to be a useful, selective inhibitor of CYP2C19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-xV8zsJrbQLVg90H21EOLACvtfcHk0lhih25JZn1ITA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFCgurs%253D&md5=0b24590f62f88d1eb4287efecd1fadf2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DJ.%2BW.%26aulast%3DSukhova%26aufirst%3DN.%26aulast%3DThacker%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DFlockhart%26aufirst%3DD.%2BA.%26atitle%3DEvaluation%2520of%2520omeprazole%2520and%2520lansoprazole%2520as%2520inhibitors%2520of%2520cytochrome%2520P450%2520isoforms%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1997%26volume%3D25%26spage%3D853%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Andersson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cederberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edvardsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heggelund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundborg, P.</span><span> </span><span class="NLM_article-title">Effect of omeprazole and cimetidine on plasma diazepam levels</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1990&pages=51-54&author=T.+Anderssonauthor=K.+Andrenauthor=C.+Cederbergauthor=G.+Edvardssonauthor=A.+Heggelundauthor=P.+Lundborg&title=Effect+of+omeprazole+and+cimetidine+on+plasma+diazepam+levels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DT.%26aulast%3DAndren%26aufirst%3DK.%26aulast%3DCederberg%26aufirst%3DC.%26aulast%3DEdvardsson%26aufirst%3DG.%26aulast%3DHeggelund%26aufirst%3DA.%26aulast%3DLundborg%26aufirst%3DP.%26atitle%3DEffect%2520of%2520omeprazole%2520and%2520cimetidine%2520on%2520plasma%2520diazepam%2520levels%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1990%26volume%3D39%26spage%3D51%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Andersson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cederberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edvardsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heggelund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundborg, P.</span><span> </span><span class="NLM_article-title">Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1038%2Fclpt.1990.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=2104790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK3cXhtFWmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1990&pages=79-85&author=T.+Anderssonauthor=C.+Cederbergauthor=G.+Edvardssonauthor=A.+Heggelundauthor=P.+Lundborg&title=Effect+of+omeprazole+treatment+on+diazepam+plasma+levels+in+slow+versus+normal+rapid+metabolizers+of+omeprazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole</span></div><div class="casAuthors">Andersson, Tommy; Cederberg, Christer; Edvardsson, Gunilla; Heggelund, Asger; Lundborg, Per</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-85</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">The effect of omeprazole treatment on diazepam plasma levels was studied in four slow and six rapid metabolizers of omeprazole.  Single i.v. doses of diazepam (0.1 mg/kg) were administered after 1 wk of oral treatment with omeprazole (20 mg) and placebo.  This was a double-blind crossover study with randomized placebo and omeprazole treatments.  Blood was collected up to 120 h after diazepam dosing (still during one-daily omeprazole and placebo administration) for measurement of diazepam and its major metabolite desmethyldiazepam.  The slow metabolizers of omeprazole also metabolized diazepam slowly, exhibiting only half the diazepam plasma clearance of the others.  The mean clearance of diazepam was decreased 26% after omeprazole in the rapid metabolizers, whereas the slow group showed no apparent interaction.  The mean plasma concns. of desmethyldiazepam showed a more rapid formation in the rapid compared with the slow metabolizers, which is a logical consequence of the rate of diazepam metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxfkdIz5fL8rVg90H21EOLACvtfcHk0lhih25JZn1ITA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtFWmsbs%253D&md5=e41ea5d2bfe4a391ea37bfaaa14518db</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fclpt.1990.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.1990.12%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DT.%26aulast%3DCederberg%26aufirst%3DC.%26aulast%3DEdvardsson%26aufirst%3DG.%26aulast%3DHeggelund%26aufirst%3DA.%26aulast%3DLundborg%26aufirst%3DP.%26atitle%3DEffect%2520of%2520omeprazole%2520treatment%2520on%2520diazepam%2520plasma%2520levels%2520in%2520slow%2520versus%2520normal%2520rapid%2520metabolizers%2520of%2520omeprazole%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1990%26volume%3D47%26spage%3D79%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Enderle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grass, U.</span><span> </span><span class="NLM_article-title">Drug interaction: omeprazole and phenprocoumon</span> <span class="citation_source-journal">BMC Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1186%2F1471-230X-1-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=11313000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A280%3ADC%252BD38nnslCksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=2&author=C.+Enderleauthor=W.+Mullerauthor=U.+Grass&title=Drug+interaction%3A+omeprazole+and+phenprocoumon"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Drug interaction: omeprazole and phenprocoumon</span></div><div class="casAuthors">Enderle C; Muller W; Grass U</div><div class="citationInfo"><span class="NLM_cas:title">BMC gastroenterology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Oral anticoagulants like the coumarin derivatives are characterised by a particularly narrow therapeutic range.  Any interfering co-medication can pose a challenge to establishing a stable anticoagulant dosage regimen and thus present a serious risk for the patient.  Here we describe two cases of patients on anticoagulant therapy that suggest possible drug interactions between phenprocoumon and the proton pump inhibitor omeprazole.  RESULTS:  In both patients, the International Normalised Ratio (INR) increased beyond the therapeutic range after they were given omeprazole for the treatment of gastrointestinal symptoms.  The INR returned to therapeutic levels after the phenprocoumon dose was reduced (Case 1) and omeprazole discontinued (Case 2).  CONCLUSIONS:  The increased anticoagulant activity of phenprocoumon observed in the two described cases and the known interaction potential of omeprazole suggest that the clearance of phenprocoumon may have been reduced due to competitive inhibition of its degradation by omeprazole.  Drug interactions may be one of the reasons for the difficulties encountered with some patients in establishing a stable anticoagulant therapy.  Physicians should carefully review any concurrently used medication and if possible opt for drugs with a low interaction potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDx4aM5th5G3thwrmtH4OBfW6udTcc2ebF4zpUNioGNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nnslCksw%253D%253D&md5=756db98333a605ce5d265892b2a9ffd5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1471-230X-1-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-230X-1-2%26sid%3Dliteratum%253Aachs%26aulast%3DEnderle%26aufirst%3DC.%26aulast%3DMuller%26aufirst%3DW.%26aulast%3DGrass%26aufirst%3DU.%26atitle%3DDrug%2520interaction%253A%2520omeprazole%2520and%2520phenprocoumon%26jtitle%3DBMC%2520Gastroenterol.%26date%3D2001%26volume%3D1%26spage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Pearson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahal, U. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig-Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">The kinetic mechanism for cytochrome P450 metabolism of type II binding compounds: evidence supporting direct reduction</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">511</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1016%2Fj.abb.2011.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=21530484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVWms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=511&publication_year=2011&pages=69-79&author=J.+Pearsonauthor=U.+P.+Dahalauthor=D.+Rockauthor=C.+C.+Pengauthor=J.+O.+Schenkauthor=C.+Joswig-Jonesauthor=J.+P.+Jones&title=The+kinetic+mechanism+for+cytochrome+P450+metabolism+of+type+II+binding+compounds%3A+evidence+supporting+direct+reduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetic mechanism for cytochrome P450 metabolism of Type II binding compounds: Evidence supporting direct reduction</span></div><div class="casAuthors">Pearson, Joshua; Dahal, Upendra P.; Rock, Daniel; Peng, Chi-Chi; Schenk, James O.; Joswig-Jones, Carolyn; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">511</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">69-79</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The metabolic stability of a drug is an important property that should be optimized during drug design and development.  Nitrogen incorporation is hypothesized to increase the stability by coordination of nitrogen to the heme iron of cytochrome P 450, a binding mode that is referred to as type II binding.  However, we noticed that the type II binding compd. has less metabolic stability at sub-satg. conditions than a closely related type I binding compd.  Three kinetic models will be presented for type II binder metab.; (1) Dead-end type II binding, (2) a rapid equil. between type I and II binding modes before redn., and (3) a direct redn. of the type II coordinated heme.  Data will be presented on redn. rates of iron, the off rates of substrate (using surface plasmon resonance) and the catalytic rate consts.  These data argue against the dead-end, and rapid equil. models, leaving the direct redn. kinetic mechanism for metab. of the type II binding compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsVJoIl9O74rVg90H21EOLACvtfcHk0lh_KI29BXVaoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVWms74%253D&md5=6f4cd09fe694d8e5cf766654a77a7f4b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2011.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2011.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DJ.%26aulast%3DDahal%26aufirst%3DU.%2BP.%26aulast%3DRock%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DC.%2BC.%26aulast%3DSchenk%26aufirst%3DJ.%2BO.%26aulast%3DJoswig-Jones%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520kinetic%2520mechanism%2520for%2520cytochrome%2520P450%2520metabolism%2520of%2520type%2520II%2520binding%2520compounds%253A%2520evidence%2520supporting%2520direct%2520reduction%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2011%26volume%3D511%26spage%3D69%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Peng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig-Jones, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">The effects of type II binding on metabolic stability and binding affinity in cytochrome P450 CYP3A4</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">497</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2010&pages=68-81&author=C.+C.+Pengauthor=J.+T.+Pearsonauthor=D.+A.+Rockauthor=C.+A.+Joswig-Jonesauthor=J.+P.+Jones&title=The+effects+of+type+II+binding+on+metabolic+stability+and+binding+affinity+in+cytochrome+P450+CYP3A4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DC.%2BC.%26aulast%3DPearson%26aufirst%3DJ.%2BT.%26aulast%3DRock%26aufirst%3DD.%2BA.%26aulast%3DJoswig-Jones%26aufirst%3DC.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520effects%2520of%2520type%2520II%2520binding%2520on%2520metabolic%2520stability%2520and%2520binding%2520affinity%2520in%2520cytochrome%2520P450%2520CYP3A4%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2010%26volume%3D497%26spage%3D68%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Chiba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tata, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">P450 interaction with HIV protease inhibitors: relationship between metabolic stability, inhibitory potency, and P450 binding spectra</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">3</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=1-3&author=M.+Chibaauthor=L.+Jinauthor=W.+Newayauthor=J.+P.+Vaccaauthor=J.+R.+Tataauthor=K.+Chapmanauthor=J.+H.+Lin&title=P450+interaction+with+HIV+protease+inhibitors%3A+relationship+between+metabolic+stability%2C+inhibitory+potency%2C+and+P450+binding+spectra"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DP450%2520interaction%2520with%2520HIV%2520protease%2520inhibitors%253A%2520relationship%2520between%2520metabolic%2520stability%252C%2520inhibitory%2520potency%252C%2520and%2520P450%2520binding%2520spectra%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2001%26volume%3D29%26spage%3D1%26epage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span> </span><span class="NLM_article-title">Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=843-855&author=H.+Liauthor=J.+Sunauthor=X.+Fanauthor=X.+Suiauthor=L.+Zhangauthor=Y.+Wangauthor=Z.+He&title=Considerations+and+recent+advances+in+QSAR+models+for+cytochrome+P450-mediated+drug+metabolism+prediction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DX.%26aulast%3DSui%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DZ.%26atitle%3DConsiderations%2520and%2520recent%2520advances%2520in%2520QSAR%2520models%2520for%2520cytochrome%2520P450-mediated%2520drug%2520metabolism%2520prediction%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2008%26volume%3D22%26spage%3D843%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Locuson, C. W.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettie, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">Charge and substituent effects on affinity and metabolism of benzbromarone-based CYP2C19 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6768</span><span class="NLM_x">–</span> <span class="NLM_lpage">6776</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049605m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6768-6776&author=C.+W.+Locusonauthor=H.+Suzukiauthor=A.+E.+Rettieauthor=J.+P.+Jones&title=Charge+and+substituent+effects+on+affinity+and+metabolism+of+benzbromarone-based+CYP2C19+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm049605m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049605m%26sid%3Dliteratum%253Aachs%26aulast%3DLocuson%26aufirst%3DC.%2BW.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DRettie%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DCharge%2520and%2520substituent%2520effects%2520on%2520affinity%2520and%2520metabolism%2520of%2520benzbromarone-based%2520CYP2C19%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6768%26epage%3D6776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ridderstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamora, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fjellstrom, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, T. B.</span><span> </span><span class="NLM_article-title">Analysis of selective regions in the active sites of human cytochromes P450, 2C8, 2C9, 2C18, and 2C19 homology models using GRID/CPCA</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4072</span><span class="NLM_x">–</span> <span class="NLM_lpage">4081</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0109107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4072-4081&author=M.+Ridderstromauthor=I.+Zamoraauthor=O.+Fjellstromauthor=T.+B.+Andersson&title=Analysis+of+selective+regions+in+the+active+sites+of+human+cytochromes+P450%2C+2C8%2C+2C9%2C+2C18%2C+and+2C19+homology+models+using+GRID%2FCPCA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0109107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0109107%26sid%3Dliteratum%253Aachs%26aulast%3DRidderstrom%26aufirst%3DM.%26aulast%3DZamora%26aufirst%3DI.%26aulast%3DFjellstrom%26aufirst%3DO.%26aulast%3DAndersson%26aufirst%3DT.%2BB.%26atitle%3DAnalysis%2520of%2520selective%2520regions%2520in%2520the%2520active%2520sites%2520of%2520human%2520cytochromes%2520P450%252C%25202C8%252C%25202C9%252C%25202C18%252C%2520and%25202C19%2520homology%2520models%2520using%2520GRID%252FCPCA%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4072%26epage%3D4081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, D. F.</span><span> </span><span class="NLM_article-title">The metabolism of CYP2C9 and CYP2C19 for gliclazide by homology modeling and docking study</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">854</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=854-861&author=Y.+Yaoauthor=W.+W.+Hanauthor=Y.+H.+Zhouauthor=Z.+S.+Liauthor=Q.+Liauthor=X.+Y.+Chenauthor=D.+F.+Zhong&title=The+metabolism+of+CYP2C9+and+CYP2C19+for+gliclazide+by+homology+modeling+and+docking+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DW.%2BW.%26aulast%3DZhou%26aufirst%3DY.%2BH.%26aulast%3DLi%26aufirst%3DZ.%2BS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DX.%2BY.%26aulast%3DZhong%26aufirst%3DD.%2BF.%26atitle%3DThe%2520metabolism%2520of%2520CYP2C9%2520and%2520CYP2C19%2520for%2520gliclazide%2520by%2520homology%2520modeling%2520and%2520docking%2520study%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D854%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kneller, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haining, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trager, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettie, A. E.</span><span> </span><span class="NLM_article-title">(+)-<i>N</i>-3-Benzyl-nirvanol and (−)-<i>N</i>-3-Benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=235-239&author=H.+Suzukiauthor=M.+B.+Knellerauthor=R.+L.+Hainingauthor=W.+F.+Tragerauthor=A.+E.+Rettie&title=%28%2B%29-N-3-Benzyl-nirvanol+and+%28%E2%88%92%29-N-3-Benzyl-phenobarbital%3A+new+potent+and+selective+in+vitro+inhibitors+of+CYP2C19"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DKneller%26aufirst%3DM.%2BB.%26aulast%3DHaining%26aufirst%3DR.%2BL.%26aulast%3DTrager%26aufirst%3DW.%2BF.%26aulast%3DRettie%26aufirst%3DA.%2BE.%26atitle%3D%2528%252B%2529-N-3-Benzyl-nirvanol%2520and%2520%2528%25E2%2588%2592%2529-N-3-Benzyl-phenobarbital%253A%2520new%2520potent%2520and%2520selective%2520in%2520vitro%2520inhibitors%2520of%2520CYP2C19%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D235%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Houston, J. B.; Kenworthy, K. E.; Galetin, A.</span><span> </span><span class="NLM_article-title">Typical and Atypical Enzyme Kinetics</span>. In  <span class="citation_source-book">Drug Metabolizing Enzymes: Cytochrome P450 and Other Enzymes in Drug Discovery and Development</span>; <span class="NLM_contrib-group">Lee, J. S.; Obach, R. S.; Fisher, M. B.</span>, Eds.; <span class="NLM_publisher-name">Marcel Dekker</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1201%2F9781420028485.ch7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=211-254&author=J.+B.+Houston&author=K.+E.+Kenworthy&author=A.+Galetinauthor=J.+S.+Lee&author=R.+S.+Obach&author=M.+B.+Fisher&title=Drug+Metabolizing+Enzymes%3A+Cytochrome+P450+and+Other+Enzymes+in+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1201%2F9781420028485.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1201%252F9781420028485.ch7%26sid%3Dliteratum%253Aachs%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26atitle%3DTypical%2520and%2520Atypical%2520Enzyme%2520Kinetics%26btitle%3DDrug%2520Metabolizing%2520Enzymes%253A%2520Cytochrome%2520P450%2520and%2520Other%2520Enzymes%2520in%2520Drug%2520Discovery%2520and%2520Development%26aulast%3DLee%26aufirst%3DJ.%2BS.%26pub%3DMarcel%2520Dekker%26date%3D2003%26spage%3D211%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M.</span><span> </span><span class="NLM_article-title">Role of CYP3A4 in human hepatic diltiazem <i>N</i>-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=9223567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK2sXksFyitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1997&pages=294-300&author=D.+Suttonauthor=A.+M.+Butlerauthor=L.+Nadinauthor=M.+Murray&title=Role+of+CYP3A4+in+human+hepatic+diltiazem+N-demethylation%3A+inhibition+of+CYP3A4+activity+by+oxidized+diltiazem+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites</span></div><div class="casAuthors">Sutton, Dylan; Butler, Alison M.; Nadin, Louise; Murray, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">294-300</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The antihypertensive agent diltiazem (DTZ) impairs hepatic drug metab. by inhibition of cytochrome P 450 (CYP).  The accumulation of DTZ metabolites in serum occurs during prolonged therapy and leads to decreased DTZ elimination.  Thus, DTZ metabolites may contribute to CYP inhibition.  This study assessed the role of human CYPs in microsomal DTZ oxidn. and the capacity of DTZ metabolites to inhibit specific CYP activities.  DTZ N-demethylation varied 10-fold in microsomal fractions from 17 livers (0.33-3.31 nmol/mg of protein/min).  DTZ oxidn. was correlated with testosterone 6β-hydroxylation (r = 0.82) and, to a lesser extent, tolbutamide hydroxylation (r = 0.59) but not with activities mediated by CYP1A2 or CYP2E1.  CYP3A4 in lymphoblastoid cell microsomes catalyzed DTZ N-demethylation but CYP2C8 and CYP2C9 were also active (∼20% and 10% of the activity supported by CYP3A4); seven other CYPs produced little or no N-desmethyl DTZ from DTZ.  The CYP3A4 inhibitors ketoconazole and troleandomycin decreased microsomal DTZ oxidn., but inhibitors or substrates of CYP2C, CYP2D and CYP2E1 produced no inhibition.  Some inhibition was produced by α-naphthoflavone, a chem. that inhibits CYP1As and also interacts with CYP3A4.  In further expts., the capacities of DTZ and three metabolites to modulate human CYP 1A2, 1A2, 2E1, 2C9 and 3A4 activities were evaluated in vitro.  DTZ and its N-desmethyl and N,N-didesmethyl metabolites selectively inhibited CYP3A4 activity, whereas O-desmethyl DTZ was not inhibitory.  The IC50 value of DTZ against CYP3A4-mediated testosterone 6β-hydroxylation (substrate concn., 50 μM) was 120 μM.  The N-desmethyl (IC50 = 11 μM) and N,N-didesmethyl (IC50 = 0.6 μM) metabolites were 11 and 200 times, resp., more potent.  From kinetic studies, N-desmethyl DTZ and N,N-didesmethyl DTZ were potent competitive inhibitors of CYP3A4 (Ki = ∼2 and 0.1 μM, resp.).  CYP3A4 inhibition was enhanced when DTZ and N-desmethyl DTZ underwent biotransformation in NADPH-supplemented hepatic microsomes in vitro, supporting the contention that inhibitory metabolites may be generated in situ.  These findings suggest that N-demethylation metabolites of DTZ may contribute to CYP3A4 inhibition in vivo, esp. under conditions in which N-desmethyl DTZ accumulates, such as during prolonged DTZ therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIL8o2n_0Da7Vg90H21EOLACvtfcHk0liWC5SCpNXdZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFyitb0%253D&md5=1b1cb145c6246ca57f1455963adc721c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DButler%26aufirst%3DA.%2BM.%26aulast%3DNadin%26aufirst%3DL.%26aulast%3DMurray%26aufirst%3DM.%26atitle%3DRole%2520of%2520CYP3A4%2520in%2520human%2520hepatic%2520diltiazem%2520N-demethylation%253A%2520inhibition%2520of%2520CYP3A4%2520activity%2520by%2520oxidized%2520diltiazem%2520metabolites%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D282%26spage%3D294%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Fukushima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushimaru, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahara, S.</span><span> </span><span class="NLM_article-title">On the error of the dixon plot for estimating the inhibition constant between enzyme and inhibitor</span> <span class="citation_source-journal">Biochem. Mol. Biol. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1002%2Fbmb.2002.494030020022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Wrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=90-92&author=Y.+Fukushimaauthor=M.+Ushimaruauthor=S.+Takahara&title=On+the+error+of+the+dixon+plot+for+estimating+the+inhibition+constant+between+enzyme+and+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">On the error of the Dixon plot for estimating the inhibition constant between enzyme and inhibitor</span></div><div class="casAuthors">Fukushima, Yoshihiro; Ushimaru, Makoto; Takahara, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Molecular Biology Education</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">90-92</span>CODEN:
                <span class="NLM_cas:coden">BMBECE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8175</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">In textbook treatments of enzyme inhibition kinetics, adjustment of the initial inhibitor concn. for inhibitor bound to enzyme is often neglected.  A specific example is the graphical plots such as the Dixon plot for estn. of an inhibition const., wherein the initial concn. of inhibitor is usually plotted instead of the true inhibitor concn.  Justification for this approxn. should be presented to students because, under certain conditions, it can be inaccurate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0VACMt3YGvbVg90H21EOLACvtfcHk0liWC5SCpNXdZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Wrs7g%253D&md5=139fbc08827730873c2457169958a8f4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fbmb.2002.494030020022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbmb.2002.494030020022%26sid%3Dliteratum%253Aachs%26aulast%3DFukushima%26aufirst%3DY.%26aulast%3DUshimaru%26aufirst%3DM.%26aulast%3DTakahara%26aufirst%3DS.%26atitle%3DOn%2520the%2520error%2520of%2520the%2520dixon%2520plot%2520for%2520estimating%2520the%2520inhibition%2520constant%2520between%2520enzyme%2520and%2520inhibitor%26jtitle%3DBiochem.%2520Mol.%2520Biol.%2520Ed.%26date%3D2002%26volume%3D30%26spage%3D90%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Carter, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leighton-Davies, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, S. J.</span><span> </span><span class="NLM_article-title">Miniaturized receptor binding assays: complications arising from ligand depletion</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1177%2F1087057106297788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=17259589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=255-266&author=C.+M.+Carterauthor=J.+R.+Leighton-Daviesauthor=S.+J.+Charlton&title=Miniaturized+receptor+binding+assays%3A+complications+arising+from+ligand+depletion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Miniaturized receptor binding assays: complications arising from ligand depletion</span></div><div class="casAuthors">Carter, Clare M. Scaramellini; Leighton-Davies, Juliet R.; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-266</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The advent of miniaturized assay formats has made possible the screening of large nos. of compds. against a single target, known as high-throughput screening.  Despite this clear advantage, assay miniaturization also increases the risk of ligand depletion, where the actual concn. of free ligand is significantly lower than that added.  This, in turn, complicates the interpretation of data from such assays, potentially introducing significant error if not recognized.  In this study, the effects of reducing assay vol. on radioligand Kd and competitor Ki values have been investigated, using the muscarinic M3 receptor as a model system.  It was found that assay miniaturization caused dramatic effects, with up to a 30-fold underestimation of ligand affinity.  A theor. model was developed and shown to accurately predict both the degree of ligand depletion in any given assay vol. and the effect of this depletion on affinity ests. for competing ligands.  Importantly, it was found that in most cases, errors introduced by ligand depletion could be largely cor. for by the use of appropriate anal. methods.  In addn. to those previously described by others, the authors propose a simple method capable of correcting errors in competition binding expts. performed in conditions of ligand depletion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGKpq8YM5oA7Vg90H21EOLACvtfcHk0liR5DAN7oCY_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFOhtb8%253D&md5=b198ce18b79c32cb5fccc20ebd54296e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1177%2F1087057106297788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057106297788%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DC.%2BM.%26aulast%3DLeighton-Davies%26aufirst%3DJ.%2BR.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DMiniaturized%2520receptor%2520binding%2520assays%253A%2520complications%2520arising%2520from%2520ligand%2520depletion%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2007%26volume%3D12%26spage%3D255%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lewis, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lake, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickins, M.</span><span> </span><span class="NLM_article-title">Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1080%2F14756360600703313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=17059170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=385-389&author=D.+F.+Lewisauthor=B.+G.+Lakeauthor=Y.+Itoauthor=M.+Dickins&title=Lipophilicity+relationships+in+inhibitors+of+CYP2C9+and+CYP2C19+enzymes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes</span></div><div class="casAuthors">Lewis, David F. V.; Lake, Brian G.; Ito, Yuko; Dickins, Maurice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">385-389</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Quant. structure-activity relationships (QSARs) within a series of cytochrome P 450 2C9 (CYP2C9) and cytochrome P 450 2C19 (CYP2C19) inhibitors are reported.  In particular, it is noted that compd. lipophilicity, in the form of log P values (where P is the octanol/water partition coeff.), is an important factor in explaining the variation in inhibitory potency within these series of compds., many of which also act as substrates for the resp. enzymes.  In addn., there is a role for hydrogen bonding and π-π stacking interactions within the P 450 active site which represent secondary factors in the binding processes of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNFMf7Q5FnTrVg90H21EOLACvtfcHk0liR5DAN7oCY_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqsLbP&md5=39391ac9ab130651bc962437d49489a9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1080%2F14756360600703313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360600703313%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BF.%26aulast%3DLake%26aufirst%3DB.%2BG.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DDickins%26aufirst%3DM.%26atitle%3DLipophilicity%2520relationships%2520in%2520inhibitors%2520of%2520CYP2C9%2520and%2520CYP2C19%2520enzymes%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2006%26volume%3D21%26spage%3D385%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kneller, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trager, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettie, A. E.</span><span> </span><span class="NLM_article-title">Active-site characteristics of CYP2C19 and CYP2C9 probed with hydantoin and barbiturate inhibitors</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">429</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2004&pages=1-15&author=H.+Suzukiauthor=M.+B.+Knellerauthor=D.+A.+Rockauthor=J.+P.+Jonesauthor=W.+F.+Tragerauthor=A.+E.+Rettie&title=Active-site+characteristics+of+CYP2C19+and+CYP2C9+probed+with+hydantoin+and+barbiturate+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DKneller%26aufirst%3DM.%2BB.%26aulast%3DRock%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26aulast%3DTrager%26aufirst%3DW.%2BF.%26aulast%3DRettie%26aufirst%3DA.%2BE.%26atitle%3DActive-site%2520characteristics%2520of%2520CYP2C19%2520and%2520CYP2C9%2520probed%2520with%2520hydantoin%2520and%2520barbiturate%2520inhibitors%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2004%26volume%3D429%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Three and four dimensional-quantitative structure–activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span> <span class="citation_source-journal">Pharmacogenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=10780267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=477-489&author=S.+Ekinsauthor=G.+Braviauthor=S.+Binkleyauthor=J.+S.+Gillespieauthor=B.+J.+Ringauthor=J.+H.+Wikelauthor=S.+A.+Wrighton&title=Three+and+four+dimensional-quantitative+structure%E2%80%93activity+relationship+%283D%2F4D-QSAR%29+analyses+of+CYP2D6+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span></div><div class="casAuthors">Ekins, Sean; Bravi, Gianpaolo; Binkley, Shelly; Gillespie, Jennifer S.; Ring, Barbara J.; Wikel, James H.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-489</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Three- and four-dimensional quant. structure activity relationship (3D/4D-QSAR) pharmacophore models of competitive inhibitors of CYP2D6 were constructed using data from our lab. or the literature.  The 3D-QSAR pharmacophore models of the common structural features of CYP2D6 inhibitors were built using the program Catalyst (Mol. Simulations, San Diego, CA, USA).  These 3D-QSAR models were compared with 3D and 4D-QSAR partial least squares (PLS) models which were constructed using mol. surface-weighted holistic invariant mol. (MS-WHIM) descriptors of size and shape of inhibitors.  The first Catalyst model was generated from multiple conformers of competitive inhibitors (n = 20) of CYP2D6 mediated bufurolol 1'-hydroxylation.  This model demonstrated a correlation of obsd. and predicted Ki (apparent) values of r = 0.75.  A second Catalyst model was constructed from literature derived Ki (apparent) values (n = 31) for the inhibition of CYP2D6.  This model provided a correlation of obsd. and predicted inhibition for CYP2D6 of r = 0.91.  Both Catalyst Ki pharmacophores were then validated by predicting the Ki (apparent) of a test set of known CYP2D6 inhibitors (n = 15).  Ten out of 15 of these Ki (apparent) values were predicted to be within one log residual of the obsd. value using our CYP2D6 inhibitor model, while the literature model predicted nine out of 15 values.  Similarly, 3D- and 4D-QSARs derived from PLS MS-WHIM for our dataset yielded predictable models as assessed using cross-validation.  The corresponding cross-validated PLS MS-WHIM model for the literature dataset yielded a comparable 3D-QSAR and improved 4D-QSAR value.  Such computational models will aid in future prediction of drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcRiE7XUQvY7Vg90H21EOLACvtfcHk0liR5DAN7oCY_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D&md5=b714320963218c19c858e31376b9b528</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DBravi%26aufirst%3DG.%26aulast%3DBinkley%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BS.%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DWikel%26aufirst%3DJ.%2BH.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThree%2520and%2520four%2520dimensional-quantitative%2520structure%25E2%2580%2593activity%2520relationship%2520%25283D%252F4D-QSAR%2529%2520analyses%2520of%2520CYP2D6%2520inhibitors%26jtitle%3DPharmacogenetics%26date%3D1999%26volume%3D9%26spage%3D477%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Three- and four-dimensional quantitative structure–activity relationship analyses of cytochrome P-450 3A4 inhibitors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=10381809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADyaK1MXktFKit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1999&pages=429-438&author=S.+Ekinsauthor=G.+Braviauthor=S.+Binkleyauthor=J.+S.+Gillespieauthor=B.+J.+Ringauthor=J.+H.+Wikelauthor=S.+A.+Wrighton&title=Three-+and+four-dimensional+quantitative+structure%E2%80%93activity+relationship+analyses+of+cytochrome+P-450+3A4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors</span></div><div class="casAuthors">Ekins, Sean; Bravi, Gianpaolo; Binkley, Shelly; Gillespie, Jennifer S.; Ring, Barbara J.; Wikel, James H.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">429-438</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The program Catalyst was used to build three-dimensional quant. structure activity relationship (3D-QSAR) pharmacophore models of the structural features common to competitive-type inhibitors of cytochrome P 450 (CYP) 3A4.  These were compared with 3D- and four-dimensional (4D)-QSAR partial least-squares (PLS) models built using mol. surface-weighted holistic invariant mol. (MS-WHIM) descriptors for size and shape of the inhibitor.  The Catalyst pharmacophore model generated from multiple conformers of competitive inhibitors of CYP3A4-mediated midazolam 1'-hydroxylation (n = 14) yielded a high correlation of obsd. and predicted Ki values of r = 0.91.  Similarly, PLS MS-WHIM was used to produce 3D- and 4D-QSARs for this data set and produced models that were statistically predictable after cross-validation.  Two addnl. Catalyst pharmacophores were constructed from literature Ki values (n = 32) derived from the inhibition of CYP3A-mediated cyclosporin A metab. and IC50 data (n = 22) from the inhibition of CYP3A4-mediated quinine 3-hydroxylation.  These Catalyst pharmacophores illustrated correlations of obsd. and predicted inhibition for CYP3A4 of r = 0.77 and 0.92, resp.  The corresponding 4D-QSARs generated by PLS MS-WHIM for these data sets were of comparable quality as judged by cross-validation.  Both Ki pharmacophores generated with Catalyst were also validated by predicting the Ki(apparent) values of a test set of eight CYP3A4 inhibitors not included in either model.  In seven of eight cases, the residuals of the predicted Ki(apparent) values were within 1 log unit of the obsd. values.  The 3D- and 4D-QSAR models produced in this study suggest the utility of future in silico prediction of CYP3A4-mediated drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNq8OnkSOfqbVg90H21EOLACvtfcHk0li9c2Tb43PJLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFKit7s%253D&md5=3b298a468a1544616bffad2cf5f1344a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DBravi%26aufirst%3DG.%26aulast%3DBinkley%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BS.%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DWikel%26aufirst%3DJ.%2BH.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThree-%2520and%2520four-dimensional%2520quantitative%2520structure%25E2%2580%2593activity%2520relationship%2520analyses%2520of%2520cytochrome%2520P-450%25203A4%2520inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D290%26spage%3D429%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">Pharmacophore and three-dimensional quantitative structure–activity relationship methods for modeling cytochrome p450 active sites</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=936-944&author=S.+Ekinsauthor=M.+J.+de+Grootauthor=J.+P.+Jones&title=Pharmacophore+and+three-dimensional+quantitative+structure%E2%80%93activity+relationship+methods+for+modeling+cytochrome+p450+active+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DPharmacophore%2520and%2520three-dimensional%2520quantitative%2520structure%25E2%2580%2593activity%2520relationship%2520methods%2520for%2520modeling%2520cytochrome%2520p450%2520active%2520sites%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2001%26volume%3D29%26spage%3D936%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Sciabola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morao, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M. J.</span><span> </span><span class="NLM_article-title">Pharmacophoric fingerprint method (TOPP) for 3D-QSAR modeling: application to CYP2D6 metabolic stability</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci060143q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2it7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=76-84&author=S.+Sciabolaauthor=I.+Moraoauthor=M.+J.+de+Groot&title=Pharmacophoric+fingerprint+method+%28TOPP%29+for+3D-QSAR+modeling%3A+application+to+CYP2D6+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophoric Fingerprint Method (TOPP) for 3D-QSAR Modeling: Application to CYP2D6 Metabolic Stability</span></div><div class="casAuthors">Sciabola, Simone; Morao, Inaki; de Groot, Marcel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-84</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The application of a new 3-point pharmacophore-fingerprinting package (TOPP, Triplets Of Pharmacophoric Points) to develop QSAR models is discussed.  In the CYP2D6 metabolic stability case, these 3D pharmacophoric fingerprints have shown to be as valid as other 3D descriptors and 2D features.  Interestingly, it was found in the 3D models that the use of more realistic substrate conformations, by an addnl. docking step, did not improve the statistical results significantly.  A detailed anal. of the generated pharmacophoric hypotheses is consistent with the previously proposed dual interaction mode of substrates within the active site of CYP2D6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZRgg9XUktNbVg90H21EOLACvtfcHk0li9c2Tb43PJLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2it7fP&md5=5e15dc4e7bd371ca4b7e92dc32cec393</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fci060143q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci060143q%26sid%3Dliteratum%253Aachs%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DMorao%26aufirst%3DI.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26atitle%3DPharmacophoric%2520fingerprint%2520method%2520%2528TOPP%2529%2520for%25203D-QSAR%2520modeling%253A%2520application%2520to%2520CYP2D6%2520metabolic%2520stability%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D76%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leydon, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxbrow, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenery, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. M.</span><span> </span><span class="NLM_article-title">Crystal structure of human cytochrome P450 2D6</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7614</span><span class="NLM_x">–</span> <span class="NLM_lpage">7622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1074%2Fjbc.M511232200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=16352597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ygtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7614-7622&author=P.+Rowlandauthor=F.+E.+Blaneyauthor=M.+G.+Smythauthor=J.+J.+Jonesauthor=V.+R.+Leydonauthor=A.+K.+Oxbrowauthor=C.+J.+Lewisauthor=M.+G.+Tennantauthor=S.+Modiauthor=D.+S.+Egglestonauthor=R.+J.+Cheneryauthor=A.+M.+Bridges&title=Crystal+structure+of+human+cytochrome+P450+2D6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human cytochrome P 450 2D6</span></div><div class="casAuthors">Rowland, Paul; Blaney, Frank E.; Smyth, Martin G.; Jones, Jo J.; Leydon, Vaughan R.; Oxbrow, Amanda K.; Lewis, Ceri J.; Tennant, Mike G.; Modi, Sandeep; Eggleston, Drake S.; Chenery, Richard J.; Bridges, Angela M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7614-7622</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cytochrome P 450 2D6 is a heme-contg. enzyme that is responsible for the metab. of at least 20% of known drugs.  Substrates of 2D6 typically contain a basic N atom and a planar arom. ring.  Here, the crystal structure of human 2D6 was solved and refined to 3.0Å resoln.  The structure showed the characteristic P 450 fold as seen in other members of the family, with the lengths and orientations of the individual secondary structural elements being very similar to those seen in 2C9.  There were, however, several important differences, the most notable involving the F helix, the F-G loop, the B' helix, β-sheet 4, and part of β-sheet 1, all of which were situated on the distal face of the protein.  The 2D6 structure had a well-defined active site cavity above the heme group, contg. many important residues that have been implicated in substrate recognition and binding, including Asp-301, Glu-216, Phe-483, and Phe-120.  The crystal structure helped to explain how Asp-301, Glu-216, and Phe-483 could act as substrate-binding residues and suggested that the role of Phe-120 is to control the orientation of the arom. ring found in most substrates with respect to the heme.  The structure was compared with published homol. models and has been used to explain much of the reported site-directed mutagenesis data and to help understand the metab. of several compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon7FdjHI2WD7Vg90H21EOLACvtfcHk0li9c2Tb43PJLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ygtbg%253D&md5=f31403bf56fadab86a694b1add06859c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M511232200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M511232200%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DSmyth%26aufirst%3DM.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BJ.%26aulast%3DLeydon%26aufirst%3DV.%2BR.%26aulast%3DOxbrow%26aufirst%3DA.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DChenery%26aufirst%3DR.%2BJ.%26aulast%3DBridges%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520human%2520cytochrome%2520P450%25202D6%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7614%26epage%3D7622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Schoch, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span> </span><span class="NLM_article-title">Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">9497</span><span class="NLM_x">–</span> <span class="NLM_lpage">9503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1074%2Fjbc.M312516200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=14676196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Omt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=9497-9503&author=G.+A.+Schochauthor=J.+K.+Yanoauthor=M.+R.+Westerauthor=K.+J.+Griffinauthor=C.+D.+Stoutauthor=E.+F.+Johnson&title=Structure+of+human+microsomal+cytochrome+P450+2C8.+Evidence+for+a+peripheral+fatty+acid+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Human Microsomal Cytochrome P450 2C8: evidence for a peripheral fatty acid binding site</span></div><div class="casAuthors">Schoch, Guillaume A.; Yano, Jason K.; Wester, Michael R.; Griffin, Keith J.; Stout, C. David; Johnson, Eric F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">9497-9503</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A 2.7-Å mol. structure of human microsomal cytochrome P 450 2C8 (CYP2C8) was detd. by x-ray crystallog.  The membrane protein was modified for crystn. by replacement of the hydrophobic N-terminal transmembrane domain with a short hydrophilic sequence before residue 28.  The structure of the native sequence is complete from residue 28 to the beginning of a C-terminal histidine tag used for purifn.  CYP2C8 is one of the principal hepatic drug-metabolizing enzymes that oxidizes therapeutic drugs such as taxol and cerivastatin and endobiotics such as retinoic acid and arachidonic acid.  Consistent with the relatively large size of its preferred substrates, the active site vol. is twice that obsd. for the structure of CYP2C5.  The extended active site cavity is bounded by the β1 sheet and helix F' that have not previously been implicated in substrate recognition by mammalian P450s.  CYP2C8 crystd. as a sym. dimer formed by the interaction of helixes F, F', G', and G.  Two mols. of palmitic acid are bound in the dimer interface.  The dimer is obsd. in soln., and mass spectrometry confirmed the assocn. of palmitic acid with the enzyme.  This novel finding identifies a peripheral binding site in P450s that may contribute to drug-drug interactions in P 450 metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM_mLgb6K1XrVg90H21EOLACvtfcHk0lgX9S5ULFCbcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Omt78%253D&md5=433aca9f612b396ff3cc6f30291200a2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M312516200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M312516200%26sid%3Dliteratum%253Aachs%26aulast%3DSchoch%26aufirst%3DG.%2BA.%26aulast%3DYano%26aufirst%3DJ.%2BK.%26aulast%3DWester%26aufirst%3DM.%2BR.%26aulast%3DGriffin%26aufirst%3DK.%2BJ.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26atitle%3DStructure%2520of%2520human%2520microsomal%2520cytochrome%2520P450%25202C8.%2520Evidence%2520for%2520a%2520peripheral%2520fatty%2520acid%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D9497%26epage%3D9503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Wester, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span> </span><span class="NLM_article-title">The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">35630</span><span class="NLM_x">–</span> <span class="NLM_lpage">35637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=35630-35637&author=M.+R.+Westerauthor=J.+K.+Yanoauthor=G.+A.+Schochauthor=C.+Yangauthor=K.+J.+Griffinauthor=C.+D.+Stoutauthor=E.+F.+Johnson&title=The+structure+of+human+cytochrome+P450+2C9+complexed+with+flurbiprofen+at+2.0-A+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWester%26aufirst%3DM.%2BR.%26aulast%3DYano%26aufirst%3DJ.%2BK.%26aulast%3DSchoch%26aufirst%3DG.%2BA.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DGriffin%26aufirst%3DK.%2BJ.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26atitle%3DThe%2520structure%2520of%2520human%2520cytochrome%2520P450%25202C9%2520complexed%2520with%2520flurbiprofen%2520at%25202.0-A%2520resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D35630%26epage%3D35637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Williams, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angove, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matak Vinkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Crystal structure of human cytochrome P450 2C9 with bound warfarin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">424</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1038%2Fnature01862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=12861225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1aqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2003&pages=464-468&author=P.+A.+Williamsauthor=J.+Cosmeauthor=A.+Wardauthor=H.+C.+Angoveauthor=D.+Matak+Vinkovicauthor=H.+Jhoti&title=Crystal+structure+of+human+cytochrome+P450+2C9+with+bound+warfarin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human cytochrome P450 2C9 with bound warfarin</span></div><div class="casAuthors">Williams, Pamela A.; Cosme, Jose; Ward, Alison; Angove, Hayley C.; Vinkovic, Dijana Matak; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">424</span>
        (<span class="NLM_cas:issue">6947</span>),
    <span class="NLM_cas:pages">464-468</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cytochrome P 450 proteins (CYP450s) are membrane-assocd. heme proteins that metabolize physiol. important compds. in many species of microorganisms, plants and animals.  Mammalian CYP450s recognize and metabolize diverse xenobiotics such as drug mols., environmental compds. and pollutants.  Human CYP450 proteins CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 are the major drug-metabolizing isoforms, and contribute to the oxidative metab. of more than 90% of the drugs in current clin. use.  Polymorphic variants have also been reported for some CYP450 isoforms, which has implications for the efficacy of drugs in individuals, and for the co-administration of drugs.  The mol. basis of drug recognition by human CYP450s, however, has remained elusive.  Here the authors describe the crystal structure of a human CYP450, CYP2C9, both unliganded and in complex with the anti-coagulant drug warfarin.  The structure defines unanticipated interactions between CYP2C9 and warfarin, and reveals a new binding pocket.  The binding mode of warfarin suggests that CYP2C9 may undergo an allosteric mechanism during its function.  The newly discovered binding pocket also suggests that CYP2C9 may simultaneously accommodate multiple ligands during its biol. function, and provides a possible mol. basis for understanding complex drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogGWLKcJNO47Vg90H21EOLACvtfcHk0lgX9S5ULFCbcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1aqtrk%253D&md5=f5bcc91bd3c7c1332506f7671a09da6f</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature01862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01862%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DCosme%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DA.%26aulast%3DAngove%26aufirst%3DH.%2BC.%26aulast%3DMatak%2BVinkovic%26aufirst%3DD.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520human%2520cytochrome%2520P450%25202C9%2520with%2520bound%2520warfarin%26jtitle%3DNature%26date%3D2003%26volume%3D424%26spage%3D464%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Yano, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span> </span><span class="NLM_article-title">The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">38091</span><span class="NLM_x">–</span> <span class="NLM_lpage">38094</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm201346g&amp;key=10.1074%2Fjbc.C400293200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm201346g&amp;key=15258162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm201346g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1Oqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=38091-38094&author=J.+K.+Yanoauthor=M.+R.+Westerauthor=G.+A.+Schochauthor=K.+J.+Griffinauthor=C.+D.+Stoutauthor=E.+F.+Johnson&title=The+structure+of+human+microsomal+cytochrome+P450+3A4+determined+by+X-ray+crystallography+to+2.05-A+resolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution</span></div><div class="casAuthors">Yano, Jason K.; Wester, Michael R.; Schoch, Guillaume A.; Griffin, Keith J.; Stout, C. David; Johnson, Eric F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">38091-38094</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The structure of P 450 3A4 was detd. by x-ray crystallog. to 2.05-Å resoln.  P 450 3A4 catalyzes the metabolic clearance of a large no. of clin. used drugs, and a no. of adverse drug-drug interactions reflect the inhibition or induction of the enzyme.  P 450 3A4 exhibits a relatively large substrate-binding cavity that is consistent with its capacity to oxidize bulky substrates such as cyclosporin, statins, taxanes, and macrolide antibiotics.  Family 3A P450s also exhibit unusual kinetic characteristics that suggest simultaneous occupancy by smaller substrates.  Although the active site vol. is similar to that of P 450 2C8 (PDB code: 1PQ2), the shape of the active site cavity differs considerably due to differences in the folding and packing of portions of the protein that form the cavity.  Compared with P 450 2C8, the active site cavity of 3A4 is much larger near the heme iron.  The lower constraints on the motions of small substrates near the site of oxygen activation may diminish the efficiency of substrate oxidn., which may in turn be improved by space restrictions imposed by the presence of a second substrate mol.  The structure of P 450 3A4 should facilitate a better understanding of the substrate selectivity of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpOI8NmLt-drVg90H21EOLACvtfcHk0lgX9S5ULFCbcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1Oqs7c%253D&md5=59a8fa760069d365165ddeeb9e4081d4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C400293200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C400293200%26sid%3Dliteratum%253Aachs%26aulast%3DYano%26aufirst%3DJ.%2BK.%26aulast%3DWester%26aufirst%3DM.%2BR.%26aulast%3DSchoch%26aufirst%3DG.%2BA.%26aulast%3DGriffin%26aufirst%3DK.%2BJ.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26atitle%3DThe%2520structure%2520of%2520human%2520microsomal%2520cytochrome%2520P450%25203A4%2520determined%2520by%2520X-ray%2520crystallography%2520to%25202.05-A%2520resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D38091%26epage%3D38094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R9O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R9O','PDB','1R9O'); return false;">PDB: 1R9O</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=CAH73444.1" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=CAH73444.1','Genbank','CAH73444.1'); return false;">Genbank: CAH73444.1</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201346g&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm201346g%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-3%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201346g" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a4455923234a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
